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Introduction 
Incisional hernia is by far the most common complication after laparotomies, 
occurring in 10 – 20%,1, 2 being twice as often as bowel obstruction, the second most 
frequent complication.3 Its occurrence is secondary to insufficient healing of the 
postoperative scar, resulting in wound dehiscence and protrusion of abdominal 
contents through an opening in the musculo-fascial layer of the abdominal wall. The 
mainstay of treatment for small and simple incisional hernias is the placement non-
absorbable synthetic mesh to bridge the defect (Chapter 2), the focus of most 
literature. 
In more complex cases of incisional hernia, the modes of treatment are more elaborate 
and patient-tailored, as synthetic bridging usually does not suffice. In this thesis we 
focused on “complex” abdominal wall hernias for which optimal approach is yet to be 
defined. “Complex” abdominal wall hernias are often referred to in the literature, 
although a clear definition is lacking. These complex cases mostly occur after 
abdominal catastrophes such as anastomotic leakage, generalized peritonitis, 
necrotizing fasciitis and tumor resection. In Chapter 3 an attempt is made to define and 
classify complex abdominal wall hernias by using hernia and patient characteristics 
that have important consequences for treatment and prognosis.  
Parastomal hernia is a unique kind of incisional hernia in which the defect arises in the 
scar between the bowel en the edge of the abdominal wall through which the ostomy 
exists, involving a potentially contaminated environment. Chapters 4 and 5 focus on 
the best treatment options for parastomal hernias. From follow-up study we know that 
the Sugarbaker mesh technique is a safe method of repair with a low-recurrence rate.4 
However, in cases of complex abdominal wall defects, the parastomal hernia repair is 
often performed in infected environment with the potential for deleterious mesh-
related infectious complications. Biologic meshes have been introduced to overcome 
the drawbacks associated with non-absorbable synthetic mesh. They are made of 
acellular collagen matrices derived from human or animal tissue. Claims are made that 
they are less infection-prone due to their bio-degradable nature. Therefore, we did a 
systematic review to explore the results of hernia repair with biologic prosthetic 
materials as an alternative to synthetic meshes (Chapters 5 and 9).  
Chapters 6 and 7 focus on repair of extremely large abdominal wall defects. These 
present a unique challenge since synthetic prosthetic bridging is not sufficient as it 
leaves a significant surface of the abdominal wall void of the myofascial contracting 
apparatus, allowing less dynamic support. The Component Separation Technique 
popularized by Ramirez et al. is an autologous method of repair that has proved to be 
valid, allowing for dynamic closure of defects measuring up to 20 – 30 cm at 
waistline.5 However, the Component Separation Technique coincides with a high 
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recurrence rate when rigorous follow-up is applied (Chapter 6), and synthetic mesh 
should probably be utilized in combination as this is safe even under selected 
contaminated conditions (Chapter 7).6 An extremely complex group of patients are 
those presenting with large abdominal wall defects with enterocutaneous fistulas, an 
abnormal connection between bowel and skin. Traditionally these patients were treated 
with a multi-staged strategy involving multiple procedures with their coinciding risks. 
Chapter 8 presents our one-stage repair treatment strategy involving the Component 
Separation Technique with synthetic mesh on-demand. 
 
Aim 
The aim of the present thesis was to determine the results of various modes of repair 
for complex incisional abdominal wall hernias. This is achieved by analysis of the 
available literature, and by studying patients with complex abdominal wall defects 
operated on in the Radboud university medical center.  
 
Outline 
In Chapter 2 a summary is given regarding the causes, mechanisms, risk factors, 
treatment options and prevention of abdominal wall hernias. In Chapter 3 the product 
of an international effort is presented in which criteria are laid down with which the 
“complex” abdominal wall hernia (patient) can be described. Chapters 4 and 5 explore 
and compare the various surgical techniques for parastomal hernia repair including 
synthetic and biologic mesh use. Chapters 6 through 8 present our results of repair of 
various large and complex abdominal wall defects, focusing around the Component 
Separation Technique with and without synthetic mesh utilization. Chapter 9 reviews 
the use of biologic mesh for repair of contaminated ventral hernia repair. In Chapter 
10 a summary of the thesis is presented, alongside a general discussion and 
recommendations. Chapter 11 provides a Dutch translation of the summary. 
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Abstract 
The prevention and treatment of wound dehiscence and incisional hernia is a constant 
challenge to surgeons and other specialists operating in the abdomen. This paper 
discusses the risk factors and proposed mechanisms of pathophysiology of wound 
dehiscence and incisional hernia, followed by a discussion of the evidence regarding 
the best surgical technique of incision and closure of the abdomen in open surgery 
with focus on prevention of dehiscence and hernia. Lastly, the principles of 
management when faced with wound dehiscence and incisional hernia are addressed 
along with the treatment algorithm used at our institution. The focus of this paper is on 
median incisions and ventral median incisional hernia repair, being most common and 
extensively studied in the literature. 
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Definition 
Abdominal wound dehiscence is defined as separation of the abdominal fascia after 
surgery, complete or partial, without complete cutaneous healing and with or without 
protrusion of bowel contents outside the abdominal cavity. An incisional hernia is 
defined as any abdominal wall opening in the area of a postoperative scar, with or 
without a bulge, evident by clinical examination or imaging. 
 
Incidence 
Wound dehiscence occurs in 0.4-1.2% of patients after elective laparotomy, while 
rates up to 12% are observed after emergency procedures. The consistency of its 
prevalence over the past century despite improved surgical technique is attributed to 
the counterweight of an increasingly morbid population that undergoes surgery 
nowadays. The associated mortality rate is high, lying somewhere between 15 and 
35%. Wound dehiscence shows a mean presentation around postoperative day 9. 
Incisional hernia occurs in 10-20% of patients after laparotomy. Repair of incisional 
hernia results in recurrence rates of 23.5% for first time repairs and 34.8% for 
recurring hernias after 5 years follow-up.7 Even beyond 5 years incisional hernias tend 
to occur at a steady rate well up to 10 years after operation.8 
 
Diagnosis 
The diagnosis of wound dehiscence is based on clinical signs and is not easy to make 
as it generally coincides with superficial tissue disruption and infection. Blood-tinged 
peritoneal exudate may seep through the intact superficial tissue layer. Exaggerated 
abdominal pain and tenderness, and unexplained vomiting are also indicative of wound 
dehiscence. Radiographic imaging may be aptly performed to confirm suspicion. In 
contrast to wound dehiscence, the majority of incisional hernias are asymptomatic. 
However, a hernia may grow larger and become debilitating. Patients may also 
experience poor body image. Incarceration and strangulation are potential 
complications necessitating emergency surgery to prevent ischemia, necrosis, and 
ultimately perforation of the afflicted bowel. Diagnosis of incisional hernia can usually 
be made at physical examination while the patient is standing, in which position the 
hernia often becomes evident. However, clinical diagnosis remains a challenge in 
small asymptomatic hernias and in obese patients, resulting in many missed diagnoses. 
Computed tomography (CT) is considered the gold standard and is very accurate in 
defining the defect, and providing information on the musculofascial quality and on 
viscera outside the abdominal cavity.  
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Mechanisms and risk factors of wound dehiscence and incisional hernia 
Stages of wound healing  
Fundamentally, the wound proceeds through three stages of healing, namely, the 
inflammatory stage, the regenerative (or proliferative) stage, and the remodeling (or 
maturation) stage.  
The inflammatory stage commences directly after the disruption of tissue (e.g. after 
incision) and generally lasts for about four days. Vasodilatation and angiogenesis take 
place, and proteinglycanes from mast cells form a gel matrix for deposition of collagen 
later on (in the regenerative stage). Macrophages are recruited and clear the 
environment of bacteria and debris, but most importantly recruit fibroblasts for the 
later stages. The presence of polymorphonuclear leukocytes is of relevance for the 
surgeon. They accomplish phagocytosis of debris partly by proteinases, which 
essentially weaken the tensile strength of the tissue. The area in which these 
proteolytic enzymes are active normally varies up to 5 mm on either side of the 
wound, but this can increase up to 1 cm in the presence of infection.  
The regenerative stage (or proliferative stage) is characterized by movement of 
fibroblasts into the wound area, synthesis of collagen and contraction of the wound, 
and lasts for about 3 weeks. At the end of this stage, almost all new collagen has been 
formed in the wound. Tensile strength, albeit increased relatively quickly due to the 
newly formed collagen matrix, is still not sufficient due to the lack of cross-linking 
between collagen molecules. 
During the final and remodeling stage which may last for years, the new collagen 
matrix undergoes qualitative changes brought on by mechanical environmental forces, 
resulting in optimal alignment of fibres to withstand these pressures. Crosslinking, in 
which inter-molecular covalent bonds are formed within the collagen matrix, is 
responsible for the continued increase in tensile strength.  
 
Malnutrition 
Besides adequate intake of carbohydrates, protein, and fat, it has been shown that 
vitamins A, B complex and C, the micronutrients copper, zinc and iron, and certain 
essential amino acids are involved in one or more stages of the wound healing cascade, 
and deficiencies hereof can cause poor and delayed healing. Interestingly, creating an 
adequate preoperative nutritional state is more important (and susceptible to 
20 
 
intervention) to successful wound-healing than the overall nutritional status of the 
patient, and proper preoperative assessment is essential.   
 
Risk factors and mechanisms of wound dehiscence and incisional hernia 
It is a widely held concept that dehiscence is primarily a result of erroneous surgical 
technique. Indeed, during the first stage of wound healing the laparotomy wound has 
practically no strength, relying completely on the sutures to hold it together. 
Documentation of the mechanisms of wound dehiscence after major abdominal 
surgery indicates most cases are caused by tearing of sutures through the fascia, 
followed by infection, broken suture, fascial necrosis, and loose knots.9 Factors 
associated with surgical technique are discussed in the How to sections. 
Patient-related risk factors for wound dehiscence are: age, male gender, chronic 
pulmonary disease, coughing, ascites, jaundice, anaemia, emergency surgery, wound 
infection, obesity, steroid use, hypoalbuminaemia, hypertension, perioperative shock, 
and type of surgery.10 Vascular procedures and surgery of the large bowel and 
oesophagus are associated with increased risk of wound dehiscence, whereas surgery 
of the small bowel and gallbladder/bile duct result in less wound dehiscence.9 
The mechanism of incisional hernia recurrence is most often infection, or inadequate 
fixation or overlap of prosthesis. Although incisional hernia mainly occurs in the 
remodeling stage or even after healing has taken place, hernia formation may be 
attributable to improper healing in the inflammatory and regenerative stages. Indeed, 
risk factors involved in wound dehiscence are also related to incisional hernia, and 
wound dehiscence is itself a strong predictor of incisional hernia.11 Specifically, 
patient-related factors associated with incisional hernia development are mainly 
obesity, chronic lung disease, wound infection and age. Interestingly, recurrent hernia 
is a risk factor for future incisional hernias, implying that these patients suffer a 
common underlying dysfunction in wound-healing that predisposes to hernia 
formation.8 
 
Collagen metabolism and incisional hernia 
There are many types of collagen, of which type I and type III are important in 
incisional hernia. Type I collagen is responsible for strong tensile properties, whereas 
type III collagen is thinner and more flexible, and is considered an immature variant in 
connective tissue, as it is expressed early on in the healing process later replaced by 
type I. A decreased collagen type I/type III ratio results in altered arrangement and 
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smaller diameter of collagen fibrils, and a decreased amount of cross-linking, overall 
reducing the mechanical stability of the connective tissue. A decreased type I/type III 
ratio has been observed in patients with incisional hernia,12 suggesting a causative role 
for abnormal collagen metabolism.  
Inordinate extracellular matrix degradation is probably involved in the derangement of 
the collagen ratios. Important enzymes in this collagenolytic process are matrix 
metalloproteinases (MMPs). A decreased expression of at least one MMP subtype has 
been linked to incisional hernia development. However, it remains unclear whether 
responses set in motion due to hernia development cause deviant MMP expression, or 
if a genetic predisposition for abnormal MMP expression itself induces the hernia 
formation. Interestingly, different mesh materials appear to induce varying degrees of 
fibroblast MMP expression in patients with recurrent incisional hernia, allowing for 
new possibilities in prosthetics development.13 
Genetic disorders of connective tissue have also been linked to incisional or other 
types of hernia, including Ehlers-Danlos, Marfans syndrome, autosomal dominant 
polycystic kidney disease, osteogenesis imperfect and congenital dislocation of the 
hip. Similarly, increased incisional hernia rates in patients treated for abdominal aortic 
aneurysm are possibly related to an underlying disorder in collagen metabolism 
pathogenic for both ailments. These observations support an important biological role 
(genetic or acquired) in the pathogenesis of incisional hernia. 
 
How to open the abdomen 
Consensus on the superior type of incision regarding early postoperative wound 
complications and development of incisional hernia has remained elusive for a long 
time and subject of debate. A recently updated Cochrane review of randomized 
controlled trials comparing midline and transverse incisions revealed a trend of lower 
wound dehiscence and incisional hernia rates associated with transverse incisions.10 
Even though pulmonary function was significantly less affected after a transverse 
incision, pulmonary complications did not differ between midline and transverse 
incisions. Analgesic requirements were significantly lower with transverse incisions, 
although the studies involved displayed significant heterogeneity. Data on cosmesis 
could not be pooled due to differences in assessment criteria, although the two studies 
that evaluated this aspect both suggested a significant preference for transverse 
incision. No differences were found with regard to recovery time (hospital stay and 
time to return to work) and wound infection.  
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Paramedian incisions were included in a systematic review by Burger et al.14 Three 
randomized clinical trials compared lateral paramedian with midline incisions, with 
significantly increased incisional hernia rates observed after the midline incisions. In 
two other randomized trials the lateral paramedian was proven superior to the medial 
paramedian technique concerning incisional hernia rates. One randomized trial 
compared the medial paramedian with the transverse incision and found no statistical 
difference. Also, no significant differences were found between techniques regarding 
wound dehiscence rates (Figure 1).  
 
 
 
Intuitively, transverse incisions seem the most natural and ‘anatomic’, in which 
dissection through the aponeurotic fibres is done in a parallel fashion, leaving the 
integrity of the contracting apparatus relatively intact. Still, midline incisions are 
preferred while commencing emergency and exploratory procedures to achieve quick 
and complete access to intra-abdominal organs while allowing for easy extension of 
the incision. Patients with bowel disease that might necessitate repeated laparotomies 
are preferably operated on using the midline incision. 
 
 
Figure 1 Overview of 
common types of incision, 
represented by dashed lines. 
a Median incision. b 
Paramedian incision. c 
Lateral paramedian incision. 
d Transverse incision. 
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How to close the abdomen 
Mass closure (all layers taken in each bite) of median laparotomies has been advocated 
for a long time taking big bites. However, new developments suggest other techniques 
might be superior. Although not widely accepted, it has been argued that a suture 
length (SL) to wound length (WL) ratio of at least 4 should be used, as using a lower 
ratio increases incisional hernia formation threefold. In a comparative trial, using large 
stitches with a SL:WL ratio of 4 or even well above yielded several risk factors for 
infection, while the use of small bites with the same SL:WL ratios revealed no such 
risk factors.15 Experimental data show that small bites (0.3-0.6 cm) and a small suture 
distance as opposed to big bites (1.0 cm) with a big suture distance result in a stronger 
wound strength.16 It is found that by stitching the aponeurosis only, and avoiding 
sutures compression and cutting through subcutaneous tissue, muscle, and peritoneum, 
there is less separation of wound edges.17 Layered closure (separate components 
sutured separately) should be abandoned in any case, as it is associated with longer 
operation time and an increased incidence of wound dehiscence compared to mass 
closure.  
Regarding suture material, monofilament suture material is preferred over 
multifilament suture in which bacteria can find a niche between the braided material, 
adhere and grow. Using a continuous technique (vs. interrupted) with slowly 
absorbable (vs. rapid absorbable) suture material results in lower incisional hernia 
rates. 
It is duly acknowledged that employing small bites through the aponeurosis seems to 
conflict with the knowledge that the vulnerable proteolytic area varies up to 0.5 cm 
from the wound edge under normal circumstances. However, being able to apply more 
stitches this way, distributes the tension to a larger number of stitches, thus reducing 
the tension on each stitch. Also, the use of thinner suture material (2-0) produces less 
inflammation and closure of only the aponeurosis prevents tissue compression and 
thus minimizes necrosis and proteolysis. 
Tissue adhesives have been introduced as an alternative to sutures for surgical wound 
closure, but generally take longer to apply and result in more wound dehiscence. 
However, tissue adhesives may be safer and quicker in trocar port-site closure after 
laparoscopy. 
There is current debate as to the safety and efficacy of placing prophylactic mesh at 
the initial operation to prevent future incisional hernias in patients at risk (e.g. the 
morbidly obese, open aortic aneurysm repair). This is currently being investigated in 
various randomized controlled trials. The currently available evidence suggests that 
24 
 
prophylactic mesh prevents incisional hernias in patients undergoing bariatric and 
open aortic aneurysm surgery. However, caution is needed concerning infectious 
complications that may arise after mesh implantation necessitating subsequent mesh 
excision and risking the development of an incisional hernia. 
 
How to treat wound dehiscence 
Wound dehiscence needs an urgent patient-tailored management plan. If the wound 
dehisced secondarily to improper surgical technique (e.g. loose knots) the patient is 
brought straight back to the operating theatre to resuture the wound. In the majority of 
cases, however, there are more severe underlying problems that first need attention 
such as deep wound or intra-abdominal infection and necrosis of the fascia. If there is 
evisceration of abdominal contents, they need to be checked for injury and replaced in 
the abdomen. Infection and necrosis of the fascial edges necessitate liberal 
debridement of afflicted tissue until healthy well-perfused fascia is encountered. If 
possible, primary closure entails using the same technique as normal wound closure 
after laparotomy. Retention sutures are not recommended as they mainly result in 
inconvenience, pain and complications, and do not prevent incisional hernia. Many 
surgeons prefer to leave the skin open in infectious circumstances to prevent wound 
abscess although evidence for this approach is lacking. 
Another cause of wound dehiscence is distended bowel with visceral oedema, in which 
case ‘tension-free’ closure might not be possible. A delayed presentation of fascial 
dehiscence may have caused lateral retraction of the abdominal wall muscles further 
jeopardizing medial fascial advancement. Before closure one has to check for an 
anastomotic leak as the cause of abdominal infection and prolonged ileus. If there is 
inability to close the abdomen, the principles of incisional hernia repair should be 
applied (see below). 
There are several techniques of temporary closure available aiming at delayed closure 
or bridging the period to secondary abdominal wall repair. Negative pressure pumps or 
packs keep pressure on the fascial edges and collect fluid which aid in resolving 
oedema. An artificial burr (Velcro patches), plastic silo, prosthetic mesh (absorbable or 
non-absorbable) or a zipper can be placed to maintain tension on the fascial edges and 
allow for stepwise reapproximation. Loose packing or skin approximation can also be 
applied but do not prevent retraction of the fascia. 
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How to treat incisional hernia 
Except for very small defects (<3 cm, small trocar hernias), direct suture repair of 
incisional hernias results in unacceptably high recurrence rates. There are two main 
categories of ventral median incisional hernia repair; prosthetic mesh repair and 
autologous tissue repair using the components separation technique. 
Mesh repair: the use of synthetic mesh prostheses has become the mainstay of 
treatment for incisional hernia repair showing good short- and long-term results.8 
There are various approaches depending on the anatomic position of the prosthesis 
(Figure 2). Onlay placement requires extensive undermining of subcutaneous tissue 
predisposing for seroma and  haematoma formation, while disrupted skin perforators 
may impair healing. Also, given its anatomic position, intraabdominal forces may 
Figure 1 Schematic drawings of the 
anatomic positions of mesh 
placement in incisional hernia 
repair. Arrows indicate direction of 
dissection. a Onlay mesh is 
subcutaneously placed and fixed 
onto the fascia of the anterior 
rectus sheath. b Inlay mesh is 
placed within the defect as a bridge 
between the two rectus muscles. c 
Pre-peritoneal underlay mesh is 
placed dorsally to the rectus muscle 
and anterior to the posterior rectus 
sheath. d Intraperitoneal mesh is 
placed intra-abdominally on to the 
peritoneum. 
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cause lateral distraction of the prosthesis. Conversely, underlay techniques should 
benefit from these forces which may help keep the graft in place. In contrast to onlay 
positioning, prostheses positioned in an inlay or intraperitoneal underlay fashion will 
more easily come in contact with viscera potentially causing adhesions, erosion and 
fistulization. 
When using the prosthesis as a reinforcement of fascial closure (onlay and underlay 
techniques), an overlap of at least 5 cm must be applied to provide sufficient 
anchorage while taking mesh shrinkage into consideration. Sutures are placed around 
the periphery of the mesh 1-1.5 cm apart. When this is not possible for example in the 
case of a lumbar hernia, the prosthesis can inferiorly be fixated to bone-anchors placed 
on the iliac crest. 
Unfortunately, there is no conclusive evidence pertaining to the best anatomic position 
of the prosthesis. However, when the growing body of evidence of non-comparative 
studies is taken into account, it seems that the underlay and sublay techniques yield the 
most promising results, while inlay positioning of the prosthesis has the highest 
recurrence rates.18 
Most prostheses are made from either polypropylene, expanded polytetrafluorethylene 
(e-PTFE), or polyester. Main differences are the material pore size, pliability, 
suppleness, weight and thickness. A large pore size allows for tissue in-growth and 
adherence to surrounding structures, a property that is desirable for the meshefascia 
interface, but disadvantageous where mesh comes in contact with viscera. For this 
reason composite prostheses have been developed including a large pore size (i.e. 
polypropylene) on the side facing the fascia, with mesh of smaller pore size on the 
visceral side (e-PTFE). It is suggested that there are significant differences in the 
extent of mesh shrinkage between the various prostheses, complications which may 
lead to recurrence and pain. However, experimental studies show great inconsistencies 
with mesh shrinkage in the ranges 3.6-25.4% for polypropylene, 4.0-51.0% for e-
PTFE and 6.1-33.6% for polyester mesh,19 and do not seem to translate very well to 
results in humans. Light-weight meshes in comparison to heavy-weight meshes may 
reduce the ‘stiff abdomen feeling’ and chronic pain. Other developments are meshes 
coated with anti-adhesive barriers at the visceral side preventing adhesion formation to 
the mesh, gentamicin-supplemented mesh aimed at improved tissue integration and 
fibroblast growth-factor treatment aimed at stronger scar formation.  
Recently, biologic grafts have been developed consisting of acellular collagen matrices 
processed from human or animal tissues. They are supposedly degraded and replaced 
by native fibro-collagenous tissue resembling the original tissue (fascia). Due to their 
bio-compatibility they hold potential for ameliorating problems found with synthetic 
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prostheses, notably infection necessitating explantation. This makes them a seemingly 
attractive alternative to synthetic mesh when operating in a contaminated or infectious 
wound environment. Biologic grafts are optionally cross-linked during processing, in 
which additional bonds are formed between the matrix polymers. This provides extra 
strength, preventing a too rapid graft degradation that might weaken the repair, but 
potentially decreases their biocompatibility. Biologic grafts are expensive, and proof 
of their usefulness in incisional hernia repair remains unclear.  
Well-designed clinical trials are needed to properly delineate the superior surgical 
technique and materials in different surgical scenarios. 
 
Laparoscopic repair: laparoscopic repair of (uncomplicated) incisional hernia is 
gaining popularity with potential benefits of less pain, less infection and earlier 
recovery. Potential drawback is the persistence of the hernia sac and the intraperitoneal 
position of the mesh in contact with viscera. Laparoscopic technique employs an 
intraperitoneal mesh repair and is a bridging technique by definition not approximating 
the rectus muscles and not restoring abdominal wall contour. Briefly, after 
adhesiolysis and reduction of the hernia sac content, mesh is placed and inspected of 5 
cm overlap. Tacks are placed 1-1.5 cm apart along the border of the prosthesis at 0.5 
cm from the edge. Alternatively or in addition, sutures are placed in a transfascial 
fashion for fixation. Available evidence suggests no superiority between the two 
fixation techniques concerning recurrence rates, but infection rate increases with the 
use of transfascial sutures. A recent development is to glue the mesh to the peritoneal 
layer avoiding pain associated with tacks and sutures, but preliminary data on mesh 
fixation and recurrence are equivocal.  
There is debate whether laparoscopic or open repair is the superior method of repair. 
Adequate comparison is hampered by the differences in indication for open and 
laparoscopic hernia repair with a predominance of relatively simple cases in 
laparoscopic series. A recent Cochrane review of randomized trials revealed no 
significant difference in recurrence rate between open and laparoscopic repair of 
incisional hernia.20 Duration of surgery, enterotomies, seroma and haematoma 
formation, infection requiring mesh removal, patient satisfaction, pain, and quality of 
life were also not significantly different between groups. However, the infection rate 
was significantly lower after laparoscopic repairs. Costs were significantly higher with 
laparoscopic repairs. Most trials registered a significant advantage for laparoscopic 
repair regarding length of stay. The authors concluded that short-term results of 
laparoscopic repair are promising, but that a longer follow-up is needed.20 By 
minimizing peritoneal trauma and postoperative inflammation, laparoscopic surgery 
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may result in less adhesion formation than with open abdominal surgery. As yet 
laparoscopic ventral hernia repair has not been linked to a reduction of adhesive small 
bowel obstruction. A major concern with the use of laparoscopy is inadvertent 
enterotomy. This complication occurs in less than 2% of laparoscopic repairs of 
incisional and ventral hernias, but when present it increases mortality from 0.05% to 
1.7%, and even to 7.7% if unrecognized during surgery (18% of cases). Considering 
the rareness of this complication, large trials are needed for valid risk assessment of 
open and laparoscopic repair. 
 
Component Separation Technique 
In the more complex incisional hernias, the use of prosthetic material is often 
contraindicated. Complex hernias have not been properly defined, but include repairs 
combined with enterocutaneous fistula, multiple recurrent hernias, previous or current 
wound infection, very large defects and defects following trauma or tumour resection 
resulting in significant loss of domain. An alternative in these situations is the 
component separation technique (CST). The CST was popularized by Ramirez et al. in 
1990 and is a technique using transposition of autologous tissue in a way the 
abdominal wall integrity is restored (Figure 3). This way, defects of 20-30 cm at 
waistline can be bridged. Modifications of the technique have since been devised, 
including release of the external oblique muscle via a separate skin incision in 
presence of an enterostomy, endoscopically assisted CST, CST with perforator 
preservation, and CST with additional division of the internal oblique component of 
the anterior rectus sheath. 
Results of CST are acceptable, especially considering the complexity of the hernia and 
the patient population. A meta-analysis of the Components Separation Technique 
(CST) for repair of large incisional hernias yielded an 18.2% recurrence rate after at 
least 12 months follow-up.21 Infection occurred in 18.9% of patients with an overall 
complication rate of 23.8%. Modifications of the technique show promising results, 
but need further evaluation in comparative trials. Mesh reinforcement of the CST with 
the mesh placed in a sublay position has been advocated to reduce recurrence rate. We 
are currently performing a randomized controlled trial comparing CST with CST 
reinforced with a light-weight mesh (RAPP trial) to address wound infection and long-
term recurrence rate. 
 
Other autologous techniques: other techniques of autologous repair of abdominal 
wall defects have been documented in the literature. An attractive method of local 
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tissue transfer besides CST is the da Silva technique. This utilizes the posterior and 
anterior rectus sheaths and hernia sac creating a three-layer repair which can be used 
for small midline hernias (<10 cm) with good results. Another technique utilizes the 
fascia lata graft. Advantages are its strength and full incorporation without eliciting a 
foreign-body response. However, repair with free fascia lata grafts results in 
considerable wound morbidity, not to mention donor-site complications, and recurrent 
hernia in up to 29% of patients.21 Autodermal grafts have been used as fascial 
substitutes to bridge fascial defects. Pedicled or free vascularized flaps are other 
options, but involve very complex procedures and should be used as a last resort. 
Overall, the evidence for the use of alternative autologous techniques is scarce, and 
they should be considered only when other techniques are not feasible. 
 
 
Figure 2 Schematic illustrations of the 
Component Separation Technique. 
Arrows and dashes represent direction of 
dissection. a Dissection of subcutaneous 
fat from the anterior rectus sheath and 
the aponeurosis of  the external oblique 
muscle. b Longitudinal release of the 
aponeurosis of the external oblique 
muscle just lateral to the rectus 
abdominis muscle, and separation of the 
internal and external oblique muscles up 
to the midaxillary line. c Mobilization of 
the posterior rectus sheath for additional 
medial advancement of the rectus 
abdominis muscle. 
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Algorithm for ventral incisional hernia repair 
Surgical treatment of incisional ventral hernia is tailor-made and should be based on 
hernia and patient characteristics. Level 1 evidence-based guidelines do not exist. 
Having extensive and long-term experience with large and complex hernia and various 
mesh repairs we provide here an algorithm used in our institution (Figure 4). In all 
elective repairs measures are taken to diminish risk factors for wound infection and 
recurrence such as weight loss or weight gain, cessation of smoking and optimizing 
blood glucose control. 
1. A small initial incisional or first recurrent incisional hernia (less than 10 cm in 
length and 7-10 cm in width, first recurrence is after previous autologous or 
onlay, inlay or sublay mesh repair) with intact skin and subcutaneous tissue, is 
treated by laparoscopic mesh repair. When during laparoscopic adhesiolysis an 
inadvertent enterotomy is made, conversion to an open procedure is done with 
primary closure and with sublay synthetic mesh repair as reinforcement, if 
possible, or a CST repair with or without synthetic mesh reinforcement 
depending on the severity of wound contamination.  
2. A small recurrent hernia after intraperitoneal mesh repair is treated by open 
surgery, explanting the mesh and closing the defect with CST reinforced with 
synthetic mesh in a sublay and/or preperitoneal position.  
3. A large incisional ventral hernia repair (more than 10 cm in length and between 
10 and 25 cm in width) without loss of fascia is repaired by CST. Synthetic 
mesh reinforcement (sublay and/or preperitoneal) depends on the degree of 
contamination during the procedure and is avoided in dirty operations. 
Modified CST (separate incisions) is done in the presence of an enterostomy. 
4. When complete closure in the midline is not accomplished by CST a bridging 
composite synthetic mesh with anti-adhesive barrier is placed intraperitoneally 
to cover the defect. The peripheral of the mesh is overlapping the detached 
posterior rectus sheath in a sublay position, minimizing the surface of mesh 
(edges) in contact with viscera. Care is taken to ‘bury’ anastomoses avoiding 
contact with the mesh and to interpose omentum between bowel and mesh. 
Surplus skin and subcutaneous tissue is excised sparingly to avoid tension on 
skin and subcutaneous sutures and necrosis. 
5. A remaining gap after CST in a contaminated environment is bridged with a 
synthetic resorbable mesh supported by a vacuum-assisted closure technique to 
prevent retraction of fascial edges. Secondary surgery after resolution of 
contamination is often needed to close the remaining defect.  
6. A large incisional ventral hernia with loss of domain or without loss of domain 
but unsuitable for CST, is treated by free fascia lata flaps, pedicle or free 
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vascularized flaps or sandwich techniques tailored to the remaining abdominal 
wall and patient characteristics. These procedures are typically done by a 
multidisciplinary team including a plastic and reconstructive surgeon. Mesh 
reinforcement is done whenever possible and safe. 
 
Thus far biological grafts do not have a role in abdominal wall reconstructions in our 
institution for several reasons. (I) The majority of incisional ventral hernias without 
loss of domain can be closed with CST. (II) We do reinforcement with synthetic mesh 
in combination with contaminated procedures such as colostomy take down and 
excision and closure of enterocutaneous fistula. (III) We prefer reinforcement and 
avoid bridging with mesh as much as possible except in smaller hernias done 
laparoscopically. If anticipated that CST will not be sufficient to close the defect, other 
autologous techniques are applied. (IV) With this algorithm remaining defects after 
CST in infectious circumstances, being an indication for biological mesh, are rare and 
are treated with temporary closure techniques and in two stages similar to semi-open 
abdomen treatment. (V) Cost-effectiveness of highly priced biological grafts for 
incisional hernia repair has not at all been proven. 
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Figure 4 Treatment algorithm for 
ventral incisional hernia repair 
CST, component separation technique; 
VAC, vacuum-assisted closure.  
* depending on level of contamination 
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Abstract 
Purpose: A clear definition of “complex (abdominal wall) hernia” is missing, though 
the term is often used. Practically all “complex hernia” literature is retrospective and 
lacks proper description of the population. There is need for clarification and 
classification to improve patient care and allow comparison of different surgical 
approaches. The aim of this study was to reach consensus on criteria used to define a 
patient with “complex” hernia. 
Methods: Three consensus meetings were convened by surgeons with expertise in 
complex abdominal wall hernias, aimed at laying down criteria that can be used to 
define “complex hernia” patients, and to divide patients in severity classes. To aid 
discussion, literature review was performed to identify hernia classification systems, 
and to find evidence for patient and hernia variables that influence treatment and/or 
prognosis. 
Results: Consensus was reached on 22 patient and hernia variables for “complex” 
hernia criteria inclusion which were grouped under four categories: “Size and 
location”, “Contamination/soft tissue condition”, “Patient history/risk factors”, and 
“Clinical scenario”. These variables were further divided in three patient severity 
classes (‘Minor’, ‘Moderate’, and ‘Major’) to provide guidance for perioperative 
planning and measures, the risk of a complicated postoperative course, and the extent 
of financial costs associated with treatment of these hernia patients. 
Conclusion: Common criteria that can be used in defining and describing “complex” 
(abdominal wall) hernia patients have been identified and divided under four 
categories and three severity classes. Next step would be to create and validate 
treatment algorithms to guide the choice of surgical technique including mesh type for 
the various complex hernias. 
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Introduction 
The term “complex (abdominal wall) hernia” is used often by general surgeons and 
other specialists operating in the abdomen to describe abdominal wall hernias that are 
technically challenging and time-consuming. Regarding this term many questions arise 
for example as to what are the criteria that define the complexity; is it the number of 
previous surgical attempts, the size of the defect, loss of domain or the degree of 
contamination? Lack of proper description of hernia (patients) in the literature often 
leads to ambiguity concerning the reason why the hernia is regarded as such. 
There is no consensus as to what exactly constitutes a complex hernia. The estimation 
of the degree of difficulty of a hernia repair may vary amongst surgeons depending on 
their knowledge and experience. Often the complexity is identified prior to operation, 
but in some cases events that happen (bowel perforation) or situations that are 
encountered (e.g. dense adhesions) intra-operatively  may promote a hernia from one 
that was regarded preoperatively as simple to one being complex. 
Lack of consensus hampers the guidance of treatment modality for the individual 
patient, the identification of patients who need specialized care, and the comparability 
of reports on hernia treatments. There is need for better description of “complex” 
hernias and hernia patients. The aim of this report was to set criteria for the definition 
“complex abdominal wall hernia” based on hernia and patient characteristics that 
either affect the choice of the surgical treatment or have prognostic value concerning 
short and/or long-term outcomes. To achieve this three consensus meetings were 
convened by hernia experts supported by an extensive review of the literature 
concerning abdominal wall hernia classifications and for (risk) variables potentially 
being involved in complex abdominal wall hernias. It was explicitly not the intention 
of this group to make a final definition of complex hernia under the assumption that 
this needs a much broader international consensus group process.    
 
Methods 
Three consensus meetings by hernia repair experts aiming to define criteria for 
“complex abdominal wall hernia” were arranged. To aid discussion literature review 
was performed. The consensus meetings were convened in: Berlin, Germany 
September 8th 2009, Orlando, Florida, USA March 16th, 2010 and New York, USA on 
March 27th, 2012. Surgeons were invited to participate based on their international 
recognition and scientific interest in abdominal wall hernia repair. The meetings were 
financially supported by Ethicon Products Inc. (Bedminster, NJ). Ethicon had no 
influence on the working process of the group. 
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The initial meeting was aimed at reviewing the results of pre-meeting questionnaires 
and exploring topics specific to patients with complex abdominal wall hernia. Open 
discussion was held aimed at creating a list of potential hernia and patient 
characteristics deemed important in describing the complexity of abdominal wall 
hernias. Factors taken into consideration during this exercise included: the frequency 
at which these characteristics are seen in practice, the severity of such characteristics 
when present, whether there is a patient profile typically associated with these 
characteristics. 
 
 
A literature search was undertaken to identify classification and grading systems with 
variables that are used to describe the severity of an abdominal wall hernia (Table 1). 
Electronic databases MEDLINE and EMBASE were used to identify reports. Search 
terms used were “ventral hernia”, “incisional hernia”, “abdominal wall 
repair/reconstruction/closure/defect”, “classification” and “grading/grade”. No 
restrictions were set on article type or language. The last search was performed on 01-
12-2012. The different classification systems were scrutinized in detail for variables 
included. Furthermore, the literature on abdominal wall hernias was also reviewed 
thoroughly regarding variables from the classification systems or those proposed by 
the group. Where applicable, the Level of Evidence (LoE) according to Oxford Centre 
for Evidence-based Medicine (CEBM) was provided in the discussion hereof.  
With aid of the products of the literature review and the first meeting, the second and 
third meetings included open and moderated debate to reach consensus on laying down 
#1 “Hernia, Ventral”[Mesh] 
#2 “ventral hernia”[All Fields] 
#3 “incisional hernia”[All Fields] 
#4 “abdominal wall”[All Fields] 
#5 “repair”[All Fields] or “reconstruction”[All Fields] or “closure”[All Fields] or “defect”[All Fields]
#6 “Classification”[Mesh] or “classification”[Subheading] or “classification”[All Fields] or 
“grading”[All Fields] or “grade”[All Fields] 
#7 #1 or #2 or #3 
#8 #4 and #5 
#9 #7 or #8 
#10 #9 and #6 
Total hits: 293. Relevant hits after title and abstract assessment and cross-referencing: 111-11 
Table 1 Search strategy for identifying abdominal wall hernia classification 
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criteria that should be included in the definition of a complex abdominal wall hernia. 
These criteria were further grouped in three patient severity classes that were felt to 
provide an insight into the expected need for extra peri-operative measures and 
planning, the risk of a complicated post-operative course, and an increase in associated 
costs. 
 
Results 
Classification systems for abdominal wall hernia in the literature 
The search strategy yielded a total of 11 reports that included classification or grading 
systems for (ventral) abdominal wall hernias. An overview of the classification 
systems and their components are presented in Table 2. 
In 1998 Sharma et al. reported on an anatomic classification of abdominal wall defects 
based on the location of the hernia and provide a scheme of donor flaps to be used for 
each of their closure.1 A horizontal line passing through the umbilicus divided the 
supra and infra-umbilical regions, while two lines running vertically through the mid-
clavicular divided each region into a central and two lateral parts; creating six regions 
in total. They also divided the defects based on size (<100, 100-200 and >200 cm2).  
In 2000 Chevrel and Rath documented a classification system of predictive value 
based on statistical analysis of a retrospective study including 435 patients.2 The 
attempt was to recommend either an autologous or non-autologous reconstruction. 
After analysis of the data and duly considerations, they employed a classification 
including location (medial and lateral), the size measured by the width of the defect (< 
5 cm, 5-10 cm, 10-15 cm, and > 15 cm), and whether or not it was a recurrent hernia. 
They initially divided medial hernias by supra-, juxta- and infraumbilical, and xipho-
pubic incisional hernias. Lateral hernias were divided between subcostal, transverse, 
iliac and lumbar incisional hernias. It was concluded that there was no correlation 
between the site and recurrence rate after taking into consideration both recurrence 
rates and the increased use of prostheses in certain locations. The authors also found 
that the amount of recurrent hernias had no impact on outcome. Considering the width 
of a hernia being more important than the length for the choice of technique and 
outcome of repair, they concluded that a surface calculation (using width and length) 
should not be performed as this could lead to hernias with an identical surface size that 
may not be equal in their treatment outcome. The authors commented that the 
following variables were also involved in hernia repair outcome: age, anemia, 
malnutrition, systemic diseases, steroid therapy, radiotherapy, closure technique of the 
previous procedure and complications, especially sepsis and wound infection.
Table 2 Overview of the variables included in classification systems for abdominal wall hernias found in the literature 
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Size and location  
   Hernia defect size Surface W W W/L SAW/WDS X W/L W W
   Number of hernia defects X 
   Location X X X X X X X X X
   Loss of domain X  X
Contamination / soft tissue conditions  
   Contamination/ infection X  X X
   Abdominal wall depth P/C  
Patient history and risk factors  
   Risk factors X* X**  X***X****
   Primary or incisional X X 
   Recurrent hernia Yes / No Amount X Amount  Amount
   Symptoms Yes/No  
   Previous incisions X  
   Body type/sternocostal angle X†  
Clinical scenario  
   Hernia reducibility X X  
   Hernia obstruction X X  
Grading system included X1 X2 X3 X4 X5 X6
W=Width, L=Length, P/C = Partial / 
Complete, SAW/WDS = Ratio from Surface 
of the Abdominal Wall / Wall Defect Surface 
*      Immunosuppression, steroids, 
nutritional status, smoking and alcohol 
**    Obesity, sex, age, smoking, 
attenuated muscles, wound complications, 
postoperative complications 
***  Smoking, obesity, diabetic, COPD, 
immunosuppression 
**** Smoking, obesity, diabetic, COPD, 
immunosuppression, excessive weight loss  
X† Subcostal angle, attenuated 
muscles, voluminous abdomen  
X1      Grade 1-7  
X2  Grade system including four 
parameters; recurrence, location, size and 
risk factors 
X3   Type I-III; primary hernia, incisional 
with multiple defects, >10 cm width and 
distance from bone <3 cm 
X4   Grid; including location, size and 
recurrence status 
X5  Grades 1-4; low risk, co-morbidity, 
potentially contaminated and infected 
X6  Grades I-IV; low risk and co-
morbidity, contaminated and infected, 
massive weight loss and loss of domain 
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In 2000 Rohrich and colleagues presented a classification of abdominal wall defects 
aimed at enabling the plastic surgeon to develop an algorithmic approach for their 
repair.3 The division included the depth of the defect of abdominal wall; partial (either 
skin or muscolofascial) or complete (full-thickness loss including the skin). The 
location of the defect was classified as either lateral or medial, and then as belonging 
to the upper, middle or lower third of the abdominal wall, resulting in six distinct 
regions (or nine if right and left lateral regions are counted separate). Lastly, the size of 
defect was classified in width for different locations being  < 5 cm, 5 to 15 cm, > 15 
cm. Contamination status and infection were taken into account. The authors also 
commented on the importance of risk factors including pulmonary function in relation 
to loss of domain, and factors influencing wound healing like immunosuppression, 
steroid dependency, nutritional status, smoking and alcohol. 
In 2001 Korenkov and co-workers reported on the results on an experts’ meeting under 
the auspice of the European Hernia Society that took place in 1998 aimed at answering 
current questions of incisional hernia surgery.4 Concerning classification the following 
variables were included; localisation, size, recurrence, reduceability and symptoms. 
Localisation (adjusted from Chevrel and Rath’s original site classification2) included 
vertical (midline above or below umbilicus, midline including umbilicus right or left, 
para-median right or left), transversal (above or below umbilicus right or left, crossed 
midline or not), oblique (above or below umbilicus right or left), and combined. The 
size was small, medium or large (< 5 cm, 5-10 cm and > 10 cm, respectively, in width 
or length). Besides the amount of recurrences, the type of repair is noted. The situation 
at the hernia gate is regarded as reducible or irreducible and with or without 
obstruction. Finally, whether the hernia is symptomatic or not is noted. The authors 
added that a patient-tailored surgical technique is probably of great importance and 
will need to take many local and systemic factors into account. 
In 2005 Ammaturo and Bassi suggested a new parameter elaborating on the hernia 
size.5 The ratio between the surface of the abdominal wall (SAW) and the wall defect 
surface (WDS) was added to the classification of Chevrel and Rath. A low SAW/WDS 
ratio was significantly associated with increased intra-abdominal pressure, resulting in 
major abdominal wall tension, suggested as a relevant surrogate outcome for 
recurrence. An open mesh placement in an intraperitoneal position, without closure of 
the gap, resulted in a decreased intra-abdominal pressure compared to the 
retromuscular mesh placement according to Rives–Stoppa. 
In 2006 Chowbey et al. proposed a classification of ventral hernias based on the 
expected level of intraoperative difficulty during endoscopic repair.6 A Grading 
system with seven grades (1 to 7) was constructed based on whether the hernia was 
primary, incisional or a recurrent incisional, the sac contents and their reducibility, 
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(sub-acute) obstruction, multiple previous incisions, ‘scarred’ abdomen, size and 
location. These variables are not elaborated on and no explanation was provided on 
how they were introduced into this classification system. 
In 2006 Dietz and colleagues developed a classification system aimed at making 
comparative evaluation possible of long-term results, and provided indications and 
limitations for the various surgical techniques.7 The Grading system includes four 
parameters; recurrence status, location, size (width and length) and risk factors for 
recurrence. Risk factors include obesity, male sex, nicotine abuse, wound 
contamination, age, and postoperative complications. Morphology takes into account 
the location of the hernia (following Chevrel and Rath2), and various body types based 
on subcostal angle, attenuated muscles, and the volume of the abdomen. Depending on 
body type various surgical techniques are deemed more or less appropriate. For 
example, lateral mobilisation was considered to be impracticable in thin patients or in 
those with a narrow sternocostal angle. Attenuated muscles in the elderly were 
considered a risk factor. Supported by the literature, they provided the indications for 
the common techniques of repair, along with factors that limit their feasibility. 
In 2006 Conze and co-workers suggested a prognostic-based classification system for 
incisional hernias into three therapeutical groups, based on size, location and primary 
or recurrent (Type I-III).8 Type I: uncomplicated primary and incisional hernias with a 
defect < 3 cm, that can be treated with a conventional non-absorbable suture repair; 
Type II: incisional hernia with defect size < 10cm or multiple defects and recurrent 
incisional hernias after previous suture repair, that are an indication for a 
retromuscular mesh augmentation;  Type III: complex incisional hernias with a defect 
>10 cm and distance from bone < 3 cm, where a combination of Component 
Separation Technique and retromuscular mesh bridging is advised. 
In 2009 Muysoms et al. presented the ‘grid’ classification for primary and incisional 
hernias of the European Hernia Society.9 A consensus group met for two days and 
discussed the creation of the grid. Classification for primary hernia included location 
(epigastric, umbilical, spigelian, lumbar) and size (< 2 cm, 2-4 cm and > 4 cm). This 
primary hernia classification will not be further discussed. A final consensus on a grid 
was not achieved for incisional hernias, but a tentative classification grid was provided 
based on location, size and recurrence status. Medial hernias were defined by five 
zones: subxiphoidal, epigastric, umbilical, infraumbilical and suprapubic. The lateral 
zones on each side were defined: subcostal, flank (transverse in the Chevrel and Rath 
classification2), iliac and lumbar. No consensus was achieved on a format for size. 
Width was defined as < 4 cm, 4-10 cm, and ≥ 10 cm, but space was left in the 
classification grid for the exact width and length measurements. They proposed that 
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when multiple defects exist, the length of a horizontal and vertical line between the 
most extreme borders of the defects should be used. The amount of recurrent hernias 
was not considered of enough importance to be included. The recurrence status was 
recorded as a “Yes” or “No”. 
In 2010 Breuing and colleagues created the Ventral Hernia Working Group (VHWG) 
Grading system, consisting of four grades (Grade 1-4) based on risk factors, 
contamination and infection status. The goal was to identify patients that are at 
increased risk of developing a surgical site occurrence based on patient and hernia 
characteristics.10 The hypothesis was that postoperative complications, especially 
infection, increased the risk of having an incisional hernia recurrence. The definition 
of grades are: Grade 1, ‘Low-risk’ (low risk of complications, no history of wound 
infection); Grade 2, ‘Co-morbid’ (smoker, obese, diabetic, COPD, 
immunosuppressed); Grade 3, ‘Potentially contaminated’ (previous wound infection, 
stoma present, violation of the gastrointestinal tract); Grade 4, ‘Infected’ (infected 
mesh, septic dehiscence). The authors recognised that there are other factors that may 
influence the risk of complications and recurrence, but concluded that there was 
insufficient data in the literature to reliably quantify the risk of a recurrence secondary 
to these variables. They also provided recommendations concerning the best surgical 
technique and choice of prosthetic materials based on the grade. They backed their 
algorithm up with (quality graded) evidence from the literature. Recently, Rosen’s 
group attempted to validate the VHWG grading scale by determining the actual risk of 
surgical site occurrences for each hernia grade by applying it to 299 patients that 
underwent various types of open ventral hernia repair. They found that although the 
VHWG grading scale is successful at dividing patients into groups with an 
independent risk of developing a surgical site occurrence, contiguous comparisons of 
groups (grades 2 vs 3 and grade 3 vs grade 4) show no statistical differences when 
evaluating surgical site occurrences. They suggest several modifications to strengthen 
its ability to predict surgical site occurrences based on their analyses. A history of 
immunosuppression (grade 2) failed to show statistical significance to surgical site 
occurrences and is removed. Moreover, by re-categorizing ‘history of wound 
infection’ to grade 2, and ‘stoma present’ and ‘violation of GI tract’ to grade 4, greater 
(and significant) differences are found in comparisons of grade 2 vs grade 4. 
Effectively, this transforms the 4-class grading scale into a 3-class grading scale: 
Grade 1, ‘Low risk’ (low risk of complications, no history of wound infection); Grade 
2, ‘Co-morbid’ (smoker, obese, diabetic, history of wound infection); and Grade 3 (A. 
Clean-contaminated, B. Contaminated, C. Dirty). Surgical site occurrences developed 
respectively in 14%, 27% and 46% of patients in the three grades. 
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In 2011 Hadeed and co-workers designed a classification system with a grading 
system of five grades, similar to that of Breuing et al., including risk factors, 
contamination, infection and loss of domain.11 Grades I and II are the same as those by 
Breuing et al., whereas grade III encompasses both grade III and IV of the Breuing et 
al. classification (contamination and infection). Furthermore, they included a grade IV 
for patients who have experienced massive weight loss, and grade V for patients with a 
loss of domain, with or without co-morbidities. The authors commented that patients 
with excessive weight loss have an increased risk of a complicated wound healing, 
including a concomitant panniculectomy that might be included. They further mapped 
the surgical techniques onto the classification grades of 133 patients that underwent 
ventral hernia repair and evaluated the outcomes. A recommendation of a surgical 
technique for different surgical scenarios was suggested. 
 
Discussion on criteria for inclusion 
Four categories were created to arrange and discuss the criteria proposed for inclusion 
in the definition “complex abdominal wall hernia”, derived from the criteria proposed 
by the consensus group and the classification systems found in the literature: Defect 
size and location, patient history and risk-factors, contamination and soft tissue 
condition, and clinical scenario. 
 
Size and location 
Size of defect was considered an important variable in hernia repair. Indeed, increased 
hernia size is a risk factor for both 30-day readmission due to complications12 (LoE 
2b) and recurrence13 (LoE 2b). The classification in different sizes in the literature 
seems arbitrary and is not based on statistical analyses. We agree with Chevrel and 
Rath that the width is more informative than the length of the defect, and that surface 
size may be misleading in some cases.2 Moreover, the width of the defect is usually 
sufficient when the location is known. 
The novel technique devised by Ammaturo and Bassi to calculate the ratio between the 
abdominal wall surface and the defect surface (taking into consideration the 
individuals build) is compelling, but the method is too complicated to be widely 
applied.5 The group agrees that before easy and reliable measurement methods with 
prognostic value are available to determine the extent of a hernia, a defect width 
greater than 10 cm is a useful cut-off point for complex hernia provided there are other 
complicating factors at play, such as multiple co-morbidities or recurrent hernia (LoE 
5). There was no consensus on what width would make a hernia complex if this was 
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the only complicating factor. The group recognizes that the width is relative to the 
body size but could not find data that addressed the importance of this relationship in 
hernia repair.  
There are subtle differences found in the classification of hernia location. Most authors 
notice the need for differentiation between lateral and medial hernias, and those in 
complicated locations, such as close to bony structures. Lumbar, lateral and subcostal 
locations of hernias were considered by the group to be complex because of mesh 
anchorage difficulty and risk of recurrence (LoE 5). The literature does not specifically 
address parastomal hernias in the grading/classification of abdominal wall hernias. 
Based on its clean-contaminated wound class alone parastomal hernia repair as such 
does not fulfil the criterion of complex hernia. However, considering lack of consensus 
on the best repair technique,14 the complexity of these procedures, and the associated 
morbidity and recurrence rate, the group recognized parastomal hernias as complex 
(LoE 3a).  
When a large proportion of the abdominal contents resides permanently in the hernia 
sac (determined by CT imaging) one speaks of significant loss of intra-abdominal 
domain. This is considered by the consensus group to be a complex hernia as such. 
This might occur due to fascial retraction that might result after open abdomen 
treatment or delayed presentation of a huge hernia in progress. A recent prospective 
study determined that an incisional hernia volume/peritoneal volume ratio below 20% 
was predictive of a tension-free fascia closure (LoE 1b).15 This indicates that closure of 
the abdomen will probably not succeed without significant tension or that even 
releasing incisions will be needed for closure with hernia volume/peritoneal volume 
ratios above 20%.  
The group considers a CT scan mandatory in determining the complexity of an 
abdominal wall hernia, allowing for exact measurement of the hernia defect, 
calculation of intra-abdominal volume, and evaluation of the quality and quantity of 
soft-tissues.  
 
Contamination and soft tissue condition 
Contamination of the wound environment is an important factor and is included in 
three classifications, while most other authors comment on its relevance. Wound 
contamination for incisional hernias are usually classified according to the US 
National Research Council Group16 including clean (I), clean-contaminated (II), 
contaminated (III), and dirty/infected (IV). It is well known that contamination and 
subsequent infection are an important cause of wound dehiscence and reherniation by 
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disturbing wound healing dynamics.17 Many surgeons are reluctant to use non-
absorbable synthetic mesh in (clean-)contaminated wounds due to fear of mesh 
infection that could result in explantation of the mesh and a subsequent recurrent 
hernia. However, available evidence shows that permanent mesh (polypropylene and 
expanded-polytetrafluorethylene) can be used in hernia repair with concomitant 
procedures involving clean-contaminated (bowel resection, enterostomy closure), and 
selected contaminated procedures (enterocutaneous fistula takedown, 
necrotisized/infected fascia debridement)18-23 (LoE 4). Following this, there is no 
absolute contra-indication for its use in (clean-) contaminated surgery. However, 
contaminated and dirty ventral hernia repair results in increased wound infections and 
recurrent hernias even when using alternatives such as autologous techniques and 
biologic grafts (LoE 3a).24, 25 The group considered hernias with wound classes III 
(contaminated) and IV (dirty/infected) to be complex (LoE 3a). 
The depth of the abdominal wall defect was taken into account in one classification 
system,3 distinguishing between partial or a complete abdominal wall defect including 
loss of skin. The condition of the soft-tissue is important as it has consequences for the 
complexity of surgical treatment. These include significant loss of skin or presence of 
a laparostomy covered with skin-graft, ‘battle-scarred’ abdomen, and loss of 
myofascial tissue due to trauma, tumor resection or debridement. Full-thickness 
abdominal wall defects, loss of substance, denervated muscles, skin grafts, ulcers, 
open abdomen and other hernia conditions including significantly affected soft-tissue 
were considered by the group to be complex. Disease-related fascial defects, including 
omphalocele, necrotizing fasciitis, and prior fascial dehiscence of laparotomy wound 
were also regarded as complex cases (LoE 5). 
 
Patient history and risk factors 
A recurrent hernia is considered a risk factor for a new recurrence. The recurrence 
status of the patient is included in five classification systems. It is proposed that these 
patients suffer an underlying dysfunction in the wound healing process, leading to 
weakened scar tissue. Abnormal collagen type I/type III ratio, which is responsible for 
connective tissue strength, have been demonstrated in patients with (recurrent) 
incisional hernias.26 Genetic connective tissue disorders are also associated with 
abdominal wall hernias, including Ehlers-Danlos,27-29 Marfans syndrome,30 autosomal 
dominant polycystic kidney disease,31 osteogenesis imperfecta,32 and congenital 
dislocation of the hip.33 
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Repeated hernia repairs cumulatively decreases the quality of abdominal wall tissues 
due to tissue dissection, mesh explantation, fascial retraction and debridement, 
resulting in increasingly vulnerable reconstructions. A large cohort study showed that 
the recurrence rate of incisional hernia increased from 24% after first repair, to 35% 
after second repair, and 39% after the third repair (LoE 2c).34 This suggests that the 
amount of previous repairs is important, at least up to the second recurrent incisional 
hernia. A second incisional hernia after a former mesh repair was considered by the 
group to be complex (LoE 2c). 
Various other patient-related variables are considered risk factors for a complicated 
course and are included in several classification systems. Most risk factors are based 
on their negative impact on wound-healing, such as steroid use and smoking.35 Studies 
aimed specifically at risk factors for incisional hernia often fail to yield these variables. 
Still, wound dehiscence is a major complication after laparotomy and is related to 
incisional hernia (LoE 4).36 A recently validated risk model based on 363 cases of 
wound dehiscence was constructed, aimed at identifying patients at increased risk of 
abdominal wound dehiscence.37 It revealed the following risk factors: age, male 
gender, chronic pulmonary disease, coughing, ascites, jaundice, anaemia, emergency 
surgery, wound infection, obesity, steroid use, hypoalbuminaemia, hypertension, 
perioperative shock, and type of surgery (LoE 2b). Given the broad complexity of the 
hernia population and the different mechanisms of wound failure, factors that do not 
relate directly to the hernia characteristics also need ample attention. A patient with a 
small and ‘simple’ hernia but with deleterious patient factors (old age, smoker, steroid 
use) and co-morbidities (diabetes, obesity) will potentially make for a complicated 
course. On the other hand, a young and healthy patient with a large hernia may be 
treated successfully without complication. Here the distinction is made between a 
complex hernia and a complex hernia patient. It is not possible to know the relative 
influence of each variable in a specific patient. However, the group agrees it is 
important to properly assess (and treat) co-morbidities in patients undergoing 
abdominal wall hernia repair. 
 
Clinical scenario 
Two studies included hernia reducibility and presence of obstruction in their 
classification.4, 6 An acute irreducible and incarcerated hernia needs direct attention. If 
the afflicted bowel is still vital after reduction, the hernia repair can proceed in a 
standard fashion. An emergency hernia operation including bowel resection was 
considered by the group to be a complex repair (LoE 5) although it was acknowledged 
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that some of these emergency cases are relatively simple and can be repaired with 
mesh. 
The presence of a previously placed mesh which needs to be explanted for any reason 
creates an especially complex situation. This often involves extensive adhesiolysis, 
longer operating time, and increased risk of inadvertent enterotomies resulting in dense 
adhesions, fistulas and infection (LoE 1b).38 Abdominal wall reconstruction in the 
setting of intraperitoneal mesh explantation was considered by the consensus group to 
be a complex repair. An exception to this may be in the case of a small previous mesh 
repair (e.g. after an umbilical hernia). 
Table 3 Criteria for definition of a complex abdominal wall hernia (patient) 
1.  Size and location 
• Large-sized abdominal wall hernia, ≥ 10 cm in width 
• Parastomal, lumbar, lateral and subcostal locations of hernias 
• Loss of domain ≥ 20% 
 
2.  Contamination and soft-tissue condition 
• Wound environment with Surgical wound class III (‘Contaminated’) or IV (‘Dirty’)
• Full-thickness abdominal wall defects 
• Loss of substance(e.g. after tumor resection, trauma, infection) 
• Distorted anatomy (e.g. after multiple previous procedures) 
• Denervated muscles 
• Skin grafts 
• Wound ulcers/non-healing wound 
• Open abdomen 
• Disease-related (omphalocele, necrotizing fasciitis) 
• Presence of enterocutaneous fistula 
 
3.  Patient history and risk factors 
• Recurrent hernia after an earlier mesh repair or component separation 
• Co-morbidities/risk factors that impair wound healing: obesity, diabetes, old age, 
steroid use, or poor nutritional state (albumin < 30 g/dl). 
• Increased intra-abdominal pressure: obesity, COPD 
• Previous wound dehiscence 
• Previous mesh infection 
 
4.  Clinical scenario 
• Emergency operation with bowel resection 
• Intraperitoneal mesh removal 
• Multiple hernia defects (e.g. ‘battle-scarred abdomen’) 
• No primary closure possible without component separation 
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Besides the clinical scenarios described in the classification systems, the group added 
the following complicating situations that necessitate significant pre- and perioperative 
measures and planning: abdominal wall with multiple hernia defects (e.g. a “battle-
scarred abdomen”), a non-healing wound, and when no primary closure is possible 
(LoE 5). In particular, presence of enterocutaneous fistulas are known to coincide with 
high morbidity, mortality and fistula and hernia recurrence rates (LoE 4).39, 40 
 
Table 4 Complex hernia criteria grouped in the patient severity classes ‘Minor’, ‘Moderate’ and 
‘Major’ dependent upon expected increase in peri-operative measures and  planning, risk of 
complications, and costs 
* Obesity, diabetes, steroid use, smoking, old age, poor nutritional state (albumin < 30 g/dl) 
 
Minor Moderate Major 
Only one wound healing 
impairing risk factor* 
Two or more wound healing 
impairing risk factors* 
Two or more wound healing 
impairing risk factors* and one or 
more ‘Moderate’ class criteria 
 Hernia ≥10 cm in width, or no 
primary closure possible without 
component separation 
Surgical wound class III 
(‘Contaminated’) or IV (‘Dirty’) 
 Loss of domain ≥ 20% Open (burst) abdomen 
 Parastomal, lumbar, lateral and 
subcostal hernias 
Disease related: necrotizing 
fasciitis 
 Full-thickness defects, loss of 
substance, distorted anatomy or 
multiple hernia defects 
Current mesh infection 
 Skin grafts, wound ulcers, non-
healing wound 
Enterocutaneous fistula present 
 Disease related: omphalocele  
 Increased intra-abdominal 
pressure: COPD, obesity 
 
 History of wound dehiscence or 
wound/mesh infection 
 
 Intraperitoneal mesh removal  
 Emergency operation with bowel 
resection 
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An overview of the criteria divided by the four categories regarding complex hernia 
laid down by the group is presented in Table 3. Additionally, the criteria within the 
four categories were accommodated in three patient severity classes: ‘Minor’, 
‘Moderate’ and ‘Major’. The group believes these classes respectively require 
increasingly demanding peri-operative planning and measures, result in a more 
complicated post-operative course, and coincide with more financial costs. The results 
of grouping the criteria into three patient classes are presented in Table 4. 
 
General discussion 
The aim of the current report is novel in that it is not to put forth a classification 
system for abdominal wall hernias, but to comprehensively lay down criteria that can 
be used in a definition of ”complex abdominal wall hernia”. This was attained through 
consensus meetings aided with literature review, resulting in an opinion and evidence-
based product. The members of the international group were uniquely fit to construct 
criteria for a complex abdominal wall hernia as they have extensive experience within 
a broad range of complex scenarios of abdominal wall hernia repair, sharing over 150 
publications related to hernia repair.25, 41-51 
The literature review of classification systems was aimed at promoting discussion 
within the group regarding criteria important in defining complex abdominal wall 
hernias. These classification systems are based mostly on expert opinions, while some 
use the aid of related research or statistical analysis of patient cohorts. Most are aimed 
at making future evaluation and comparison of surgical techniques possible. This is 
important, especially considering that reports on reconstruction of complex abdominal 
wall hernias mostly consist of retrospective studies evaluating a single technique. The 
differences in and inadequate reporting of patient and hernia characteristics within and 
between studies make proper evaluation and comparison of surgical techniques very 
troublesome at present. Other classification systems go a step further and provide 
treatment recommendations for the different hernia classes based on best available 
evidence.10 Recently, an attempt was made to validate the VHWG grading scale, a 
hernia patient classification that has quickly gained popularity. This lead to proposal of 
a revised version based on patient outcomes in a cohort.52 Validation of scoring 
systems is essential to allow proper evaluation and to increase their accuracy. 
Unfortunately, these undertakings are scarce and should be encouraged in future 
studies. Most classification systems did not find their way into the clinic due to 
complexity or lack of clarity. Nevertheless, there does seem to be considerable 
agreement in the literature regarding the grading of hernias, given there are several 
common denominators found in the classification systems (Table 2). 
52 
 
The product of this report is a set of criteria that are grouped under the four categories 
“Size and location”, “Contamination and soft-tissue condition”, ”Patient and risk 
factors”, and “Clinical scenario”, and provides an overview of patient and hernia 
characteristics that are considered important and affect choice of treatment and clinical 
outcome. We believe that describing a complex hernia patient based on criteria 
grouped in categories will allow for better outcome comparison between studies and 
techniques including evaluation of the impact of these variables on outcomes. 
Additionally, the consensus group devised three patient severity classes to 
accommodate the criteria used to describe patients with complex abdominal wall 
hernias: ‘Minor’, “Moderate’ and ‘Major’ (Table 4). Although to a certain extent this 
simplifies and disregards differences in hernia patients, these classes allow for an easy 
quick overview of the degree of expected peri-operative measures and planning and 
risk of a complicated post-operative course. Another benefit of grading hernia patients 
is the possibility to objectively define complex hernia (patients) eligible for referral to 
a centre of excellence and for more appropriate financial reimbursement than at 
current. This is important regarding the increased costs of perioperative care and the 
use of new and expensive (bio-) materials.24 Biologic mesh is a new generation of 
prosthesis that is promoted for (potentially) contaminated surgical sites, as reservations 
are held concerning synthetic mesh use in these situations due to fear of infectious 
complications. However, the debate is still ongoing as to which prosthetic materials 
should be used under which circumstances in patients. This discussion is complicated 
as it appears biologic mesh is often being utilized in clean procedures,24 while 
synthetic materials have shown acceptable results in clean-contaminated and even 
selected contaminated procedures.18-23 A clear indication for the use of biologic mesh 
is all the more important considering their high costs. The VHWG point out the role of 
biologic mesh in patients with co-morbidity (grade 2), and in potentially contaminated 
(grade 3) and infected (grade 4) wound environment. Unfortunately, convincing 
evidence is currently not available regarding superiority of biologic materials in these 
situations compared to other techniques,10 and caution is warranted concerning their 
use. A worry with a detailed grading of hernia patients as is done by the VHWG is the 
lack of knowledge regarding the relative contribution of various variables concerning 
outcomes, as a patient with multiple co-morbidities (grade 2) may very well be a more 
complex patient (and more prone to develop complications) than a patient with no co-
morbidities but has a stoma present (grade 3).    
The current report is qualitative and based to a large extent on expert opinion. Many 
criteria included in the definition of complex hernia still require subjective 
interpretation. For other factors a quantitative cut-off is provided based on intuition, 
experience or scant low quality literature, such as regarding a defect width of >10 cm 
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as complex. Still, it is important to first agree on hernia and patient elements that are 
most relevant (i.e. having implications for treatment and prognosis) when describing 
the “complex” hernia patient, rather than using non-validated classification systems, 
based on low evidence literature, that do not take important differences into account. 
The next step would be to create and validate treatment algorithms for these complex 
hernia patients, to benefit choice of surgical technique including type of mesh. 
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Abstract 
Background: Parastomal hernias are a frequent complication of enterostomies that 
require surgical treatment in approximately half of patients. This systematic review 
aimed to evaluate and compare the safety and effectiveness of the surgical techniques 
available for parastomal hernia repair. 
Methods: Systematic review was performed in accordance with PRISMA. Assessment 
of methodological quality and selection of studies of parastomal hernia repair was done 
with a modified MINORS. Subgroups were formed for each surgical technique. Primary 
outcome was recurrence after at least one year follow-up. Secondary outcomes were 
mortality and postoperative morbidity. Outcomes were analysed using weighted pooled 
proportions and logistic regression. 
Results: Thirty studies were included; the majority retrospective. Suture repair resulted 
in a significantly increased recurrence rate when compared to mesh repair (odds ratio 
[OR] 8.9, 95% confidence interval [CI] 5.2-15.1; p<0.0001). Recurrence rates for mesh 
repair ranged from 6.9% to 17% and did not differ significantly. In the laparoscopic 
repair group, the Sugarbaker technique had less recurrences than the keyhole technique 
(OR 2.3, 95% CI 1.2-4.6; p=0.016). Morbidity did not differ between techniques. The 
overall rate of mesh infections was low (3%, 95% CI 2%-5%) and comparable for each 
type of mesh repair.  
Conclusions: Suture repair of parastomal hernia should be abandoned because of 
increased recurrence rates. The use of mesh in parastomal hernia repair significantly 
reduces recurrence rates and is safe with a low overall rate of mesh infection. In 
laparoscopic repair the Sugarbaker technique is superior over the keyhole technique 
showing fewer recurrences. 
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Introduction 
A parastomal hernia is an incisional hernia related to the presence of an enterostomy.1 It 
is a common complication of stoma formation and the reported incidence varies and 
depends on the type of stoma.1,2 For colostomies, the incidence ranges from 3 to 39 per 
cent whereas for loop ileostomy its incidence is reported between 0 and 6%.2 The 
majority of parastomal hernias develop in the first years after stoma formation.3 Most of 
the parastomal hernias are asymptomatic and therefore can be treated conservatively. 
Indications for surgery are ill fitting appliances causing leakage, pain, discomfort, and 
cosmetic complaints. Treatment is mandatory when incarceration or strangulation of 
hernia content occurs. Surgical treatment options are relocation of the stoma or repair 
with or without the use of prosthetic material, either by an open or laparoscopic 
approach. This review focuses on recurrence rates and postoperative morbidity of suture 
and prosthetic repair of parastomal hernias either by open or laparoscopic approach. 
Stoma relocation is not taken into account.4 
 
Methods 
Search strategy 
A flowchart of the search strategy is shown in Figure 1. Articles for this review were 
identified by search of PubMed, EMBASE, and Medline (January 1950-November 
2010). The keywords used were paracolostomy, paraileostomy, parastomal, colostomy, 
ileostomy, hernia, defect, closure, repair, reconstruction, and combinations hereof. 
Furthermore, reference lists of selected articles were cross-searched for additional 
literature. There was no date limit set and papers published in English, French, Spanish, 
and German were included. Papers discussing treatment of parastomal hernia by 
relocation or prevention of parastomal hernia were excluded. In cases of overlapping 
patient cohorts between reports from the same authors, the most recent report with the 
longest follow-up was chosen. 
 
Critical appraisal  
All selected papers were evaluated for methodological quality using a modified 
Methodological Index of Non-Randomized Studies (modified MINORS, Table 1).5 The 
MINORS tool has been shown a consistent and reliable instrument to assess 
methodological quality and potential bias in non-randomized studies.5 The modification 
consists of leaving out points that concern mainly prospective trials (prospective 
collection of data, blinded assessment of end-points, prospective study size calculation), 
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and the addition of points needed for proper subgroup formation employed in the 
current study (stoma type and surgical technique). Three authors (A.P.S.V.D.V., 
B.M.E.H. and N.J.S) produced the modified MINORS score for all selected 
publications. Papers with a score ‘zero’ on either item were considered ineligible and 
the minimum score for a study to be included was set at nine points. Any disagreement 
was resolved by consensus with a fourth reviewer (R.P.B.) For determination of 
weighted pooled recurrence rates, only studies with a follow-up of at least 12 months 
were included in analysis. 
 
Primary and secondary outcome 
Figure 1 Search flow-chart 
following PRISMA. 
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The primary outcome measure was recurrence rate of parastomal hernia. Secondary 
outcomes were in-hospital mortality, wound infection, mesh infection, other 
complications (medical and surgical), and overall morbidity. Primary and secondary 
outcomes were as defined by the individual investigators. Overall morbidity was 
calculated by counting wound infection, mesh infection, and other complications.  
 
Table 1 Modified Methodological Index of Non-Randomised Studies (MINORS) 
 
Data extraction and analysis 
All reports were thoroughly reviewed and data for primary and secondary outcome were 
extracted. Study design, year of publication, number of patients included and evaluated, 
surgical technique (open or laparoscopic, anatomical mesh position, keyhole or 
Sugarbaker mesh technique), re-interventions, and duration of follow-up were also 
noted.  
Subgroups were formed for every surgical technique: suture repair, onlay mesh repair, 
sublay mesh repair, open intraperitoneal mesh repair, and laparoscopic intraperitoneal 
mesh repair. Within the open and laparoscopic intraperitoneal repair groups, keyhole 
and Sugarbaker repairs were grouped separately. Patients in the reports that underwent 
parastomal hernia repair with a certain technique were grouped accordingly. 
Item Criteria Option Score 
1 A clearly stated aim Not reported 
Partially reported, no clear aim 
Clear aim 
0 
1 
2 
2 Minimum of 5 included patients No 
Yes 
0 
2 
3 Inclusion of consecutive patients Not reported 
Patients in a certain time period 
Consecutive patients + characteristics 
0 
1 
2 
4 Type of stoma specified Not reported 
Reported 
0 
2 
5 Surgical technique reported Not reported 
Incomplete 
Reported clearly, appropriate to aim 
0 
1 
2 
6 Report of end points Not reported  
Recurrences only 
Recurrences and postoperative 
complications 
0 
1 
2 
  Maximum score: 12 
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Statistical analysis 
Rates of wound infection, mesh infection, other complications, and mortality are 
provided for every subgroup with their ‘exact’ 95% confidence intervals (CI) following 
Clopper and Pearson.6 The heterogeneity of every subgroup concerning the outcomes 
recurrence and overall morbidity was determined with the Cochrans Q test statistic and 
quantified using I2.7 Weighted pooled proportions were calculated for the outcomes 
recurrence and overall morbidity using StatsDirect® statistical software.8 In cases of a 
positive Cochrans Q test (p<0.05) and a high I2 (> 50%) a random-effects model was 
chosen for the weighted pooled proportion. Otherwise a fixed-effects model was 
chosen. Comparison of subgroups was undertaken using a logistic regression analysis 
with laparoscopic repair as explanatory variable and presented as odd ratios (OR) and 
their 95% CI. Logistic regression analysis was done with SAS/STAT® software9 and a 
p-value of <0.05 was considered statistically significant. 
 
Results 
The search yielded a total of 205 titles and abstracts (Figure 1). After screening, 55 full-
text articles were retrieved for assessment of eligibility and were further subjected to the 
modified MINORS tool. A further 25 studies were excluded, which left 30 studies to be 
included in systematic review. Five studies provided information on 106 suture repairs 
(Table 2, Figure 2)10-14, 7 studies on 157 onlay mesh repairs (Table 3, Figure 3)15-21, 3 
studies on 42 sublay mesh repairs (Table 4, Figure 4)22-24, 5 studies on 65 open 
intraperitoneal mesh repairs (Table 5, Figure 5)25-29, and 11 studies on 363 laparoscopic 
mesh repairs (Table 6, Figures 6,7).14,30-39 
 
Suture repair  
With suture repair of a parastomal hernia a laparotomy is avoided. After a parastomal 
incision and reduction of the hernia sac, the fascial opening is narrowed with absorbable 
or non-absorbable sutures. Five retrospective studies including 106 patients were 
eligible for review (Table 2).10-14 Four patients died in the postoperative period.11,12 The 
cause of death in these patients is not mentioned, though in three the parastomal hernia 
repair was performed as an emergency operation. Overall morbidity was 22.6% (95% 
CI 14.6-32.4): surgical site infection developed in 11.8% (95%-CI 6.1-20.2) whereas 
other complications were reported in 10.8% (95%-CI 5.3-18.9) of patients. Follow-up 
was 
Table 2 Study characteristics and outcomes of suture repair of parastomal hernia 
 
 
 
 
 
 
Reference Time 
period 
Mod. 
MINORS 
index 
No. Of 
repairs 
Type of 
stoma 
Type of 
sutures 
No. Of complications 
(%) 
Mortality Recurrence 
(%)†† 
Follow-up** 
      Infection Other    
Rubin et al.10 1983-1991 10 36 EC, LC, EI >85 % 
nonabs. 
5 2 0 29 (80.6) 31 
Cheung et al.11 1990-1999 11 16 EC, LC Nonabs. 0 5 3 6 (46.2) 38 
Rieger et al.12 1990-2002 10 14 EC, EI, LI, 
LC  
NS 4 3 1 7 (53.8) 7**
Riansuwan et al 
13 
1999-2005 11 27 10 C, 17 IC Nonabs. 2 0 0 20 (74.1) 23 
Pastor et al.14 1999-2006 11 13 9 C, 4 IC 91% nonabs. NS NS 0 7 (53.8) 14 
           
Weighted 
pooled %; 95 
per cent c.i. 
-  106 - - 11.8%  
(6.1-20.2) 
10.8%  
(5.3-18.9)
3.8% (1.0-
9.4) 
69.4%*, (59.7-
78.3) 
Median†: 27 
* Weighted pooled proportion (fixed effects model) using only studies with ≥12 months mean follow- up 
** Values are mean months follow-up unless otherwise stated 
† Median of reported follow-up of studies with ≥12 months follow-up 
C: colostomy; IC: ileal conduit; EI: end ileostomy; EC: end colostomy; LI loop ileostomy; LC: loop colostomy; †† excluding in-
h l d h f d
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adequate in four series including a total of 92 patients, of whom 69.4% (95%-CI 59.7-
78.3) had a recurrent parastomal hernia.10,11,13,14 In the series of Rubin and colleagues a 
second suture repair in seven of 29 recurrences was undertaken. All these patients 
developed a recurrent hernia during follow-up.10 
 
Prosthetic repair 
Surgical technique 
The promising results of mesh repair for other types of hernias have encouraged its use 
for parastomal hernia repair. Prosthetic material can be used to reinforce suture repair 
or to bridge the fascial gap. Meshes can be placed in different anatomic positions 
(Figure 8). With an onlay repair, the mesh is subcutaneously placed and fixed onto the 
fascia of anterior rectus sheath and the aponeurosis of the external oblique abdominal 
Figure 2 Meta-analysis (fixed-effects model; I2=56.5%; χ2=6.9, p=0.0752) of proportion of 
recurrences of suture repair of parastomal hernia. The square size represents the weight of 
the study, and the horizontal line through the square represents the confidence interval of 
the effect estimate. 
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muscle. A retromuscular technique indicates that the prosthesis is placed dorsally to 
the rectus muscle and anteriorly to the posterior rectus sheath. With an intraperitoneal 
position, the mesh is placed intra-abdominally onto the peritoneum. The inlay 
technique, in which mesh is placed within the fascial defect and sutured to the fascial 
edges, is nowadays abandoned in incisional hernia repair because of high recurrence 
rates.40 Potential drawbacks of prosthetic repair are mesh infection, erosion causing 
perforation, fistulas and adhesions.41 Polypropylene mesh (PPM) and expanded-
polytetrafluorethylene (e-PTFE) patch are the prosthetic materials most often used. 
 
Onlay mesh repair 
In 1977, Rosin and Bonardi were the first to report the technique of a paracolostomy 
hernia repair with onlay PPM.42 Seven retrospective series reporting on a total of 157 
repairs were included (Table 3). In the majority of these repairs, the prefascial plane was 
entered through a lateral parastomal incision.15,18-21 After reduction of the hernia sac, the 
fascial opening was narrowed with sutures and a PPM was placed to reinforce the suture 
repair. Three different techniques for mesh positioning are described. The majority used 
the keyhole technique in which the prosthesis is placed around the stoma after creating a 
slit and a central hole in the prosthesis (Figure 9).15,18-21 In both other techniques the 
bowel is pulled through a hole in the prosthesis, requiring full mobilization of the 
bowel. Two series described the use of a PPM with a reinforced solid polypropylene 
ring to allow passage of bowel through the prosthesis.16,19 Data from the patients that 
underwent this procedure in the study by Luning et al. (n=2) could not be extracted 
from the rest of the patients. In the other series, de Ruiter and Bijnen present 46 
paracolostomy hernia repairs with the use of a reinforced solid polypropylene ring.16 
Infection occurred in two patients postoperatively requiring prosthesis removal in one. 
Another patient presented with a late infection after a follow-up of 23 months, who also 
had the prosthesis removed. After a mean follow-up of 51 months, seven (15%) 
paracolostomy hernias recurred. Overall, the prosthesis was removed in 12 (26%) of the 
46 patients: in two following mesh infection, in five because of a recurrent hernia, and 
in another 5 during reoperations for other reasons. Steele and colleagues described the 
so-called ‘stove pipe hat’ technique, in which a PPM is placed overlying the fascial 
repair (Figure 10).17 The stoma is pulled through the centre of the mesh, thereby 
creating a 360-degree repair. An additional piece of mesh is then fixed to both the bowel 
circumferentially and onto the onlay mesh. Steele and co-workers repaired 58 
parastomal hernias using the ‘stove pipe hat’ technique.17 In selected cases, an 
additional mesh was placed beneath the fascia to provide additional support. Surgical 
site infections were seen in two patients (3.4%) and mesh erosion in one patient (1.7%). 
Other complications were reported in 9 patients (15.5%). No patients required removal 
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of the mesh. After a mean follow-up of 51 months, 15 parastomal hernias recurred 
(25.9%).  
All 157 patients undergoing onlay mesh repair, irrespective of technique, were pooled. 
There were no deaths reported. Postoperatively, the use of short term (< 24-48 hours) 
suction drainage was noted in all but two of the seven series.16,21 Preoperative 
administration of antibiotics was reported in five series.15,16,18-21 Overall morbidity was 
12.7% (95%-CI 8.0-19.0). Surgical site infection occurred in 3 patients (1.9% (95%-CI 
0.4-5.5)), mesh infection in 4 patients (2.6% (95%-CI 0.7-6.4)), and other complications 
in 13 patients (8.2% (95%-CI 4.5%-13.7%)). In three of the four patients with mesh 
infection the prosthesis was removed. In six series reporting on 149 patients, a follow-
up of at least 12 months was noted;15-19,21 27 patients (18.6% (95%-CI 12.8-25.1)) had a 
recurrent hernia. 
 
 
Figure 3 Meta-analysis (fixed-effects model; I2=36.3%; χ2=9.4, p=0.1513) of proportion of 
recurrences of onlay mesh repair of parastomal hernia. The square size represents the 
weight of the study, and the horizontal line through the square represents the confidence 
interval of the effect estimate. 
Table 3 Study characteristics and outcomes of onlay mesh repair of parastomal hernia 
 Reference Time 
period 
Mod. 
MINORS 
index 
No. Of 
repairs 
Type of stoma Material; 
Technique 
No. Of complications (%) Mortality Recurrence (%) Follow-up** 
  Wound 
infection 
Mesh 
infection 
Other
Ho et al.15 1982-
2001 
11 15 IC PPM; KH 0 0 2 0 1 (6.7) 15 
De Ruiter and 
Bijnen.16 
1988-
2002 
11 46 C CRE-PPM 0 3 1 0 7 (15.2) 51 
Steele et al.17 1988-
2002 
11 58 31 EC, 24 EI, 3 
LI 
PPM; ‘Stove 
pipe hat’ 
2 0 9 0 15 (25.9) 51 
Venditti et al.18 1993-
1996 
9 8 EC PPM, KH 1 0 0 0 0 (0) 38 
Lüning et al.19 1997-
2006 
11 16 12 C, 3 IC PPM (7), PE (6), 
Vicryl (1); KH 
(14), CRE-PPM 
(2) 
0 1  1 NS 3 (18.8) 33 
Amin et al.20 1999 9 9 1 C, 8 EI PPM, KH 0 0 0 0 0 (0) 7
Kald et al.21 1999-
2000 
10 5 4 C, 1 EI PPM, KH 0 0 0 0 1 (20.0) 12 
Weighted pooled % 
(95-CI) 
-  157 - - 1.9%
 (0.4-5.5) 
2.6% 
(0.7-6.4) 
8.3% (4.5-
13.7) 
0% 
(0.0-2.3) 
17.2%* (11.9-
23.4) 
Median†: 36 
* Weighted pooled proportion (fixed effects model) using only studies with ≥12 months mean follow- up; ** Values are mean months follow-up unless 
otherwise stated; † Median of reported follow-up of studies with ≥12 months follow-up; C: colostomy; IC: ileal conduit; EI: end ileostomy; EC: end 
colostomy; LI loop ileostomy; LC: loop colostomy; CRE-PPM: central ring enforced polypropylene mesh; NS: Not specified 
 Table 4 Study characteristics and outcomes of retromuscular mesh repair of parastomal hernia 
Reference Time 
period 
Mod. 
MINORS 
index 
No. Of 
repairs 
Type of 
stoma 
Material; 
Technique 
No. Of complications (%) Mortality Recurrence 
(%)* 
Follow-
up** 
      
Wound 
infection 
Mesh 
infection 
Other    
Kasperk22 1996-
2000 
11 7 4 C, 3 EI PPM; KH 0 0 0 0 2 (28.6) NS 
Longman23 2000-
2004 
11 10 7 EC, 2 EI, 1 
LI 
PPM; KH 0 0 1 0 0 (0) 30 
(median) 
Guzman-Valdivia24 2008 11 25 C PPM; KH 2 0 2 0 2 (8.0) 12 
Weighted pooled 
%; 95 per cent c.i. 
-  42 - - 4.8%  
(0.6-16.2) 
(0.0-8.4) 7.1% 
(1.5-
19.5) 
(0.0-8.4) 6.9%* (1.1-
17.2) 
Median†: 
12 
 
* Weighted pooled proportion (fixed effects model) using only studies with ≥12 months mean follow- up; ** Values are mean months follow-up 
unless otherwise stated; † Median of reported 
 follow-up of studies with ≥12 months follow-up; C: colostomy; EI: end ileostomy; EC: end colostomy; LI loop ileostomy; NS: Not specified 
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Retromuscular mesh repair 
With the retromuscular technique, the mesh is placed posterior to the rectus abdominis 
muscle onto the posterior rectus sheath. The mesh is placed either via a laparotomy or 
a parastomal incision. Three studies including a total number of 49 patients were 
included.22-24 All authors used the keyhole technique. Two reports mentioned the use 
of preoperative antibiotics.22,23 None of the patients died. Besides 4.8% (95%-CI 0.6-
16.2) wound infections, no mesh infections or other complications were reported. 
Follow-up was adequate in two series including 35 patients.23,24 The overall recurrence 
rate was 6.9% (95%-CI 1.1-17.2). 
 
Open intraperitoneal mesh repair 
Basically, two techniques are used to repair parastomal hernias with an intraperitoneally 
placed prosthesis: the ‘Sugarbaker’ technique and the keyhole technique. In 1985, 
Sugarbaker described a new technique for parastomal hernia repair.43 Via a laparotomy 
the trephine opening is covered with an intraperitoneally placed prosthetic mesh which 
is sutured to the fascial edge (Figure 11). The bowel is lateralized passing from the 
Figure 4 Meta-analysis (fixed-effects model; χ2=0.8, p=0.3716) of proportion of 
recurrences of retro-muscular mesh repair of parastomal hernia. The square size 
represents the weight of the study, and the horizontal line through the square represents 
the confidence interval of the effect estimate. 
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hernia sac between the abdominal wall and the prosthesis into the peritoneal cavity. Six 
recurrent and one primary parastomal hernia were repaired and no recurrences were 
reported after a mean follow-up of 5 years.43 This study was not included in the analysis 
because it did not meet the inclusion criteria.  
One retrospective study presenting the results of an open Sugarbaker repair in 20 
paracolostomy hernias fulfilled the inclusion criteria.29 In this report by Stelzner and 
colleagues, repair was done using a large e-PTFE prosthesis covering the trephine 
opening with an overlap of at least 5 cm. One intraoperative complication (urinary 
bladder lesion) and two major postoperative complications (bowel obstruction 
secondary to dense adhesions unrelated to the mesh and a pulmonary embolism) were 
reported. One surgical site infection was reported without infection of the prosthesis. 
Minor complications were seroma formation, bowel paralysis, and pain at the site of the 
transfascial sutures. Three recurrences (15.0%) after a mean follow-up of 42 (range 
3－48) months were found. All these recurrences were asymptomatic and treated 
conservatively.  
In four studies the keyhole technique was used including 65 intraperitoneal parastomal 
hernia repairs (Table 5).25-28 The use of perioperative antibiotics was mentioned in two 
reports.21,24 Both a single wound infection and a mesh infection were reported (2.2% 
(95%-CI 0.0-11.8)). Overall morbidity was 22.2% (95%-CI 11.2-37.1). Morris-Stiff and 
Hughes, who used an intraperitoneal PPM in seven repairs, reported complications 
related to dense adhesions in four patients (57.1%).26 Hofstetter et al. reported migration 
of the e-PTFE prosthesis resulting in angulation of the stoma in 2 out of 13 patients, 
which were still asymptomatic at the time of writing. Two patients underwent a re-
laparotomy for unrelated reasons; the prosthesis was found to be fixed to the adjacent 
fascia and the colon by ingrowth of fibro-colleagenous tissue.27 
Follow-up was adequate in 3 of the 4 series using the keyhole technique.25,26,28 
Recurrent hernia was found in 3 out of 32 patients (9.4% (95%-CI 2.0-25.0)). 
 
Laparoscopic intraperitoneal mesh repair 
The laparoscopic approach involves minimally invasive access to the abdominal cavity 
and intraperitoneal placement of prosthetic material with or without narrowing the 
trephine opening. Generally, three to four trocars are used for access. Adhesiolysis, 
reduction of the hernia sac content, and placement and fixation of the prosthesis are the 
key steps of the procedure. Similarly to the open intraperitoneal mesh repair, both the 
Sugarbaker, the keyhole and a combination of both (i.e sandwich) are used. The keyhole 
technique was used in 165 patients in eight studies, the Sugarbaker technique was used 
Table 5 Study characteristics and outcomes of ‘Open’ intraperitoneal mesh repair of parastomal hernia 
 
 
 
 
 
Reference Time 
period 
Mod. 
MINORS 
index 
No. Of 
repairs
Type of 
stoma 
Material; 
Technique
No. Of complications (%) Mortality Recurrence 
(%) 
Follow-up**
      Wound 
infection
Mesh 
infection 
Other    
Byers et al.25 1982-
1989 
11 9 6 C, 3 EI PPM, KH 1 0 0 0 0 (0) 13 
Morris-Stiff et al.26 1990-
1992 
11 7 2 EC, 5 EI PPM, KH 0 1 3 0 2 (28.6) 78 
Hofstetter et al.27 1998 10 13 C PTFE, KH 0 0 0 0 0 (0) NS 
Van Sprundel et 
al.28 
2000-
2003 
11 16 8 EC, 5 EI, 4 
US 
e-PTFE, KH 0 0 5 0 1 (6.3) 28 
Weighted pooled 
%; (95%-CI) 
- - 45 - - 2.2%  
(0.0-11.8)
2.2%  
(0.0-11.8)
17.8% 
(8.0-32.1)
0.0 
 (0.0-7.9) 
7.2%*  
(1.7-16.0) 
Median†: 28 
            
Stelzner et al.29 1994-
2002 
10 20 C PTFE, SB 1 0 2 0 3 (15.0) 42 
* Weighted pooled proportion (fixed effects model) using only studies with ≥12 months mean follow- up 
** Values are mean months follow-up unless otherwise stated 
† Median of reported follow-up of studies with ≥12 months follow-up 
C: colostomy; IC: ileal conduit; EI: end ileostomy; EC: end colostomy; LI loop ileostomy; LC: loop colostomy; SB: Sukarbaker; KH: 
keyhole; PTFE: Polytetrafluoroethylene; NS: Not specified
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in 124 patients in seven studies, and the sandwich technique was used in 47 patients in 
one study (Table 5). In another report a sandwich technique was used in a proportion 
of patients33, but these patients were excluded due to overlapping cohorts with a more 
recent report by the same authors (confirmed by personal communication).39 For the 
outcome measures other than recurrence, the data of all laparoscopic techniques were 
pooled because in most articles these outcomes were reported together and not 
extractable per technique. For the outcome recurrence, data divided per technique 
(Sugarbaker vs. keyhole) were extractable from all but one study.32 
In total, eleven series including 363 repairs are included for review of laparoscopic 
parastomal hernia repair (Table 6).14,30-39 All but two series used an-ePTFE mesh, in 
one series a polytetrafluoroethylene-polypropylene mesh (PTFE-PPM) was used34 and 
in one series a polyvinylidenefluoride-polypropylene mesh (PVDF-PPM) mesh was 
used (Table 6).39 Use of antibiotic prophylaxis was mentioned in five series31,36,35,37,38, 
and one series mentioned not using perioperative antibiotics.34 Conversion to open 
repair occurred in 13 of the 363 repairs (3.6%). Reasons for conversion were multiple 
dense  
Figure 5 Meta-analysis (fixed-effects model; I2=38.1%; χ2=4.8, p=0.1833) of proportion of 
recurrences of open intraperitoneal mesh repair of parastomal hernia. The square size 
represents the weight of the study, and the horizontal line through the square 
  
Table 6 Study characteristics and outcomes of laparoscopic repair of parastomal hernia 
Reference Time period Mod. 
MINORS 
index 
No. Of 
repairs 
Type of 
stoma 
Material; 
Technique 
No. Of complications (%) Mortality Recurrence† 
(%) 
Follow-up** 
      Wound 
infection 
Mesh 
infection 
Other    
LeBlanc et 
al.30 
N/S 10 12 8 EC, 2 EI, 2 
US 
e-PTFE; 7 SB, 
5 KH 
0 0 2 1 1 (8.3) 20 
Safadi et al.31 1998-2001 10 9 5 US, 2 EI, 2 
EC 
e-PTFE; KH 0 0 1 0 4 (44.4) 24 
McLemore et 
al.32 
1999-2006 11 19 9 US, 5 EI, 5 
EC 
e-PTFE; 14 SB, 
5 KH 
0 2 5 0 2 (10.5) 20 
Berger et 
al.33 
1999-2006 9 41 EI, US, EC e-PTFE; SB 1 2 5 0 8 (19.5) 24 (median 
Wara et al.34 1997-2008 12 72 48 
Colostomy, 
24 
Ileostomy 
e-PTFE-PP; KH 4 0 17 2 2 (2.8) 36 (median) 
Pastor et 
al.14 
1999-2006 11 12 6 Ileostomy, 
6 
Colostomy
e-PTFE; 7 
mod. SB, 3 
KH, 1 lateral 
slit 
2 0 2 0 4 (33.3) 13.9 
Mancini et 
al.35 
2001-2005 11 26 15 EC, 5 EI, 
6 IC 
e-PTFE; SB 2 1 1 1 1 (3.8) 19 (median) 
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Reference Time period Mod. 
MINORS 
index 
No. Of 
repairs 
Type of 
stoma 
Material; 
Technique 
No. Of 
complications 
(%) 
Mortality Recurre
nce† (%)
Follow-up** Reference Time period 
Muysoms et 
al.36 
2001-2007 10 24 20 C, 2 IC, 2 
I 
Various; 11 
KH, 13 SB  
0 0 0 0 10 (41.7) 22 
Hansson et 
al.37 
2002-2006 12 55 47 EC, 5 EI, 
3 US 
e-PTFE; KH 0 2 4 0 20 (36.4) 36 (median) 
Craft et al.38 2004-2006 11 21 5 C, 7 EI,  9 
US 
e-PTFE; 16 SB, 
5 KH 
1 2 5 0 1 (4.8) 14 
Berger et 
al.39 
2004-2008 10 47 NS PVDF-PP; 
‘Sandwich’ 
1 0 1 0 1 (2.1) 20 (median) 
           
Weighted 
pooled %; 95 
per cent c.i. 
- - 338 - - 3.3% (1.6-5.7) 2.7% (1.2-
5.0) 
12.7% 
(9.4-
16.8) 
1.2% (0.3-
3.0) 
* - 
* Recurrences rates of laparoscopic repair divided by technique (Sugarbaker vs. keyhole) are presented in Table 7 
** Values are mean months follow-up unless otherwise stated 
† Median of reported follow-up of studies with ≥12 months follow-up 
C: colostomy; IC: ileal conduit; EI: end ileostomy; EC: end colostomy; LI loop ileostomy; LC: loop colostomy; † excluding in-hospital 
deaths; PTFE-PP: Polytetrafluoroethylene-polypropylene; NS: Not specified 
~ table continued ~ 
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adhesions in six 34,37 and intra-operative full-thickness bowel injury in another six 
procedures14,34,37, and an inaccessible abdomen in one patient.33 Iatrogenic, intra-
operative bowel lesions were reported in 15 patients (4.1%). Five injuries were repaired 
laparoscopically34,39,30,35; in one of these, hernia repair was postponed for four days after 
which repair was successful.30 Six bowel injuries were repaired after conversion to a 
laparotomy.14,34,37 Four small-bowel injuries went undetected during operation; three 
lead to a peritonitis necessitating a re-operation34,37, and one resulted in multiple organ 
failure and death.34 Overall morbidity was 17.2% (95%-CI 13.4-21.3): wound infection 
occurred in 11 patients (3.3% (95%-CI 1.6-5.7)), mesh infection in 9 patients (2.7% 
(95%-CI 1.2-5.0)) and other complications in 43 patients (12.7% (95%-CI 9.4-16.8)).  
Meta-analyses of the pooled patient data for recurrence associated with the keyhole and 
Sugarbaker techniques are shown in Figures 6 and 7, respectively. In six studies 
reporting on 110 Sugarbaker repairs10,26,29,31,32,34, a recurrent hernia was reported in 13 
patients (11.6% (95%-CI 6.4-18.0)). In seven studies reporting on 160 repairs using the 
keyhole technique10,26,27,30,32,33,34, recurrence was reported in 38 patients (20.8% (95%-
CI 15.0-27.3)). All studies had a follow-up period of at least 12 months.  
Five studies included both the Sugarbaker and the keyhole techniques. In four studies 
the recurrence rate was lower in the Sugarbaker group14,30,36,38, whereas in one study no 
separate data were available.32 Muysoms and colleagues noted a recurrence in 8 out of 
11 (73%) patients after keyhole repair and 2 out of 13 (15%) patients after Sugarbaker 
repair36, Craft and co-workers reported a recurrence in 1 out of 5 repairs done with the 
keyhole technique and none using the Sugarbaker technique38, and Pastor et al. reported 
a reherniation in 2 out of 3 patients after keyhole repair and in 2 out of 7 (28.6%) 
patients after Sugarbaker repair.14 
Berger and co-workers report on the use of a sandwich technique which combines the 
Sugarbaker and the keyhole techniques.39 A PVDF-PPMesh was used throughout. After 
a median follow-up of 20 (range 6-48) months, one out of 47 (2.1%) patients had a 
recurrent hernia. 
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Comparison of techniques 
The results of pooled data for the different techniques of parastomal hernia repair are 
summarized in Table 7. Logistic regression analyses were performed with the outcomes 
recurrence, wound infection, mesh infection and overall complications. 
Suture repair resulted in an increased recurrence rate compared to other techniques 
(p<0.0001). The recurrence OR for suture repair versus laparoscopic repair equalled 
8.88 (95% CI 5.2-15.1). The other techniques did not differ significantly from 
laparoscopic, although both open intraperitoneal (p=0.07) and sublay (p=0.07) 
techniques approached significance in favour of these techniques. Within the 
laparoscopic procedures, the Sugarbaker technique resulted in a significantly lower 
recurrence rate compared to the keyhole technique (OR 2.3, 95% CI 1.2-4.6; p=0.016). 
The risk of mesh infection did not differ between mesh techniques (p=0.99) with an 
Figure 6 Meta-analysis (random-effects model; I2=88.1%; χ2=50.6, p<0.0001) of proportion 
of recurrences of laparoscopic mesh repair of parastomal hernia using the keyhole 
technique. The square size represents the weight of the study, and the horizontal line 
through the square represents the confidence interval of the effect estimate. 
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overall rate of 2.3% (95% CI 1.3-3.9). Similarly, other postoperative morbidity (p=0.43) 
and overall postoperative morbidity (p=0.38) did not differ between all surgical 
techniques. Wound infection was higher in suture repair compared to the other 
techniques (OR 4.0, 95% CI 1.7-9.5, p=0.02). 
 
 
 
Figure 7 Meta-analysis (fixed-effects model; I2=52%; χ2=10.4, p=0.0644) of proportion of 
recurrences of laparoscopic mesh repair of parastomal hernia using the Sugarbaker 
technique. The square size represents the weight of the study, and the horizontal line 
through the square represents the confidence interval of the effect estimate. 
Table 7 Summary of pooled proportions of outcome measures per surgical technique for parastomal hernia repair 
Technique No. Of 
studies 
No. Of 
repairs 
Complications (95%-CI) Recurrence %* (95%-
CI) 
  Wound infection Mesh infection Other
Suture repair 5 106 11.8% (6.1-20.2) - 10.8% (5.3-18.9) 69.4% (59.7-78.3) 
Onlay mesh 8 176 1.9% (0.4-5.5) 2.6% (0.7-6.4) 8.3% (4.5-13.7) 17.2% (11.9-23.4) 
Sublay mesh 3 42 4.8% (0.6-16.2) 0% (0.0-8.4) 7.1% (1.5-19.5) 6.9% (1.1-17.2) 
Open intraperitoneal 
mesh 
5 65 - - - -
Sugarbaker 1 20 5.0% (0.1-24.9) 0 (0.0-16.8) 10.0% (1.2-31.7) 15.0% (3.2-37.9) 
Keyhole 4 45 2.2% (0.0-11.8) 2.2% (0.0-11.8) 17.8% (8.0-32.1) 7.2% (1.7-16.0) 
All laparoscopic mesh 12 338 3.3% (1.6-5.7) 2.7% (1.2-5.0) 12.7% (10.2-17.5) 14.2% (10.7-18.0) 
Sugarbaker 6 110 - - - 11.6% (6.4-18.0) 
Keyhole 7 160 - - - 34.6% (13.1-60.3) 
Sandwich 1 47 2.1% 0 2.1% 2.1%
   
* Weighted pooled proportion using only studies with ≥12 months mean follow- up
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Figure 8 Schematic illustrations of the anatomic positions of prostheses placement in
parastomal hernia repair. Arrows indicate direction of dissection a Onlay mesh is
subcutaneously placed and fixed onto the fascia of the anterior rectus sheath. b
Intraperitoneal (underlay) mesh is placed intra-abdominally onto the peritoneum. c Sublay
(retromuscular) mesh is placed dorsally to the rectus abdominis muscle and anterior to the
posterior rectus sheath. Inlay mesh (not shown) is placed within the fascial defect and sutured
directly to the fascial edges; this technique is now largely abandoned due to high recurrence
rates. 
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Discussion 
Despite the abundance of literature on parastomal hernia repair, it is not possible to 
draw firm conclusions about the preferred technique. Suture repair should be abandoned 
because recurrence rate is significantly higher than in any other technique. The results 
of open and laparoscopic techniques are similar. Laparoscopic repair using the 
Sugarbaker technique results in significantly less recurrences than with the keyhole 
technique. 
The majority of the literature about treatment of parastomal hernia consists of 
retrospective studies and case series with only small numbers of patients. There have 
been no randomized clinical trials published to date. The study populations are diverse 
with different types of stomas and some series also include re-repairs. The outcome 
parameters are ill-defined and the method of follow-up to detect postoperative 
complications or recurrent hernias differs between series. Also, proper definitions of 
surgical site infection and mesh infection are lacking. Therefore, the results of the 
present review should be interpreted with care. The quality of evidence is level C/D 
Figure 9 ‘Keyhole’ 
mesh technique of 
parastomal hernia 
repair
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following Lebwohl.44 
Suture repair is attractive because it is a simple technique and it avoids a laparotomy. 
However, suture repair should be regarded as outdated because of the unacceptable high 
recurrence rate of 69.4%. Similarly to suture repair for incisional hernia, the high 
recurrence rate may be explained by an intrinsic defect in wound repair and collagen 
metabolism which is not corrected for by merely suturing the defect.45 In addition, the 
unfavourable biomechanics in suture repair which make a tension-free repair impossible 
may also be responsible for the poor results. 
Synthetic mesh repair gives significantly better results than suture repair with respect to 
wound infection and recurrence rate. Depending on technique and placement, 
recurrence rates after mesh repair vary between 6.9% and 17.8%. Nevertheless, 
surgeons are reluctant to use synthetic meshes because tight adhesions between the 
mesh and the bowel may develop and meshes may even erode into the bowel. 
Moreover, implantation of a foreign body increases the risk of seroma formation and 
infection.17,24,41 These prejudices are not supported by the available literature. The 
overall mesh infection rate is 2.4% and wound infection rate is even lower in mesh 
Figure 10 ‘Stove pipe hat’ 
mesh technique of 
parastomal hernia repair
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Figure 11 
Sugarbaker mesh 
technique of 
parastomal hernia 
repair 
repair (4.1%) than in suture repair (11.7%). These results are similar to the use of 
synthetic meshes in a contaminated field for hernia repair, which further supports that 
application of meshes for parastomal hernia repair is safe.46,47 It is therefore concluded 
that synthetic mesh repair is favoured over suture repair.  
Meshes can be implanted in an onlay, sublay, or intraperitoneal position. The rates of 
wound and mesh infection did not differ between the various techniques of mesh repair. 
Although not statistically significant, the onlay technique had the highest recurrence rate 
and the sublay (pre-peritoneal) technique the lowest. The sublay and intraperitoneal 
mesh techniques are biomechanically more attractive because the intra-abdominal 
pressure supports the fixation of the prosthesis against the fascia. The sublay position 
has the additional benefit that the mesh is enveloped in well vascularised tissue and that 
the fascia and peritoneum form a natural barrier between the prosthesis and the 
abdominal organs. 
When performing intraperitoneal repair, the choice can be made between the keyhole 
and Sugarbaker repair. The recurrence rate is significantly lower with laparoscopic 
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repair using the Sugarbaker compared to the keyhole technique. There is as yet 
insufficient evidence to show if this holds true for open intraperitoneal repair of 
parastomal hernias. With the keyhole technique, it is difficult to estimate the size of the 
hole in order to ‘snugly’ accommodate passage of the colon. Also, shrinkage of the 
mesh may result in enlargement of the central hole which is often noted as the site of 
reherniation.36,37 One laparoscopic study reported on a sandwich repair using PVDF-
PPM prostheses combining both the Sugarbaker and keyhole techniques resulting in the 
lowest recurrence rate.39 
Overall, laparoscopic repair had no advantage over open repair with respect to 
morbidity and mortality. There are insufficient data available to compare both 
techniques on other aspects such as operative time, postoperative pain, return to work 
and development of incisional hernia. Only one study compared laparoscopic and open 
repair in a non-randomized retrospective study.14 No statistically significant differences 
were found with respect to morbidity, recurrence and duration of operation. Still, length 
of stay was nearly significant (3 days [laparoscopic] versus 5 days [open]) in a small 
population (p=0.05). In the current review, inadvertent enterotomy during laparoscopic 
repair was observed in 4% of cases. Although this complication was not mentioned in 
the open repair studies, inadvertent enterotomy is reported in 4.7-20% of patients 
undergoing a relaparotomy.48-50 
Polypropylene and e-PTFE are the most frequently used prosthetic materials for 
parastomal hernia repair. Polypropylene anchors well to the adjacent fascia by ingrowth 
of fibro-collagenous tissue. However, the open mesh structure causes dense adhesions 
between the mesh and the adjacent organs. Moreover, the sharp edges and the formation 
of sharp folds due to shrinkage of the mesh may cause erosion of the mesh into adjacent 
organs.4,25 To prevent erosion into the bowel, De Ruiter and Bijnen developed a 
polypropylene mesh with a central polypropylene ring sized appropriately for passage 
of the bowel.51 Although mesh erosion was prevented, the results were disappointing 
with a 39% reoperation rate for complications or recurrences. It is well-recognized that 
implantation of PPM into the peritoneal cavity is potentially hazardous, and further 
studies and greater follow-up are mandatory before meshes including polypropylene can 
be liberally applied in this manner.26,52 
e-PTFE meshes have a microporous structure not allowing tissue ingrowth into the 
prosthesis.53-55 The anchorage of these meshes solely depends on the sutures and the 
envelop of fibrocollagenous tissue that surrounds the prosthesis, thus increasing the risk 
of reherniation.53,54 The softness of the material and the low tendency for developing 
adhesions, are major advantages. To combine the advantageous properties of both 
materials, several composite prostheses of PPM combined with either e-PTFE or PVDF 
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have been made. Berger et al. used intraperitoneally placed PVDF-PPMeshes in 47 
patients using the sandwich technique resulting in a single recurrence (2%). Only one 
patient developed a wound infection and three patients underwent a revision; two 
because of stenosis and one due to an abscess. No other mesh-related complications 
were reported.39 Wara and co-workers laparoscopically placed e-PTFE-PPM in a 
keyhole fashion which also resulted in a low recurrence rate (3%) but mesh-related 
complications required reoperation in 7% of patients.34 Infection is another major 
concern with the application of mesh. Due to its hydrophobicity and the microporous 
structure, e-PTFE is more susceptible to infections than PPM53, although no differences 
in wound and mesh infections were found in this review. Therefore, based on the 
present review no recommendations can be made about the preferred prosthetic 
material. More recently, biologic grafts have been used in parastomal hernia repair as an 
alternative, but they are very expensive and results do not differ from synthetic mesh 
repair.56 
In summary, the quality of evidence for the various surgical techniques for parastomal 
hernia repair is low and precludes firm conclusions. Randomized controlled trials 
would be ideal to compare the various techniques of parastomal hernia repair, but none 
could be identified in the literature. Also, additional prospective comparative trials 
would be more able to delineate preferred techniques than the currently available 
literature. According to the available evidence, suture repair should be abandoned in 
preference for mesh repair because of much lower recurrence rates and a low mesh 
infection rate found with mesh repair. No anatomic position of mesh is convincingly 
preferred above another, although onlay repair seems to coincide with a higher 
recurrence rate. When performing laparoscopic repair with an e-PTFE prosthesis, the 
Sugarbaker technique is preferred over the keyhole technique. New composite 
prostheses including a PPM component are now available but careful consideration 
should be taken besides rigorous long-term follow-up when placing these prostheses in 
the abdominal cavity.  
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Abstract 
Background: Biologic grafts are increasingly used instead of synthetic mesh for 
parastomal hernia repair due to concerns of synthetic mesh related complications. This 
systematic review was designed to evaluate the use of these collagen-based scaffolds 
for the repair of parastomal hernias. 
Methods: Studies were retrieved after searching the electronic databases MEDLINE, 
EMBASE and Cochrane CENTRAL. The search terms ‘paracolostomy’, 
‘paraileostomy’, ‘parastomal’, ‘colostomy’, ‘ileostomy’, ‘hernia’, ‘defect’, ‘closure’, 
‘repair’ and ‘reconstruction’ were used. Selection of studies and assessment of 
methodological quality were performed with a modified MINORS index. All reports 
on repair of parastomal hernias using a collagen-based biologic scaffold to reinforce or 
bridge the defect were included. Outcomes were recurrence rate, mortality and 
morbidity.  
Results: Four retrospective studies with a combined enrolment of 57 patients were 
included. Recurrence occurred in 15.7% (95% confidence interval [CI] 7.8 to 25.9) of 
patients and wound-related complications in 26.2% (95% CI 14.7 to 39.5). No 
mortality or graft infections were reported. 
Conclusions: The use of reinforcing or bridging biologic grafts during parastomal 
hernia repair results in acceptable rates of recurrence and complications. However, 
given the similar rates of recurrence and complications achieved using synthetic mesh 
in this scenario, the evidence does not support use of biologic grafts. 
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Introduction 
Parastomal herniation is a common complication following creation of an ileostomy or 
colostomy, with observed rates of up to 28% and 48%, respectively.1 Besides risk of 
incarceration and stenosis of the bowel, parastomal herniation can cause pain, 
discomfort and an ill-fitting pouching system that in turn may cause leakage and skin 
excoriation. Needless to say, body-image is adversely affected in patients that might 
already be experiencing social problems associated with the presence of a stoma.2 
Surgical treatment modalities available are relocation of the stoma and repair of the 
defect using either direct suture repair, or bridging or reinforcement with prostheses. 
Relocation of the stoma does not address tissue weakness secondary to systemic risk 
factors and, just like direct suture repair, often results in high recurrence rates.3,4 Since 
the introduction of synthetic mesh to reinforce or bridge the defect, this procedure has 
been regarded as the best possible care for parastomal herniation, showing lower 
recurrence rates.1,5 Its prophylactic use at the time of initial stoma creation is now 
often propagated to prevent future herniation.5,6 At the same time, reservations have 
arisen with respect to the implantation of synthetic mesh in close proximity to bowel 
and stoma due to risk of erosion and fistula formation.7 Also, dense adhesions may 
complicate future abdominal surgery.8 Besides these concerns, there is the universal 
fear of infection when implanting foreign-body material, especially in contaminated 
fields.  
Collagen-based biologic grafts have been produced since the eighties.9 These 
prostheses consist of an acellular collagen matrix that is slowly degraded and replaced 
by fibro-collagenous tissue of the host. Their properties depend on the species and type 
of tissue that the material is extracted from, the processing methods (including 
decellularisation and sterilisation), and whether or not they are intentionally cross-
linked. Biologic grafts used for incisional hernia repair are derived from either human 
dermis, porcine dermis, porcine small intestinal submucosa, or bovine pericardium. 
During processing the materials are made functionally acellular to prevent a foreign-
body response, while still maintaining their extracellular collagenous structure that 
allows for the host tissue ingrowth. Sterilisation of the materials by ethylene oxide gas 
or irradiation aims at making the final product pathogen free. Some products receive 
additional cross-linking of the collagen matrix to control or reduce the enzymatic 
degradation of the graft. This should give the host more time to deposit fibro-
collagenous tissue and remodel the prosthesis into strong native tissue. Due to their 
bio-compatibility resulting in rapid vascularisation and migration of host (immune) 
cells, it is thought that biologic prostheses are less prone to infection than synthetic 
grafts. Moreover, they are soft and pliable which potentially decreases the risk of 
discomfort and erosion into the bowel. However, given the high financial costs of 
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biologic grafts, proper evidence of more beneficial outcomes or cost-savings in the 
long-run are paramount to support their use. This systematic review aims to evaluate 
the use of these acellular collagen-based scaffolds for the repair of parastomal hernias, 
focusing on recurrence and complication rates.  
 
Methods 
Search methods for study identification 
Studies were identified using the electronic databases MEDLINE (including In-
Process & Other Non-Indexed Citations, 1950-Present), EMBASE (1980-Present) and 
the Cochrane Central Register of Controlled Trials (CENTRAL). Search terms used 
were: ‘parastomal’, ‘paracolostomy’, ‘paraileostomy’, ‘stoma’, ‘hernia’, ‘defect’ and 
‘repair’. Terms were searched for as free text and where applicable were also mapped 
to MeSH terms. Full-text articles retrieved for evaluation were scanned for other 
relevant references. No limits were set on language or publication status. Titles and 
abstracts were screened for eligibility and full-text articles were retrieved. The last 
search was performed on 13-09-2010. All reports on repair of parastomal hernias using 
an acellular collagen-based biologic scaffold as sole material to reinforce or bridge the 
defect were included. All other types of repair were excluded.  
 
Assessment of study quality 
All studies selected were subjected to a modified version of the MINORS 
(Methodological Index for Non-Randomised Studies) tool to evaluate their 
methodological quality (Table 1). This instrument was constructed and validated for 
appraisal of non-randomised trials in surgery.10 Studies were scored independently by 
2 authors (NJS, RPB). This modified version contains six items with a maximum score 
of two on each, yielding a maximum index of 12. Studies with a total score less than 
nine, or no score on item 2, 5 or 6 were excluded from systematic review. 
Disagreement was resolved by discussion and consensus between authors. Also, the 
diagnostic modality for the primary outcome was determined for every study.  
 
Data extraction 
The primary outcome was the rate of parastomal hernia recurrence observed, as 
defined by the respective authors. Study characteristics (year of publication, no. of 
patients, surgical technique, follow-up), perioperative (30-day) mortality and rates and 
98 
 
type of wound-related complications were also noted. Total amount of wound-related 
complications were calculated by adding up all relevant complications, including only 
the studies with adequate reporting. Weighted pooled proportions with their respective 
95% confidence intervals (CI) following the fixed-effects (inverse variance) model 
were determined for recurrences and wound-related complications using StatsDirect® 
statistical software.11 
Table 1 Modified Methodological Index of Non-Randomised Studies (MINORS) 
 
 
Results 
A flowchart overview of the search is depicted in Figure 1. The search strategy yielded 
333 titles and abstracts. After screening 317 records were excluded, leaving 16 articles 
to be retrieved and assessed for eligibility. Six of these were excluded after 
assessment,12-17 leaving a total of 10 articles that reported on the repair of parastomal 
hernias with biologic prostheses. After subjecting these to the modified MINORS tool 
another six were excluded due to too small sample sizes18-22 and inadequate reporting 
on surgical technique.23 This left four studies to be included in the systematic 
review.24-27 
  
Item Criteria Option Score 
1 A clearly stated aim - Not reported 
- Partially reported, no clear aim 
- Clear aim 
0 
1 
2 
2 Minimum of 5 included patients - No 
- Yes 
0 
2 
3 Inclusion of consecutive patients - Not reported 
- Patients in a certain time period 
- Consecutive patients + characteristics 
0 
1 
2 
4 Type of stoma specified - Not reported 
- Reported 
0 
2 
5 Surgical technique reported - Not reported 
- Incomplete 
- Reported clearly, appropriate to aim 
0 
1 
2 
6 Report of end points - Not reported  
- Recurrences only 
- Recurrences and postoperative 
complications 
0 
1 
2 
  Maximum score: 12 
Figure 1 Flow-chart of search strategy. 
 
 
 
 
Findings of systematic review 
All included studies were retrospective with a combined enrolment of 57 patients 
(range 11-20). The definition of a recurrence was not given by any author. Follow-up 
ranged from 8.1 to 50.2 months, and was done by clinical examination in three25-27 and 
also by CT imaging in one.26 One study was unclear as to how follow-up was 
performed.24 No mortality was reported. Study characteristics and outcomes including 
weighted pooled rates of recurrence and wound-related complications are shown in 
Table 2. The weighted pooled proportion of recurrences was 15.7% (95% CI 7.8 to 
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25.9) (Figure 2). No cases of infected grafts were reported. Araujo et al. only reported 
on infection (which was absent) and therefore their data were not included in the 
calculation of wound-related complications. Various surgical techniques were used, 
including onlay, inlay, and underlay (pre- and intraperitoneal) placement of the 
biologic graft. Both open and laparoscopic procedures were performed. Biologic grafts 
used were products derived from human acellular dermis (Alloderm®), bovine 
pericardium (Peri-Guard®), and porcine small intestinal submucosa (Surgisis®). 
Characteristics of the biologic grafts used in the included and excluded studies are 
given in Table 3. 
Table 2 Study characteristics and recurrence rates of studies included in systematic review 
Reference Year No. of 
patients 
MINORS 
index 
Material 
used 
Type of repair No. of wound 
complications 
(%) ** 
Recurrence (%) Months 
follow-up 
(range) 
Araujo et al.24 2005 13 10 Peri-Guard Onlay n/a 1 (7.7) 50.2 (n/a)*
Aycock et al.25 2007 11 9 Alloderm Inlay (n=8) and 
onlay (n=3) 
2 (18.2) 3 (27.3) 8.1 (1-21) 
Taner et al.26 2009 13 9 Alloderm Under + onlay 
sandwich 
5 (38.5) 2 (15) 9 (4-16) 
Ellis 27 2010 20 12 Surgisis Intraperitoneal 
underlay 
(Sugarbaker) 
4 (20.0) 2 (10) 18 (6-38) 
         
Weighted pooled %† 
(95 per cent c.i.) 
－ － － － － 26.2% (14.7-
39.5) 
15.7% (7.8-25.9) － 
*  This follow-up is that of a larger group of which these patients were part of 
** Complications: Wound infection (3)25,26, seroma formation (6)26,27, incisional separation (2)26 
† Using a fixed-effects (inverse variance) model 
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Table 3 Characteristics and costs of biologic and synthetic prostheses used for parastomal hernia 
repair 
 
Studies excluded from systematic review 
Six reports on the use of biologic grafts for the repair of parastomal hernias were 
excluded after subjecting them to the modified MINORS tool, including retrospective 
studies,20,23 case-reports19,21 and case-series18,22 (Table 4). Two case reports and two 
case series described the use of biologic grafts for the repair of parastomal hernia. 
Greenstein and Aldoroty reported on a patient with a history of ulcerative colitis and 
four ileostomy revisions that presented with unremitting obstructive symptoms19. An 
incarcerated parastomal hernia confirmed by CT was repaired using cross-linked 
porcine dermis (Collamend®) in a retromuscular fashion. Patient regained ileostomy 
function within a few days and when seen at 18 months was pain-free with no 
evidence of graft infection, hernia recurrence, ileostomy malfunction, or obstruction. 
Lo Menzo et al. reported on a patient with a history of abdominoperineal resection for 
rectal cancer that presented with a 3-time recurrent parastomal hernia, for which an 
Material Source Additional Cross-linking Preparation Costs per cm
2 * 
Alloderm Human dermis None Refrigeration, 
rehydration 
$ 35.31 
Permacol Porcine dermis Yes; HMDI None $ 18.97 
Surgisis Porcine SIS None Rehydration $ 20.00 
Collamend Porcine dermis Yes; EDC Rehydration $ 18.88 
Peri-Guard Bovine 
pericardium 
Yes; Gluteraldehyde Rehydration $ 3.91 
Veritas Bovine 
pericardium 
None None $ 22.02 
     
 Polypropylene / e-
PTFE / Composite 
- None $ 3.65 
* Based on sheet sizes sufficient for parastomal hernia repair, excluding account discount. 
Manufacturers and distributors were contacted directly via telephone; SIS: Small 
intestinal submucosa; HMDI: hexamethylene diisocyanate; EDC: 1-ethyl-(3-
dimethylaminopropyl) carbodiimide hydrochloride; Alloderm (LifeCell Corp., Branchburg, 
NJ, USA); Permacol (Tissue Science Laboratories, Aldershot, UK); Surgisis (Cook Surgical, 
Bloomington, IN, USA); Collamend (Bard Inc., Warwick, RI, USA); Xenmatrix (Brennen 
Medical Inc., St. Paul, MN, USA); Veritas, Peri-Guard (Synovis Surgical Innovations, St. 
Paul, MN, USA) 
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expanded polytetrafluoroethylene (e- PTFE) mesh was used for the last repair using 
the keyhole technique.21 The Sugarbaker technique28 was employed using bovine 
pericardium (Veritas®). Postoperatively a seroma developed which resolved 
spontaneously, and at 17-month follow-up there was no evidence of recurrence, the 
patient was pain free and satisfied with cosmetic results. In a case-series of 3 patients, 
Kish et al. reported on the primary repair of parastomal hernia using human acellular 
dermis (Alloderm) as onlay reinforcement.28 Two patients were followed for 6 months 
and 1 year, respectively, and remained hernia-free. One patient presented 8 months 
later with symptoms of intestinal obstruction treated conservatively. The patient 
subsequently returned 3 months later with intestinal obstruction and recurrent 
parastomal hernia that necessitated an operation for relocation of the stoma and repeat 
hernia repair. Inan et al. reported on 2 patients, one with a history of proctectomy after 
severe radiation proctitis presenting with discomfort and obstructive episodes, the 
other presenting with symptomatic hernia 18 years after abdominoperineal resection.18 
Both were repaired laparoscopically using cross-linked porcine dermis (Permacol®), 
and at nine and three months postoperatively there was no evidence of recurrence or 
mesh-related complications. 
Two retrospective studies on the use of cross-linked porcine dermis (Permacol) for 
various types of hernia repair in complex, infected or potentially contaminated 
settings, included 6 patients undergoing parastomal hernia repair. Of the total of 133 
procedures, Franklin et al. repaired parastomal hernia using intraperitoneal onlay mesh 
(IPOM)23 in two patients, showing no recurrences.20 Follow-up ranged 1-78 months 
using clinical examination. Loganathan et al. reported on repair of four parastomal 
hernias, one of which underwent reversal of the colostomy at the time of the hernia 
repair.23 Of the other three patients, one that had six previous attempts at hernia repair 
experienced a recurrence. This patient developed an ischaemic end ileostomy which 
subsequently developed a localised perforation which manifested as a fistula 
formation. Another patient also developed a fistula. Cross-linked porcine dermis 
(Permacol) was placed as inlay or onlay. Median follow-up of the complete series was 
377 days (range 85-1905 days) performed by clinical examination.  
Reference Year No. of 
patients
Material 
used 
Type of repair No. of wound 
complications 
(%) 
Recurrence 
(%) 
Follow-up 
(range) 
Kish et al.22 2005 3 Alloderm Onlay n/a 1 (33.3) (6-12) 
Inan 18 2007 2 Permacol Laparoscopic (method 
not specified) 
n/a 0 (0) 6 (3-9) 
Greenstein & 
Aldoroty 19 
2008 1 Collamend Retromuscular/sublay 0 (0) 0 (0) 18 
Franklin et al.20 2008 2 Surgisis Intraperitoneal onlay 
mesh (Laparoscopic) 
n/a 0 (0) n/a 
Lo Menzo et al 21 2008 1 Veritas Intraperitoneal 
(Laparoscopic 
Sugarbaker) 
1 (100) 0 (0) 17 
Loganathan et al.23 2010 3 Permacol n/a 2 (66) 1 (33) 12 (3-62)* 
* This follow-up is that of a larger group of which these patients were part of 
** Complications: seroma formation (1)21, ischaemic ileostomy and subsequent fistula (1)23, fistula (1)23 
 
Table 4 Study characteristics and recurrence rates of studies excluded from systematic review 
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Discussion 
The current systematic review evaluated the use of biologic grafts for parastomal 
hernia repair, which results in acceptable rates of recurrence, with a pooled rate of 
15.7% (95% CI 7.8 to 25.9). Wound-related complications were reported in 26.2% 
(95% CI 14.7 to 39.5). Given the current evidence, biologic grafts do not provide a 
superior alternative to other surgical options.  
In their review on parastomal hernia from 2003, Carne et al. shed some light on the 
outcomes of different techniques of parastomal hernia repair.1 In studies using 
synthetic meshes (intraperitoneal, preperitoneal and fascial onlay), the overall 
recurrence rate was 6/77 (7.8%). Infection is uncommon and only infrequently 
requires removal of the mesh. A search of the literature published since reveals 
reherniation occurring in 62/371 (16.7%) patients.31-43 As found by Carne et al., 
complications were low, with mesh infection reported in 15/460 (3%) of the patients. 
In the current systematic review of parastomal hernia repair using biologic grafts, rates 
of recurrence ranged from 7.7% to 27.3%, with a weighted pooled average of 15.7% 
(95% CI 7.8 to 25.9). Graft infection was zero, and other wound-related complications 
including wound infection were 26.2% (95% CI 14.7 to 39.5). Thus, these rates are 
very similar to those found for synthetic mesh. Notably, even the risk of mesh 
infection appears to be low when a synthetic graft is implanted. Given the current 
evidence, it cannot be concluded that biologic prostheses are more preferable than 
synthetic mesh to reduce the rates of immediate or long-term complications. 
Moreover, biologic grafts are very expensive compared to synthetic mesh (Table 3), 
which further refutes their superiority over synthetic mesh to provide not only 
effective but also efficient and cost-effective health-care. With limited financial 
resources, careful consideration must be taken whilst choosing the types of materials 
to use. 
It is well established that parastomal hernias can occur after great periods of time. 
Also, on the long run risk of infection may remain higher for non-absorbable synthetic 
meshes compared to degradable biologic grafts due to a prolonged presence of foreign 
body material. Studies with longer follow-up are therefore imperative to yield more 
reliable rates of recurrence and late complications for both these treatment modalities. 
The results of this systematic review were troubled by typical issues of potential bias, 
including the lack of uniformity between studies in definition and reporting of 
outcomes and patient characteristics.  
Given the scarcity of relevant studies, combined with the variety of biologic grafts 
used, it is impossible to make a direct comparison between the different products or 
types of material. The same goes for the surgical technique used (i.e. the type of 
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prosthetic placement), which is also of relevance for outcome. With synthetic meshes, 
average rates of recurrence after sublay mesh (5.7%)36,41 and intraperitoneal mesh 
(11.1%)34,35 are lower than after onlay mesh (22.8%)31-33 or laparoscopically placed 
intraperitoneal mesh (16.6%)37-40,32,33. Onlay placement requires extensive dissection 
of subcutaneous tissue which predisposes for hematoma and seroma formation and 
may disrupt skin vascularisation leading to impaired wound-healing. Moreover, due to 
its anatomical position, intra-abdominal pressure may lead to lateral detachment of the 
graft resulting in its higher recurrence rates. On the other hand, sublay and underlay 
techniques theoretically benefit from the intra-abdominal pressures which may help to 
keep the graft in place. Concerning complications, the sublay placement again 
theoretically seems the most advantageous of the techniques, resulting in the least 
contact between mesh and bowel.  
Besides its use for the repair of parastomal hernia, there has been much debate as to 
the effectiveness of the prophylactic placement of a reinforcing prosthesis at the time 
of initial stoma formation. In a recent systematic review of the use of a mesh to 
prevent parastomal hernia, Tam et al. made a strong case for the use of prophylactic 
mesh at the time of initial stoma formation, showing an overall recurrence rate of 
15.4%, compared to 55.2% in patients who received a conventional stoma6. Their 
meta-analysis performed on three randomised controlled trials yielded similar results. 
Complications were very low and did not differ between the two groups. To date, only 
one study can be identified that used a biologic graft for this purpose17. Hammond et 
al. compared the prophylactic use of cross-linked porcine dermis (Permacol) to 
conventional stoma formation. After a median follow-up of only 6.5 months, the 
conventional group had a recurrence rate of 33.3%, while the prophylactic group 
showed no recurrences. No complications were observed. Given the very low rate of 
complications associated with prophylactic synthetic mesh placement, there is as yet 
no support for the use of biologic grafts instead of synthetic ones in this surgical 
scenario.  
As mentioned earlier, when studying rates of hernia recurrence, next to an appropriate 
follow-up a properly defined outcome measure is deemed essential to create uniform 
and comparable findings. None of the studies in the current review provided a proper 
definition of a recurrence. Most studies used clinical examination to detect hernias, 
and one study also used CT imaging in all patients26. Here, the two patients that had 
radiologic evidence of a recurrence continued to be asymptomatic at 385 and 509 days 
follow-up, respectively, requiring no revision of their repair. Another study, which was 
excluded from this review due to the prophylactic placement of a biologic graft, also 
used CT imaging in all patients to determine hernia occurrence.16 Similarly, the only 
two occurrences were found on CT scan and were small asymptomatic hernias. If these 
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studies had used only clinical examination, it is conceivable that these asymptomatic 
patients might not have been found to have a recurrence. Most recently, Gurmu et al. 
examined the inter-observer reliability of clinical examination of parastomal hernia in 
three hospitals.44 This appeared to be low, with kappa values ranging between 0.29 and 
0.73. The correlation between CT and patient-reported complaints using a colostomy 
questionnaire was also low, revealing a kappa of 0.45. Even though the 
underestimation of rates of (minor) parastomal hernias may well be very common, its 
clinical relevance in asymptomatic and satisfied patients is only manifest in an 
increased risk of complications due to the hernia, such as incarceration and stenosis of 
bowel. It is hard to estimate these risks in patients with asymptomatic or small hernias, 
but given the marginal amount of recurrences and long-term complications in the 
studies discussed in this review and in the literature, they do not seem to give cause for 
concern. 
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Abstract 
Background: Recurrence rates after Component Separation Technique (CST) are low 
in the literature, but may be underestimated due to inadequate follow-up methods. 
Methods: Prospective patient follow-up was performed of consecutive patients that 
underwent repair of large and complex ventral hernias using CST without mesh 
utilization. Primary outcome was recurrent hernia determined by clinical examination 
at least one year after surgery in all living patients. Current literature underwent meta-
analysis regarding outcomes and mode of follow-up. 
Results: Seventy-five patients were included with a mean age of 52.2 years and a 
mean defect size of 214.9 cm2, respectively. Twenty-nine patients (38.7%) had a 
recurrent hernia after a mean of 40.9 months follow-up and this was significantly 
higher than in the literature (14.0%, P<0.01). Sixty-four percent of studies in the 
literature were unclear about the method of determining recurrent hernia or included 
telephone follow-up and questionnaires. 
Conclusions: CST coincides with a high recurrence rate when clinical follow-up is 
longer than a year. Reported recurrence rates are probably underestimated because the 
method and duration of follow-up are inadequate. 
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Introduction 
The reconstruction of a large and complex ventral hernia is challenging and technically 
demanding. There is no consensus regarding the best treatment despite new 
developments and evolution of existing surgical techniques.`1 The common method to 
bridge the fascial gap of a ventral hernia is placement of a synthetic prosthetic 
material. However, this may not be sufficient for very large defects, and leaves a 
significant surface of the abdominal wall void of the myofascial contracting apparatus. 
Other concerns of prosthetic bridging are infection and organ injury caused by mesh 
erosion. Biologic grafts are being recommended as an alternative to synthetic mesh to 
avoid infectious complications and erosion, but proof of their superiority is lacking2 
and serious doubts are being raised concerning their long-term durability.3 
An autologous method of ventral hernia repair that precludes the implantation of 
foreign materials is the Components Separation Technique (CST), first described by 
Ramirez and colleagues in 1990.4 Since then several modifications have been reported 
to deal for example with threatened skin ischemia or concomitant enterostomy 
placement.5-8 Besides ameliorating complications related to mesh implantation, 
restoration of the integrity and contour of the abdominal wall is a major advantage of 
CST over prosthetic bridging. 
Determining reliable recurrence rates for different surgical options in hernia repair is 
important for patients and for decision-making regarding choice of treatment. 
Published studies of CST without mesh for repair of large and complex abdominal 
wall defects show very low recurrence rates, with the majority lying between 0 – 
10%.9-22 This study was undertaken because the literature does not seem to be 
corroborated by our own clinical observations despite long term and extensive 
experience with the CST technique.6, 23-25 The aim of this study was to evaluate the 
outcomes of CST to repair large and complex ventral hernias at our institution, with a 
focus on hernia recurrence. 
A potential flaw in determining long-term outcomes is the lack of rigorous and reliable 
follow-up, utilizing telephone and postcard questionnaires. In the current study we 
performed an out-patient clinical follow-up in every patient at least one year after 
surgery. Our findings are compared to the literature, which was analysed regarding 
outcomes and mode of follow-up using systematic review and meta-analysis.  
 
Methods: Institutional chart review 
Inclusion criteria 
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All patients who underwent reconstruction of their ventral hernia with CST over a 10 
year period (2000-2010) at our institution were identified. No patients included in 
previous reports by the authors were included. Adult patients (aged 18–75 years at 
time of operation) who underwent repair including bilateral release of the external 
oblique fascia were eligible for inclusion, including patients with enterocutaneous 
fistulas and open abdomen. Patients who underwent CST including placement of 
biologic or non-absorbable synthetic mesh were excluded.   
  
Outcomes and data extraction 
The primary outcome was recurrent hernia for which all living patients were clinically 
assessed in the out-patient clinic at least 12 months after surgery. Ultrasonography or 
CT imaging was used to determine recurrent hernia in cases of suspicion of recurrence 
or inconclusive physical examination. Secondary outcomes were mortality and wound 
and medical morbidity. 
Medical records of all patients were reviewed comprehensively and the following data 
were extracted: demographic variables (sex, age, BMI), history (type and amount of 
laparotomies), co-morbidities (pulmonary, cardial, renal, gastro-intestinal, metabolic), 
risk factors (smoking, alcohol, steroids, medication, ASA score, wound class, blood 
pressure, heart rate, blood/electrolyte values), cause and size of abdominal wall defect, 
intraoperative variables (duration, blood loss, technique, iatrogenic damage), early 
postoperative (≤ 30 days after operation) variables, length of hospital/IC stay, major 
surgical (hematoma, seroma, skin necrosis, infection, wound dehiscence) and medical 
complications (pneumonia, postoperative ileus, urinary tract infection), re-operations, 
and long-term follow-up (>12 months) mortality and  reherniation. The Ventral Hernia 
Working Group (VHWG) grade was determined for each patient. This is a grading 
system (1: “Low risk”, 2: “Co-morbid”, 3: “Potentially contaminated”, 4: “Infected”) 
devised for risk assessment of surgical site occurrences in hernia patients.26 
Characteristics of the hernia were determined by CT imaging in all patients pre-
operatively, including the length and width which were transformed into the surface 
area (cm2) by using the formula for an ellipse: π * ½ length * ½ width. 
  
Statistical analysis 
Univariate logistic regression analysis was performed to identify risk factors 
associated with recurrent hernia, wound morbidity and medical morbidity, using Chi-
squared test to examine differences in proportions. Kaplan-Meier curve was generated 
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to estimate the cumulative hernia recurrence-free “survival” in time. Analyses were 
performed with SPSS version 16.0 (SPSS, Chicago, IL). 
 
Operative technique 
Antibiotic prophylaxis was started preoperatively and continued for 24 hours 
postoperatively in patients with wound classes I – III. Patients with wound class IV 
received antibiotics for five to seven days. CST was performed as described 
previously.23, 25 Briefly, the skin is opened via midline incision, or in cases of skin 
defects, just lateral to the defect. Viscera are dissected free from the ventral abdominal 
wall, identifying the lateral border of the rectus abdominis muscle from within the 
abdomen. Bowel procedures are performed as necessary. Skin and subcutaneous fat 
are dissected free from the anterior rectus sheath and the fascia of the external oblique 
muscle. The fascia of the external oblique muscle is released 1-2 cm. lateral to the 
lateral border of the rectus abdominis muscle. Release continues longitudinally 
including the muscular part that inserts on the thoracic wall extending 5-7cm cranially. 
The avascular fibrous plane between the external and internal oblique muscles is 
disunited up to the midaxillary line, taking care not to incise the internal oblique 
muscle. If tension-free midline closure is not possible at this point, the posterior rectus 
sheath is mobilized from the rectus abdominis muscle after a full length incision 
posteriorly. Skin necrosis may occur using CST, caused by transection of the 
epigastric perforators. Later in the series we therefore spared the perforating arteries 
around the umbilicus. The fascia is closed with a 2-0 polydioxanone running suture 
(PDS, Ethicon, Somerville, NJ, USA) with a suture to wound length ratio of at least 
4:1. Loose deep dermal sutures are placed to approximate wound edges as necessary 
and the skin is closed using an intracutaneous suture. Skin closure is always the aim 
even during contaminated procedures. Subcutaneous drains are always placed and are 
removed after three days or when drainage is less than 50 cc/24 hours. 
 
Methods: Systematic review of the literature  
Search Methods for Study Identification 
Studies were identified using the electronic databases MEDLINE, EMBASE and 
Cochrane CENTRAL. Keywords used were: ‘Components Separation’, ‘CST’ 
‘Ramirez’ and ‘fascial release/partition’ combined with ‘hernia’, ‘abdominal wall 
defect’, ‘midline’, ‘closure’, ‘reconstruction’ and ‘repair’. Terms were searched for as 
free text and where applicable were also mapped to MeSH terms. Full-text articles 
retrieved for evaluation were scanned for other relevant references. No limits were set 
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on language or publication status. Titles and abstracts were screened for eligibility and 
full-text articles were retrieved. The last search was performed on February 1st, 2013.  
 
Inclusion and exclusion criteria  
Studies describing CST for ventral hernia repair without standard addition of synthetic 
mesh were selected. Studies including a proportion of CST repairs that included 
permanent mesh placement were only included if this was done exclusively in patients 
in whom a sufficient reconstruction was otherwise not possible and they formed a 
minority (< 25%) of the total group studied. Studies were subjected to a modified 
Methodological Index for Non-Randomized Studies (MINORS) for further assessment 
of eligibility and methodological quality (Table 1), allowing for a maximum score of 
14. This instrument was constructed and validated for appraisal of non-randomized 
trials in surgery.27 Scoring was done independently by authors NJS and RPB and 
disagreement was resolved by HvG. Studies were excluded from systematic review if 
they scored a zero on item 2, 5, or 7.  
 
Primary and secondary outcome 
The primary outcome was recurrent hernia as defined by the respective authors. 
Specific attention was paid to the modality of follow-up used to determine recurrent 
hernias. Secondary outcomes were wound infection, wound morbidity, medical 
morbidity, and in-hospital mortality. Wound morbidity was calculated by adding up all 
relevant complications, including infection, hematoma and seroma formation, wound 
dehiscence, skin necrosis, and enterocutaneous fistula formation. 
 
Data Extraction and statistical analysis 
A data-form was used to extract all data, including the primary and secondary 
outcomes, study characteristics (study year, number of patients, length and modality of 
follow-up, surgical technique), and patients characteristics (surgical indications, age, 
BMI, size of defects). 
The outcomes recurrence, infection, and overall surgical morbidity are presented as 
weighted pooled proportions with their 95% confidence intervals (CI) following the 
random-effects (DerSimonian-Laird) model. The quantitative measure I2 was 
calculated to evaluate heterogeneity between studies concerning the pooled 
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outcomes.28 Meta-analyses were performed using StatsDirect Statistical Software 
version 2.7.9 (StatsDirect Ltd. 2008, England). 
 
Table 1. Modified Methodological Index of Non-Randomized Studies (MINORS) 
 
Item Criteria Option Score 
1 A clearly stated aim Not reported 
Partially reported, no clear aim 
Clear aim 
0 
1 
2 
2 Minimum of 10 patients included No 
Yes 
0 
2 
3 Inclusion of consecutive patients Not reported 
Patients in a certain time period 
Consecutive patients + characteristics 
 (including BMI and size of defect) 
0 
1 
2 
4 Diagnostic modality of follow-up Not reported/ telephone/postcard 
Clinical examination 
Clinical examination + CT/Ultrasound 
0 
1 
2 
5 Surgical technique Not reported 
Incomplete 
Reported clearly, appropriate to aim 
0 
1 
2 
6 End-points clearly stated in 
Methods section 
Not reported/unclear 
Stated, but inadequate 
Clearly stated 
0 
1 
2 
7 End-points appropriate to aim Not reported  
Recurrences only 
Recurrences and postoperative 
complications 
0 
1 
2 
    
  Maximum score 14 
 
 
 
Results: Institutional chart review 
Seventy-five consecutive patients that underwent CST without mesh utilization were 
included. Fifty-two (69.3%) were men, and the mean age was 52.2 (18 – 75) years. 
Additional patient demographics and hernia characteristics are described in Table 2. 
Forty-four (58.7%) patients were tertiary referrals due to the complexity of the hernia. 
Forty (53.3%) patients had undergone at least one previous ventral hernia repair with a 
median of 2 previous repairs (range 1 – 4). Additional bowel surgery was performed in 
30 (40.0%) patients, including fistula takedown in 13 (17.3%) patients. In all patients 
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release of the external oblique fascia was performed, and in 31 (41.3%) patients 
dissection of the posterior rectus sheath from the rectus muscle was done in addition.  
 
Postoperative morbidity 
Thirty-three wound complications occurred in 23 (30.7%) patients. On average, these 
patients had 1.5 (range 1 – 3) wound complications. Wound infection was the most 
common wound complication occurring in 10 (13.3%) patients, followed by seroma in 
9 (12.0%), hematoma in 5 (6.7%), skin necrosis in 7 (9.3%) and abscess formation in 1 
(1.3%). One patient had a hernia at the lateral border of the rectus abdominis muscle 
due to rupture of the internal oblique and transverse muscle at the incision site in the 
external oblique muscle. 
Medical complications occurred 26 times in 20 (26.7%) patients (range 1 – 3). 
Prolonged postoperative ileus occurred in 9 (12.0%), pneumonia in 5 (6.7%), and 
urinary tract infection in 3 (4.0%) patients, followed by miscellaneous complications 
(cellulitis, pyelonephritis, sepsis, heart failure, respiratory insufficiency) in the other 
cases.  
Overall, 48.0% of patients experienced either a wound complication, a medical 
complication, or both. Risk factor analysis for postoperative morbidity is presented in 
Table 2. 
 
Hernia recurrence 
Two patients (2.7%) died before follow-up, and had no recurrence at the last follow-up 
at 3 and 7 months. All other patients were clinically assessed for reherniation at least 
12 months postoperatively. Twenty-nine patients (38.7%) had a recurrent hernia after a 
mean follow-up of 40.9 months (range 12 – 133). The median time to reherniation was 
11 months (range 2 – 41). The Kaplan-Meier curve in Figure 1 shows the recurrence-
free “survival”. Eleven (14.7%) recurrences were small and/or asymptomatic hernias 
without desire for repair or at high surgical risk. Eighteen (24.0%) patients with a 
recurrence had physical or cosmetic complaints and were re-operated; 15 resulting in a 
sufficient abdominal wall after mesh repair. Two mesh repairs resulted in small defects 
which were accepted, while another mesh repair resulted in a reherniation. This was 
again repaired with a mesh which resulted in a new small defect which could be closed 
primarily using a prolene suture. Risk factor analysis for recurrent hernia is shown in 
Table 2. Wound morbidity was a significant predictor of hernia recurrence (odds ratio 
2.93, 95% CI 1.06 – 8.06). 
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Results: Systematic review of the literature 
The Systematic review was performed in accordance with PRISMA.29 The search 
flow-chart is presented in Figure 2 along with the reasons for exclusion of studies. A 
total of 23 studies were included in analysis, including the current report.7-13, 15-22, 24, 25, 
30-34 Study characteristics and recurrence and complication rates are shown in Table 2. 
The median MINORS score was 10 (range 6 – 14). Seven studies7-10, 24, 25 including 
450 patients reported a total of eight in-hospital deaths (1.8%). In 23 studies7-13, 15-22, 24, 
25, 30-34 including 724 patients, the weighted pooled recurrence rate was 14.0% (CI 9.4 
– 19.5) (Figure 3) with a median of 36 months follow-up (range 12 – 56). Non-
absorbable synthetic mesh was used in 27 (3.7%) of patients. Wound morbidity was 
adequately reported in 19 studies7, 9-13, 15, 16, 18-20, 22, 24, 25, 30, 31, 33 including 644 patients, 
yielding a weighted pooled proportion of 27.2% (95% CI 20.0 – 35.0). Wound 
Figure 1 Kaplan-Meier curve of recurrence-free “survival”.  
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infection occurred in 12.5% (95% CI 7.9 – 18.1) of patients. Inconsistency (I2) 
between studies was 
 
 
moderate to high for all these outcomes, with values of 73.4%, 77.2% and 75.7% for 
recurrence, overall wound morbidity, and wound infection, respectively. Medical 
morbidity was insufficiently reported in the studies for data pooling. Eight studies 
(34.8%) including the current one and two others by our group performed clinical 
and/or imaging to determine recurrent hernias in all patients, while 15 (65.2%) were 
unclear about follow-up modality or included utilization of telephone or postcard 
questionnaires.  
The recurrence rate from the current study differed significantly from the pooled 
proportion from the literature (38.7% vs 14.0%, P<0.01). No significant differences 
were found for both infection (13.3% vs 12.5%, P>0.99) and total surgical morbidity 
(30.7% vs 27.2%, P=0.56). 
Figure 5 Search flow-chart of systematic review following PRISMA.29 
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Discussion 
The current study evaluated the repair of large and complex abdominal wall defects 
using CST without mesh at a single institution. Also, systematic review and meta-
analysis of the literature was undertaken to summarize the growing body of evidence 
available pertaining to the use of CST. Since the first report by Ramirez in 1990,4 
studies reporting on CST show significant associated morbidity, but a surprisingly low 
recurrence rate. Medical and/or surgical morbidity occurred in just over half of 
patients in the current study and is corroborated by the literature. However, over a 
third of patients developed a recurrent hernia, compared to one in seven patients in the 
literature. The current study is retrospective and includes hernia patients with varying 
types and degrees of complexity, reducing generalizability and making comparisons 
with other studies and techniques troublesome. However, this is the largest study 
reporting on CST without mesh to provide a proper clinical follow-up in every patient, 
which importantly took place at least one year after surgery. This yielded a recurrence 
rate of 38.7%. This rate is nearly three times higher and statistically differs from the 
recurrence rate yielded with literature meta-analysis. If the three studies by our group 
are excluded from meta-analysis, the pooled recurrence rate from the literature drops 
to 11.0% (95% CI 7.7-14.8). 
A vital factor in ascertaining reliable recurrence rates in hernia research is long and 
rigorous follow-up, as it is well-known that recurrent hernias continue to occur many 
years after repair,35 and are most reliably detected at clinical visit. In our series, 62% 
of recurrent hernias were diagnosed within the first year after repair and 86% after a 
two year follow-up, whereas only 28% of recurrences were detected within 6 months. 
Studies were excluded from meta-analysis if their mean follow-up was less than 12 
months. Still, only seven studies stated a follow-up of at least 12 months in every 
patient. Only four of these studies performed follow-up using exclusively imaging 
and/or clinical examination, three of which (including the current study) form the 
outliers of the meta-analysis with the highest recurrence rates as is shown in Figure 
3.24, 25  Interestingly, the only randomized controlled trial to evaluate CST repairs 
(discontinued due to unacceptable wound complications and prosthetic loss in the 
comparison arm utilizing e-PTFE underlay mesh for hernia repair) reported 10 
recurrences in the 19 CST patients (52.6%). Overall, 66.6% (14 out of 21) of the 
studies in the literature either did not comment on how they performed follow-up or 
used telephone and postcard questionnaires in some or all of their patients (Table 3). 
This is a concern, considering even clinical diagnosis of incisional hernias by surgeons 
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is often a challenge, especially for small, asymptomatic hernias and in obese patients. 
Ideally, follow-up should include the use of clinical examination and imaging in all 
patients after long periods of time. This is corroborated by a recent study reporting 
20% undetected hernias using clinical examination compared to a combination of 
examination and imaging.36  
The current population is a very complex and co-morbid one, and it is felt a high 
recurrence rate may be expected. More than half of patients in our study were tertiary 
referrals due to the complexity of the patient and/or hernia. Also, over half of patients 
had already undergone (often multiple) prior attempts at hernia repair, thereby creating 
a selection of problematic hernia-forming patients with additionally compromised 
abdominal wall tissues. Also, the hernias were generally quite large in size. Although 
not ideal, in our study we used the formula for an ellipse, which more closely 
represents hernia defects than the square (length x width) applied in other studies 
leading to overestimation with about 25%. Not all recurrences have the same clinical 
relevance, as just over half of the recurrences detected in the current study were 
deemed necessary of repair by surgeon and patient. Eventually, over three-quarter of 
patients achieved an acceptable (very small/asymptomatic hernia) or better (no 
recurrent hernia) result after one procedure, while most others did after a second 
procedure.  
CST is known for its significant postoperative wound morbidity secondary to 
extensive procedures, tissue undermining, and multiple co-morbidities. Wound 
infection occurred in 13.3% of patients and contributed to 30.7% wound morbidity, 
which are on par with rates from the meta-analysis: 12.5% (P>0.99) and 27.2% 
(P=0.56), respectively. Medical morbidity was insufficiently reported in the literature 
precluding meta-analysis, but occurred in 26.7% of patients in the current study. To 
minimize wound morbidity there was adoption of the technique saving the perforating 
epigastric arteries, as was suggested in literature.7, 37 This is important as skin blood 
supply from the intercostals arteries might be interrupted by prior surgery. 
Unfortunately, it was not possible to discern from the operative reports which patients 
had undergone this technique, precluding analysis of its influence on morbidity. Still, 
studies applying techniques aimed at minimizing subcutaneous undermining and 
disruption of cutaneous blood-supply have resulted in decreased skin necrosis37 and 
wound complications7 compared to the standard technique. In the current study there 
was a nearly three times increased risk of recurrent hernia development in patients 
with a wound complication (Table 2), underscoring the importance of minimizing 
wound problems also for long-term outcome. 
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Figure 6 Meta-analysis (random-effects model; I2=73.6%) of proportion of recurrences 
after ventral hernia repair using Components Separation Technique. The square size 
represents the weight of the study, and the horizontal line through the square represents 
the confidence interval of the effect estimate. 
125 
 
 
 Univariate odds ratio (95% confidence interval) 
Variable Recurrent hernia 
Wound 
complication 
Medical 
complication 
Patient characteristics    
 Age, per year increase 1.02 (0.98 – 1.06) 1.00 (0.97 – 1.04) 1.09 (1.03 – 1.16)*
 Male 2.25 (0.76 – 6.62) 1.38 (0.46 – 4.12) 1.46 (0.46 – 4.65)
 ASA score 2.25 (0.87 – 5.79) 1.02 (0.40 – 2.58) 8.29 (2.34 – 
29.42)* 
 BMI > 30 kg/m2 2.14 (0.72 – 6.39) 1.84 (0.60 – 5.66) 0.30 (0.06 – 1.43)
 Smoker 0.92 (0.37 – 2.47) 0.60 (0.21 – 1.70) 0.60 (0.20 – 1.79)
 COPD 1.01 (0.34 – 3.00) 0.83 (0.26 – 2.70) 2.15 (0.70 – 6.68)
 Diabetes 0.79 (0.07 – 9.08) 1.14 (0.10 – 13.20) 1.40 (0.12 – 16.28)
  Hypertension 1.15 (0.38 – 3.45) 0.63 (0.18 – 2.20) 1.71 (0.54 – 5.48)
 Previous hernia repair 1.42 (0.55 – 3.62) 2.03 (0.73 – 5.59) 1.10 (0.39 – 3.06)
 Previous Platzbauch 0.99 (0.29 – 3.38) 1.01 (0.28 – 3.68) 2.94 (0.85 – 10.18)
 No. previous 
laparotomies 
0.86 (0.64 – 1.14) 1.09 (0.82 – 1.45) 1.11 (0.83 – 1.50)
Perioperative factors    
 Size of defect, per 100 
cm2 increase 
0.94 (0.64 – 1.37) 0.80 (0.52 – 1.22) 1.21 (0.80 – 1.84)
 ECF takedown (%) 0.99 (0.29 – 3.38) 0.63 (0.16 – 2.54) 6.67 (1.85 – 24.04)†
 Concomitant bowel 
procedure (%) 
1.94 (0.71 – 5.34) 0.79 (0.26 – 2.39) 1.95 (0.66 – 5.75)
 Mesh removal (%) 0.47 (0.14 – 1.64) 1.58 (0.49 – 5.05) 1.30 (0.39 – 4.37)
 Surgical wound class (%) 1.22 (0.77 – 1.95) 0.86 (0.52 – 1.43) 1.80 (1.07 – 3.02)*
 VHWG grade 1.21 (0.66 – 2.19) 0.82 (0.44 – 1.52) 2.40 (1.10 – 5.23)*
 VHWG grade 
modification† 
1.13 (0.52 – 2.43) 0.52 (0.23 – 1.17) 3.94 (1.39 – 
11.14)* 
 Pre-op Hb level, per g/dl 1.14 (0.77 – 1.67) 0.92 (0.62 – 1.37) 0.59 (0.39 – 0.92)*
Table 2 Patient characteristics divided by patients who did and did not develop a recurrent hernia 
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Modifications of CST have been devised to improve outcomes, mostly based on 
minimizing subcutaneous undermining. Our group first described the modified 
technique using a separate incision aimed at preserving blood supply to skin and 
subcutaneous tissue, and to overcome the problem of stoma reconstruction.5 Other 
modifications include using a smaller (2-4 cm) separate incision and a modified 
Collin-Hartmann contractor to aid in the transaction of the external oblique 
aponeurosis,20 and endoscopically assisted CST using a dilation balloon and a 30-
degree laparoscope to visualize the intermuscular plane.6, 37 Clark and colleagues 
described the ‘perforator preservation’ modification  in which the fascial separation is 
done by separate inguinal incisions and balloon dissection, while ultrasonic shears are 
used to release the fascia of the external oblique muscle.7 DiCocco and co-workers 
reported on an anatomical modification of the CST, in which patients undergo anterior 
release of the fascia of the external oblique muscle along with division of the anterior 
fascial component of the internal oblique muscle, hereby freeing the lateral border of 
the anterior rectus sheath.8 The posterior rectus sheath is mobilized from the rectus 
abdominis muscle, and its medial border is sutured to the lateral border of the anterior 
increase 
 Procedure duration, per 
60 min. increase 
0.84 (0.59 – 1.20) 0.85 (0.58 – 1.24) 1.23 (0.85 – 1.77)
 Procedure duration, per 
100 min. increase 
0.76 (0.43 – 1.33) 0.94 (0.52 – 1.68) 1.53 (0.84 – 2.80)
 Blood loss, per 500 cc 1.01 (0.59 – 1.73) 1.20 (0.69 – 2.07) 1.72 (0.96 – 3.07)
 Inadvertent enterotomy 0.29 (0.03 – 2.64) § 0.53 (0.06 – 4.80)
Postoperative factors    
 Wound infection (%) 1.71 (0.45 – 6.51) – 2.04 (0.51 – 8.16)
 Wound morbidity (%) 2.93 (1.06 – 8.06)* – 1.31 (0.44 – 3.89)
 Medical morbidity (%) 1.08 (0.38 – 3.08) 1.31 (0.44 – 3.89) – 
~ table continued ~ 
ECF: Enterocutaneous fistula; COPD: Chronic obstructive pulmonary disease; ASA: 
American Society of Anesthesiologists; BMI: Body mass index; VHWG: Ventral Hernia 
Working Group 
* Statistically significant odds ratio with P < 0.05 
† Proposed by Kanters et al. 
§ Could not be calculated because one cell count was zero 
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rectus sheath. This way, a further 3-5 cm of medial mobilisation from each side is 
possible compared to standard CST. 
Suture repair of ventral hernias is regarded as obsolete given its very high recurrence 
rates, and it is unlikely that release of the external oblique muscle aponeurosis solves 
all problems. A popular method that potentially decreases recurrences after CST is 
augmentation of the repair with a mesh prosthesis. However, concerns with mesh 
implantation are infection or erosion of the prosthesis after these often contaminated 
procedures, necessitating re-operation for its removal. Biologic grafts are increasingly 
being used as an alternative and initially showed promising results,2 but a recent report 
seriously raises the question whether they may be considered a permanent solution in 
hernia repair as over half of hernias recurred by three years follow-up after single-
staged contaminated abdominal wall repair.3  
 
Clinical implications 
The literature pertaining to CST without mesh for repair of large and complex 
abdominal wall defects shows very low recurrence rates, but this is probably 
underestimated due to inadequate follow-up methods. Studies should stop using 
unreliable follow-up methods such as postcard and telephone questionnaires to 
determine recurrences. Instead, clinical examination or even imaging should be 
performed in all patients. Also, at least 12 months follow-up should be provided for all 
included patients to prevent significant underestimation of recurrence rates. 
Furthermore, it is essential to properly define the complexity of hernia patient 
populations using uniform variables, to allow more valid comparisons between studies 
and techniques.38 In our experience, repair of large ventral hernias using CST 
coincides with a high recurrence rate. Therefore, repair using CST without mesh must 
be reserved for patients in whom the use of mesh is contra-indicated, and patients 
should be informed about the risk of recurrence. In all other cases, mesh augmentation 
will probably decrease recurrences, but risk of mesh-related morbidity needs to be 
taken into account. 
 
 Table 3 Characteristics and results of studies reporting on CST without mesh for ventral hernia repair 
 
Study MINORS 
score 
n n with mesh (%) Size of defect 
LxW cm 
Infection (%) Wound 
complications (%)
Recurrence (%) Follow-up* 
(range) 
Exclusively  
imaging or 
clinical follow-up 
DiBello and Moore 1996 7 35 3 (8.6) 225 (15x15) (median) 2 (5.7) 5 (14.3) 3 (8.6) 22 (1-43) NS 
Shestak et al. 2000 8 22 1 (4.5) 7-15x12-25 2 (9.1) 3 (13.6) 1 (4.5) 52 (44-84) NS 
Cohen et al. 2001 9 24 5 (20.8) 20-30x15-27 0 3 (12.5) 1 (4.2) (12-36) NS 
De Vries-Reilingh et al. 
2003 11 38 0 (0) 234 cm
2 (18x13) 6 (15.8) 16 (42.1) 12 (31.6) 15.6 (12-30) Yes 
Girotto et al. 2003 6 96 0 (0) 140 cm2 25 (26.0) 25 (26.0) 21 (21.9) 26† No 
Szczerba et al. 2003 10 11 0 (0) 13 (width) 2 (18.2) 2 (18.2) 1 (9.1) 24 (6-54) NS 
Vargo et al. 2004 10 27 2 (7.4) 7-10x18-25 9 (33.3) 10 (37.0) 2 (7.4) (6-27) No 
Van Geffen et al. 2005 9 26 4 (15.4) 267 5 (19.2) 11 (42.3) 2 (7.7) Median 27 Yes 
Borud et al. 2007 9 12 0 (0) 8-15 (width) NS 6 (50.0) 1 (8.3) 18 (NS) NS 
Chang et al. 2007 10 30 0 (0) 18x13 2 (6.7) 3 (10.0) 1 (3.3) 44 (13-66) NS 
De Vries-Reilingh et al. 
2007 14 19 0 (0) 25x15 3 (15.8) 11 (57.9) 10 (52.6) 36 (36-36) Yes 
Shabatian et al. 2008 12 17 0 (0) 318 cm
2 (150-
625) 2 (11.8) 6 (35.3) 1 (5.9) 21 (NS) NS 
Dragu et al. 2009 7 17 0 (0) 107 cm2 NS NS 3 (17.6) 56 (14-103) No 
Wind et al. 2009 12 32 0 (0) ‘large or huge’ 8 (25.0) 10 (31.3) 7 (21.9) 18 (1-54) Yes 
Baumann et al. 2010 12 15 0 (0) 9.7 (width) 2 (13.3) 2 (13.3) 1 (6.7) 21.8 (9-42) Yes 
Clarke et al. 2010 9 65† 0 (0) 132 cm2 2 (3.1) 2 (3.1) 9 (13.8) 38† No 
Mazzochi et al. 2010 12 22 0 (0) 525 cm2 1 (4.5) 10 (45.5) 1 (4.5) 26.8 (12-44) Yes 
~ table continued ~ 
Study MINORS 
score 
n n with mesh (%) Size of defect 
LxW cm 
Infection (%) Wound 
complications (%)
Recurrence (%) Follow-up* 
(range) 
Exclusively  
imaging or 
clinical follow-
up 
Celdran-Uriarte et al. 2011 9 14 0 (0) 8.6 (width) NS 1 (7.1) 1 (7.1) 20.1 (±13.2) NS 
Fraccalvieri et al. 2011 13 30 0 (0) 10-28 (width) NS NS 0 36 (NS) Yes 
Kanaan et al. 2011 8 63 11 (17.4) NS 12 (19.0) NS 15 (23.8) 38 NS 
Yegiyants et al. 2011 11 34 1 (2.9) 255 cm2 (30-625) 7 (20.6) 15 (44.1) 2 (5.9) 47 (4-92) NS 
Authors 13 75 0 (0) 215 cm
2 (16-778) 
§ 10 (13.3) 33 in 23 (30.7) 29 (38.7) 40.9 (12-133) Yes 
          
Combined – 724 27 (3.7) – 12.5 (7.9-18.1)∥ 28.3 (22.3-34.7)∥ 14.0 (9.4-19.5)∥ – – 
 
 
 
 
NS: Not specified or inadequate reporting 
* Mean unless specified otherwise  
† Subset of a larger sample in which a diﬀerent technique or CST including mesh in the majority of paƟents was uƟlized 
§ Using the formula for an ellipse instead of length x width 
∥ Weighted pooled percentage (random-effects model) with 95% confidence interval 
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Abstract 
Background: Large ventral hernia repair represents a major surgical challenge, 
especially under contaminated conditions. Synthetic mesh is usually avoided due to 
fear of mesh infection and removal. However, evidence on synthetic mesh use in 
contaminated or infectious repairs regards outdated materials and techniques. The aim 
of this study was to evaluate the safety of (light and medium weight) polypropylene 
mesh use in contaminated ventral hernia at our institution, with a focus on surgical site 
infections and mesh removal. 
Methods: All large ventral hernias repaired with Component Separation Technique 
(CST) and polypropylene mesh were included in analysis. Primary outcomes were 
surgical site infection (SSI) and mesh removal. For risk analysis patients were 
stratified by various grading systems, including surgical wound class (SWC), Ventral 
Hernia Working Group (VHWG) and modified VHWG grade. 
Results: One hundred thirty-seven patients were included, with a mean age of 58.6 
years, a mean BMI of 26.6 cm2 and mean defect size of 235.6 cm2. SSI and total 
wound complication rates were 16.1% and 48.9%, respectively. The surgical wound 
class distribution of SSI’s was clean: 5/56 (9.1%), clean-contaminated: 5/34 (14.7%), 
contaminated: 3/19 (15.8%) and dirty/infected: 9/28 (32.1%). Seven meshes (5.1%) 
needed removal (6 complete and 1 partial), 2 after clean repairs, 3 after clean-
contaminated repairs, and 2 after dirty/infected repairs. Both SWC (OR 1.77, 95%-CI 
1.20 – 2.61) and VHWG grade (OR 2.31, 95%-CI 1.24 – 4.28) were predictors of SSI, 
whereas modified VHWG grade was not. 
Conclusion: Rate of surgical site infection after large contaminated ventral hernia 
repair is considerable but acceptable when considering the low mesh removal rate. 
Both surgical wound class and Ventral Hernia Working Group grade are predictors of 
surgical site infection. 
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Introduction 
The choice of repair technique in large ventral hernia is difficult even in the hands of 
experienced abdominal wall surgeons and especially when the hernia surrounding 
tissues are contaminated or infected. Bridging and reinforcement mesh techniques can 
be employed during repair. Bridging can be performed via laparoscopic or open 
technique. Laparoscopic repair is not always feasible due to absence of skin coverage 
or because of the need for extensive, time-consuming and complicated adhesiolysis. 
Also, bridging does not restore integrity of the abdominal wall musculofascial 
contracting apparatus resulting in dysfunction and loss of contour. Reinforcement 
restores abdominal wall integrity prior to mesh placement. The Component Separation 
Technique (CST), a common method applied for closure of large defects, 
accommodates more tension-free midline approximation. The key feature is release of 
the external oblique aponeurosis, allowing for significant medial advancement of the 
edges of the defect. Various alterations have been described, mainly aimed at 
minimizing wound morbidity.1 Both synthetic mesh and biologic mesh are used in 
combination with CST. Synthetic mesh is usually reserved for clean ventral hernia 
repair. The reluctance to use it in contaminated wound environments is due to fear of 
mesh-related complications. These suboptimal wound environments arise frequently 
due to concomitant bowel procedures, enterocutaneous fistula takedown, or treatment 
of the open abdomen. Mesh-related morbidity includes infection and erosion of the 
mesh into viscera or skin, necessitating re-operation for removal of the prosthetic. The 
Ventral Hernia Working Group (VHWG) therefore recommends biologic mesh during 
(clean-) contaminated procedures.2 However, true rates of synthetic mesh 
complications after contaminated procedures are unknown, as quoted evidence is 24 – 
32 years old and regards old and obsolete mesh materials and perioperative measures. 
3-5 In contrast, several recent small case-series from Europe suggest that synthetic 
mesh might be safe in clean-contaminated and selected contaminated cases.6-9 
We have extensive experience with the CST combined with synthetic mesh, both in 
clean and contaminated conditions. We believe synthetic mesh use is safe and feasible 
if an optimal technique is applied (including mesh coverage with well vascularized 
tissue) and appropriate perioperative measures are taken. The aim of the current study 
was to assess the safety of large and contaminated ventral hernia repair by CST with 
synthetic mesh, with a focus on surgical site infections and reoperation for mesh 
removal. 
 
Patients and Methods 
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Inclusion criteria 
Consecutive ventral hernia repairs performed between September 2000 and March 
2013 at our institution were identified from the hospital electronic patient database 
using the appropriate procedure codes. The operative reports were reviewed to 
determine if patients fulfilled the inclusion criteria of the study population: a ventral 
hernia repaired with CST combined with a non-absorbable synthetic mesh. CST was 
considered as any uni- or bilateral release of the external oblique aponeurosis to 
achieve medial translation of the rectus complex, with or without mobilization of the 
posterior rectus sheath. Department policy was to only perform a CST for large ventral 
hernia defects (more than 20 cm in length and 10 cm in width) or in 
contaminated/infected cases, and was performed exclusively by a group of 4 
experienced abdominal wall hernia surgeons. Main elements of the perioperative care 
protocol, e.g. comprehensive preoperative work-up, antibiotic prophylaxis and 
treatment, were unchanged during the study period.  
 
Outcomes and data extraction 
Data were extracted from electronic and paper charts and noted in a predefined case 
record form. Patient demographics, co-morbidities and hernia characteristics were 
retrieved, as well as variables relevant to the pre-, peri- and postoperative course 
(Table 1). The primary outcomes were the incidence of surgical site infection (SSI), 
mesh involvement, and reoperation for mesh removal. Surgical site infections were as 
defined by the CDC and determined by clinical suspicion or wound culture.  
Secondary outcomes were other wound complications, medical complications and 
recurrent hernia. Other wound complications included hematoma, seroma, wound 
ischemia, skin necrosis, fistula, and wound dehiscence. Medical complications 
included intra-abdominal fluid collections determined by CT imaging, sepsis, 
prolonged ileus, urinary tract infection, myocardial infarction, hypovolemia warranting 
blood transfusion, cerebrovascular accident, respiratory insufficiency warranting non-
invasive pulmonary pressure ventilation, pneumonia, pulmonary embolism, 
thrombosis and mortality. All complications except recurrent hernia were defined as 
those occurring 30 days postoperatively or during hospital stay in cases where this was 
longer than 30 days. Recurrent hernia was diagnosed by clinical examination and/or 
CT imaging during follow-up 
The ventral hernia size was determined by physical examination, CT imaging or 
intraoperative measurement. The surface area (cm2) was calculated by using the 
formula for an ellipse: π * ½ length * ½ width. 
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Severity of contamination was classified according to the Center for Disease Control 
and Prevention surgical wound class (SWC): ‘Clean’, ‘Clean-contaminated’, 
‘Contaminated’ and ‘Dirty/infected’.81 Hernias were also graded using the Ventral 
Hernia Working Group (VHWG) grades. This grading system was developed to 
estimate the risk of surgical site occurrences based on patient characteristics and 
intraoperative details: ‘Low-risk’, ‘Co-morbid’, ‘Potentially contaminated’ and 
‘Infected’.10 The modified VHWG grades involving three classes (‘Low-risk’, ‘Co-
morbid’ and ‘Contaminated’) and proposed recently by Kanters et al. was also applied 
to the data.12 
 
Surgical technique 
An incision is made in the scar of the previous laparotomy. Adhesiolysis is performed 
and viscera are dissected free from the ventral abdominal wall as necessary. Intra-
abdominal procedures are performed as required. The CST is performed as previously 
described.12 Briefly, subcutis is dissected free from the anterior rectus sheath and 
extended laterally to the external oblique aponeurosis, sparing as many periumbilical 
perforators as possible. An incision is made 1-2 cm lateral of the rectus abdominis 
muscle and the aponeurosis of the external oblique muscle is released. Incision is 
extended caudally and cranially, including the muscular part extending 5-7 cm over 
the thoracic wall. The fibrous avascular plane between the external and internal 
oblique muscles is created up to the midaxillary line. If additional mobilization is 
needed at this point, the posterior rectus sheath is released from the rectus abdominis 
muscle after full-length incision posteriorly. A medium or lightweight polypropylene 
synthetic mesh is placed preferably in the sublay position (between the abdominal 
rectus muscle and the posterior rectus sheath). If this was not possible an underlay 
(intraperitoneal) placement was performed. If this was considered hazardous at the 
surgeons discretion the mesh was placed as an onlay (between subcutis and the 
abdominal rectus muscle). Fascia is closed with a running suture with a suture to 
wound length ratio of at least four. The skin is always closed, applying deep dermal 
sutures as necessary. Drains are placed and are removed if production is less than 50 
cc per 24 hours or after 5 days. 
 
Statistical analysis 
Subgroup analyses were performed regarding primary and secondary outcomes for 
SWC, VHWG and modified VHWG grades. Univariate logistic regression was 
performed to identify risk factors for primary and secondary outcomes. Odds-ratio 
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(OR) with its 95% confidence interval (CI) was noted. Significance was set at a P 
value of 0.05. Analyses were performed with SPSS version 20 (SPSS, Chicago, IL).  
 
Results 
The operative reports of 1479 consecutive patients were identified in the electronic 
database and scrutinized for eligibility. One hundred thirty-seven patients met the 
inclusion criteria, having undergone large ventral hernia repair by CST in combination 
with synthetic mesh. Demographics and patient and hernia characteristics are 
presented in Table 1. Sixty-five percent of the patients were male and the mean age 
was 58.6 years (range 21 – 79). The median size of incisional hernia defect was 235.6 
cm2 (range 18.9 – 824.7) with a mean mesh size of 525.5 cm2. On average, patients 
had undergone 3 previous laparotomies (range 0 – 12). Patient distribution according 
to SWC and the VHWG and modified VHWG is listed in Table 1. Additional 
mobilization of the posterior rectus sheath was performed in 74 patients (54.0%). 
Polypropylene based meshes were applied in all cases. Vypro mesh and Proceed mesh 
(Ethicon, Somerville, NJ, USA), both lightweight macroporous polypropylene meshes, 
were used most often, in 62 (45.6%) and 42 (30.7%) patients, respectively. The 
majority of meshes were placed in a sublay fashion (n=100, 73.0%), followed by the 
intraperitoneal (n=23, 16.9%) and onlay (n=19, 13.9%). 
 
Surgical site infection and mesh removal 
SSI’s occurred 28 times in 22 patients (16.1%), including wound infection in 11 
(8.0%), enterocutaneous fistula in 5 (3.6%) of which 2 were recurrences, wound 
abscess in 5 (3.6%), mesh infection in 4 (2.9%), infected hematoma in 2 (1.5%) and 
infected seroma in 1 (0.7%). 
Mesh was removed in 7 patients (5.1%), 4 because of a mesh infection (3 complete 
and 1 partial excision), 2 because of an enterocutaneous fistula (one in a patient with 
Crohn’s disease) and 1 in a patient reoperated on for a re-bleeding and inadvertent 
small bowel damage. Distribution of mesh removal according to SWC was 2 in SWC I 
(3.6%), 3 in SWC II (8.8%) and 2 in SWC IV (7.1%). Mesh removal according to the 
VHWG grades was in 2 patients with VHWG grade 2 (5.6%), in 3 with VHWG grade 
3 (5.0%) and in 2 with VHWG grade 4 (7.1%). Three of the removed meshes were in 
modified VHWG grade 2 (5.9%) patients and 4 were in modified VHWG grade 3 
(7.3%) patients. 
Significant risk factors for SSI’s were diabetes mellitus (OR 3.12, P=0.037), SWC 
(P=0.017), VHWG grade (P =0.017), modified VHWG grade (P=0.012), duration of 
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surgery (P=0.008) and Proceed mesh (P=0.002). Vypro mesh was a protective factor 
(P=0.012) for SSI’s. 
 
Other complications 
There were four postoperative deaths (2.9%). Eighty-three patients (60.6%) 
experienced a postoperative complication, including wound complications in 67 
(48.9%) and medical complications in 51 patients (37.2%). Seroma occurred in 24 
patients (16.8%), hematoma in 20 (14.6%), necrosis in 17 (10.9%) and wound 
dehiscence in 6 (4.4%). Forty patients with wound complications (59.7%) necessitated 
intervention (29.2% of the total group). Medical complications included pneumonia in 
11 patients, respiratory insufficiency in 9, prolonged ileus in 9, sepsis in 8 and urinary 
tract infection in 7 patients, followed by miscellaneous complications in 16 patients 
(some patients experienced more than one medical complication). Sixteen patients 
underwent a reoperation (11.7%) due to (suspected) rebleeding in 3, drainage of a 
hematoma in 2, acute wound dehiscence in 2, intra-abdominal fluid collections in 2, 
skin flap necrosis in 2, and adhesive bowel obstruction, inadvertent colovesicostomy, 
abdominal compartment syndrome, anastomotic leakage and bowel perforation each in 
1 patient. 
Risk factor analysis for wound complications (including SSI) and medical 
complications are presented in Table 2. Age (P=0.017), male gender (P=0.022), 
hypertension (P=0.041), ASA class (P=0.022), VHWG class (P=0.043) and blood loss 
(P=0.001) were significant predictors for wound complications. Significant predicting 
factors for medical complications were age (P=0.038), COPD (P=0.002), steroids use 
(P=0.007), ASA score (P=0.003), SWC (P=0.036), VHWG grade (P=0.036), modified 
VHWG grade (P=0.013), blood loss (P=0.043), Proceed mesh (P=0.046) and 
intraoperative complications (P=0.029) (Table 2). 
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Table 1 Demographics and perioperative patient and hernia characteristics 
Preoperative variable n (%)* 
Patients 137 (100%) 
Age, y, mean (range) 58.6 (21 – 79) 
Male 89 (65.0%) 
BMI, kg/m2, median (range) 26.6 (17.9 – 45.9) 
COPD 24 (17.5%) 
Diabetes mellitus 17 (12.4%) 
Smoking 34 (25.2%) 
Steroid/immunosuppressant use 30 (21.9%) 
ASA score, median 2 (1 – 4) 
Previous laparotomies, median (range) 3 (0 – 12) 
Previous hernia repairs, mean (range) 0.7 (0 – 7) 
Previous SSI 40 (29.4%) 
Previous open abdomen treatment 35 (25.7%) 
Size of hernia defect, cm2, median (range) 235.6 (18.9 – 824.7)
Stoma present 38 (27.7%) 
Enterocutaneous fistula present 26 (19.0%) 
Wound class 
I. Clean 
II. Clean-contaminated 
III. Contaminated 
IV. Dirty/infected 
56 (40.9%) 
34 (24.8%) 
19 (13.9%) 
27 (20.4%) 
VHWG grade 
1. Low risk 
2. Co-morbid 
3. Potentially contaminated 
4. Infected 
13 (9.5%) 
36 (26.3%) 
60 (43.8%) 
28 (20.4%) 
Modified VHWG grade 
1. Low risk 
2. Co-morbid 
3. Contaminated 
16 (11.7%) 
66 (48.2%) 
55 (40.1%) 
Days hospitalized, median (range) 8 (4 – 155) 
IC stay 41 (29.9%) 
Days IC stay, median (range) 4 (1 – 132) 
 
* Unless otherwise specified 
BMI: body mass index; COPD: chronic obstructive pulmonary disease; ASA: American 
association of anesthesiologists; SSI: surgical site infection; VHWG: ventral hernia working 
group; IC: intensive care 
 
  
144 
 
Table 2 Risk factor analysis for wound and medical complications and recurrent hernia 
 Univariate odds ratio (95% confidence interval)
Preoperative variable Woundcomplications 
Medical
complications 
Recurrent
hernia 
Age, per year increase 1.04 (1.01 – 1.07)* 1.03 (1.00 – 1.06)* 1.01 (0.97 – 1.05)
Male 0.43 (0.21 – 0.88)* 0.58 (0.27 – 1.23) 0.90 (0.35 – 2.29)
n previous laparotomies 1.08 (0.94 – 1.24) 1.01 (0.88 – 1.16) 1.01 (0.85 – 1.20)
n previous hernia repairs 0.97 (0.73 – 1.29) 0.72 (0.50 – 1.04) 1.39 (1.01 – 1.92)*
BMI, per kg/m2 increase 0.98 (0.91 – 1.05) 1.01 (0.94 – 1.09) 1.05 (0.96 – 1.15)
COPD 1.59 (0.65 – 3.87) 4.46 (1.75 – 11.38)* 1.74 (0.61 – 4.99)
Diabetes mellitus 2.10 (0.73 – 6.03) 2.75 (0.98 – 7.76) 0.59 (0.13 – 2.76)
Hypertension 2.13 (1.03 – 4.40)* 1.54 (0.74 – 3.19) 0.62 (0.23 – 1.68)
Smoking 0.74 (0.34 – 1.63) 1.97 (0.90 – 4.34) 0.99 (0.36 – 2.74)
Steroid use 1.63 (0.65 – 4.12) 3.69 (1.42 – 9.57)* 2.66 (0.95 – 7.49)
Immunosuppressive use 0.14 (0.02 – 1.16) 0.23 (0.03 – 1.93) 0.65 (0.08 – 5.51)
ASA score 1.76 (1.08 – 2.86)* 2.21 (1.31 – 3.74)* 1.44 (0.77 – 2.69)
SWC 1.32 (0.99 – 1.78) 1.40 (1.03 – 1.89)* 1.08 (0.74 – 1.58)
VHWG grade 1.67 (1.01 – 2.77) * 1.56 (0.91 – 2.64) 1.43 (0.72 – 2.83)
Modified VHWG grade 1.02 (0.61 – 1.73) 2.24 (1.24 – 4.03)* 0.99 (0.49 – 1.97)
Previous surgical site 
infection  
1.93 (0.91 – 4.08) 0.77 (0.35 – 1.67) 1.55 (0.61 – 3.90)
Previous platzbauch 1.40 (0.62 – 3.20) 1.54 (0.67 – 3.54) 1.67 (0.62 – 4.51)
Previous open abdominal 
treatment 
1.00 (0.46 – 2.16) 1.20 (0.55 – 2.65) 0.37 (0.10 – 1.32)
Size of hernia defect, per 
100 cm2 increase 
1.06 (0.78 – 1.42) 1.00 (0.74 – 1.36) 1.27 (0.85 – 1.89)
Fistula takedown 1.88 (0.79 – 4.51) 1.92 (0.81 – 4.55) 1.21 (0.40 – 3.63)
Surgery time, per 120 
min. increase 
 
1.43 (0.78 – 2.64) 1.81 (0.95 – 3.45) 
 
0.81 (0.37 – 1.79) 
Blood loss, per 500 ml 
increase 
 
1.96 (1.30 – 2.94)* 1.47 (1.01 – 2.14)* 
 
0.62 (0.35 – 1.09) 
Mesh position 
- Onlay 
- Inlay 
- Sublay 
- Intraperitoneal 
 
0.48 (0.17 – 1.37) 
0.52 (0.05 – 5.91) 
1.32 (0.63 – 2.79) 
0.97 (0.40 – 2.37) 
0.60 (0.20 – 1.80) 
3.43 (0.30 – 38.80) 
1.10 (0.51 – 2.38) 
1.09 (0.43 – 2.73) 
 
4.16 (1.39 – 12.42)*
10.0 (0.87–115.16) 
0.38 (0.15 – 0.95)* 
0.97 (0.30 – 3.16)  
    
 
* statistically significant difference (P ≤ 0.05) 
COPD: chronic obstructive pulmonary disease; BMI: body mass index; ASA: American 
association of anesthesiologists; SWC: surgical wound class; VHWG: ventral hernia working 
group 
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Table 3 SSI and total wound complication distribution divided by (modified) VHWG and SWC 
 
 
Long-term follow-up 
Twenty-four patients (17.5%) developed a recurrent ventral hernia with a median 
follow-up of 15.0 months (mean 26.1 months, range 1 – 127). The median time to 
reherniation was 11.5 months (range 3 – 69). The Kaplan Meier curve in Figure 1 
depicts the estimated recurrence-free “survival” in time, showing that by 36 months an 
estimated 11.7% of patients have developed a recurrent hernia. Thirteen patients with a 
recurrence (54.2% of recurrences) underwent surgery for their recurrent ventral hernia. 
All others had a small recurrent ventral hernia and/or had minimal complaints and 
were not re-operated. Previous ventral hernia repair (P=0.045) and onlay mesh 
position (P=0.031) were predictive variables for recurrent hernia, whereas sublay mesh 
position (P=0.038) was protective (Table 2). 
 
 
 n SSI (%)* n wound complications (%)* 
VHWG grade   
 1: n=13 0 (0) 5 (38.5) 
 2: n=36 4 (11.1) 14 (38.9) 
 3: n=60 9 (15.0)  30 (50.0) 
 4: n=28 9 (32.1) 18 (64.3) 
OR (95% CI) 2.31 (1.24 – 4.28)** 1.67 (1.01 – 2.77) ** 
   
Modified  
VHWG grade 
  
 1: n=16 1 (6.3) 6 (37.5) 
 2: n=66 8 (15.7) 33 (50.0) 
 3: n=55 13 (18.6) 28 (50.9) 
OR (95% CI) 2.10 (0.96 – 4.56) 1.02 (0.61 – 1.73) 
   
Surgical wound class   
 I: n=56 5 (9.1) 25 (44.6) 
 II: n=34 5 (14.7) 16 (47.1) 
 III: n=19 3 (15.8) 10 (52.6) 
 IV: n=28 9 (32.1) 16 (57.1) 
OR (95% CI) 1.77 (1.20 – 2.61) ** 1.35 (1.01 – 1.82) ** 
SSI: surgical site infection; VHWG: ventral hernia working group; OR: odds ratio 
* Unless otherwise specified 
** Statistically significant difference (P ≤ 0.05) 
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Discussion 
The current study is the first to evaluate the safety of synthetic mesh use in large and 
contaminated ventral hernias by comparing clean and contaminated repairs. 
Contaminated hernia repair resulted in increased wound morbidity, with SSI’s 
occurring in over a quarter of patients. However, rates of mesh infection and removal 
were low, occurring in less than five percent of non-clean hernia repairs. 
The current data was collected in a retrospective manner allowing for introduction of 
selection and information bias and is affected by heterogeneity. Also, in certain cases 
of extreme contamination or other troubling factors, repairs at our institution are 
performed using CST without mesh at the surgeons discretion, realizing the increased 
risk of recurrent hernia.1 However, provided the large amount of contaminated repairs 
included in the current report, meaningful conclusions may be drawn regarding 
synthetic mesh in contaminated environment, and comparisons can be made with other 
series utilizing biologic mesh. Also, subgroup analysis allowed us to evaluate the 
influence of (variable extents) of contamination on patient outcomes in this relatively 
large sample using the currently prevailing hernia grading systems.  
It is well documented that CST results in significant morbidity, due to both the 
extended tissue mobilization and patient co-morbidities.14 There was a high overall 
wound complication rate in the current study. Whereas wound complications increased 
only slightly with higher contamination class, SSI rates elevated profoundly with 
contamination class, from 9.1 % after clean repairs up to 32.1% after dirty repairs. 
Both SWC and VHWG grade were significant predictors of SSI and overall wound 
morbidity.  It is evident that contamination class remains a very important predictor of 
postoperative course. While the VHWG grade intuitively takes more important aspects 
into consideration, proof of its superiority to surgical wound class is still awaited. It is 
conceivable that patients with higher contamination classes usually have more co-
morbidities, making these different systems more alike than one might suspect. For 
instance, patients with enteric fistulas often are malnourished and have electrolyte and 
metabolic disturbances, and diabetics more often have non-healing wounds and 
infections. 
Comparison of the current results with other studies is troublesome because every 
study contains a heterogenous patient sample and results of synthetic mesh in a 
contaminated wound is rarely described in the literature. Also, outcomes are poorly 
defined and reporting is inconsistent. In the current study (minor) wound 
complications that did not necessitate any kind of intervention were also included. If 
these cases are excluded from analysis, the overall wound complication rate drops 
significantly to 29.2%. 
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Figure 1 Kaplan-Meier curve of estimated hernia recurrence-free “survival” in time. 
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Most studies reporting on CST without mesh present infection rates between 10% and 
33%, whereas overall wound morbidity varies between 10 and 58%.1 Results of clean 
and contaminated ventral hernia repair using biologic mesh has recently been 
reviewed.15 Clean repairs resulted in infection and overall wound complication rates of 
5% and 33%, whereas these were of 19% and 52%, respectively, after contaminated 
and dirty repairs. According to the available evidence, there does not seem to be much 
difference between the use of biologic mesh, synthetic mesh or no mesh regarding 
overall wound morbidity. 
Mesh infection necessitating mesh removal is a much feared complication and the 
reason it is not used in contaminated wound environments. Overall, mesh was 
involved in infection and needed removal in six percent of non-clean repairs. Numbers 
were too small to relate mesh infection to a higher contamination grade. Six mesh 
removals were due to SSI’s (27.2% of SSI’s). In the literature, biologic mesh was 
removed in only 5% of infections.15 It seems that biologic mesh does not prevent 
infection, but can be more easily salvaged when infection arises. However, given the 
low overall synthetic mesh removal rate, the current study challenges the idea that 
contaminated hernias should be repaired with expensive biologic mesh. Also, the 
durability of biologic mesh is seriously being called into question. Although initial 
reports with short-term follow-up showed promising results,15 the first report with a 
reasonable follow-up period shows that over half of hernias repaired with biologic 
mesh recur by 3 years.16 CST without mesh also results in high recurrences rates, and 
should be reserved for patients for which there is a contra-indication for mesh use.1  
Vital factors regarding outcomes besides type of mesh material are surgical technique 
and position of the prosthesis. Overall, recurrences developed in 17.5% of patients in 
the current study. Kaplan-Meier estimation of recurrence at three years was 11.7%, 
comparing favorably with biologic mesh repair. We found a significant increase in 
recurrences after onlay mesh positioning, whereas sublay mesh resulted in the fewest 
recurrences. Placing the macroporous mesh in a well-vascularized envelope between 
the rectus muscle and the posterior rectus sheath probably promotes ingrowth and 
attachment increasing the strength of the repair, while in addition keeping the mesh 
more protected from sources of contamination. Also, onlay positioning theoretically 
makes the mesh more susceptible to detachment caused by the outward facing intra-
abdominal forces.17  
Classification of (complex) hernias and hernia patients according to the VHWG grades 
has quickly gained popularity in hernia research. Its aims are two-fold: to estimate the 
risk of surgical site occurrences, and to make a recommendation based on type of 
mesh material. They point out the potential use of biologic mesh in grades 2 (‘Co-
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morbid’), 3 (‘potentially contaminated’) and 4 (‘Infected’). Unfortunately, the 
evidence cited is scarce and of low-quality. Only three studies pertaining to biologic 
mesh use are referred to, none of which report long-term (> 12 months) outcome.18-20 
Also, half of the evidence on synthetic mesh refers to studies that are 24 to 32 years 
old,3-5 while others describe selected samples of patients with (expanded 
polytetrafluorethylene) mesh infections, without elaborating on the risk of developing 
this complication.21, 22 Development of new synthetic meshes and surgical techniques 
over the past decades, alongside more vigilant perioperative and anti-biotic measures, 
have undoubtedly allowed for a significant improvement in outcomes. Indeed, there 
are several more recent reports suggesting that macroporous synthetic mesh use is a 
feasible option in clean-contaminated and selected contaminated procedures.6-9 These 
findings are corroborated by the current study, and further evaluation of synthetic 
mesh in non-clean setting is essential to properly construct treatment regimens 
including type of mesh for all types of hernia patients. 
 
Clinical implications 
Contrary to current beliefs, synthetic mesh seems safe in large and contaminated 
ventral hernia repair, provided modern perioperative care, appropriate surgical 
technique and modern materials are used. The decrease in recurrence rate probably 
outweighs the small amount of mesh infections resulting in prosthesis loss, when 
comparing the current method with CST alone or CST with biologic mesh. Sublay 
technique should be used when possible using a light-weight polypropylene mesh, 
whereas onlay and inlay techniques should be avoided. Variables influencing risk of 
complication and recurrent hernia need proper study so an optimal hernia grading 
system can be created. 
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Abstract 
Objective: To evaluate the safety and long-term durability of one-stage repair of 
enteric fistulas in the presence of an abdominal wall defect.  
Background: Patients with enteric fistulas and an abdominal wall defect present an 
extreme challenge to surgeons and has been associated with significant morbidity and 
mortality. Durability of repair is unknown as studies fail to report this or use limited 
follow-up periods. 
Methods: Chart review was done of consecutive patients that underwent one-stage 
repair. Short-term outcomes included morbidity (wound and medical) and mortality. 
Long-term durability of repair was determined by prospective out-patient follow-up at 
least 3 years after surgery. 
Results: Thirty-nine patients were included with a mean age of 61.2 years, a mean 
BMI of 24.4 kg/m2 and a mean abdominal wall defect size of 247.9 cm2. Component 
Separation Technique was used in 34 (87.2%) and synthetic mesh in 13 (33.3%) 
patients. There was one (2.6%) post-operative death. Twenty-four wound 
complications developed in 18 (46.2%) patients, including surgical-site infection in 8 
(20.5%) patients. Two (5.1%) enteric fistulas recurred and were treated conservatively 
resulting in closure. Medical complications were seen 36 times in 23 (59%) patients. 
Twelve out of 33 (36.4%) living patients developed a recurrent hernia after a mean 
follow-up of 62.7 months (range 36–130). 
Conclusions: One-stage abdominal wall reconstruction with enteric fistula takedown 
is feasible at the cost of considerable morbidity. Our treatment strategy including 
Component Separation Technique with synthetic mesh on-demand results in a durable 
repair in 6 to 7 out of 10 patients. 
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Introduction 
Repair of the abdominal wall and restoration of bowel continuity in the setting of an 
enteric fistula is a surgical challenge for which an optimal approach is yet to be 
defined. Morbidity is high due to continuous leakage of bowel contents into the 
wound, metabolic disturbances and malnutrition, and mortality rates up to 21% are 
reported.1 
Repair of the abdominal wall and restoring the continuity of the gastro-intestinal tract 
needs thorough preparation. The cornerstones of treatment are elimination of all septic 
foci including deviation of the bowel contents, correction of metabolic disturbances 
and optimization of the nutritional status. After stabilizing the patient, a period of three 
or more months are bridged before a reconstruction is done.2 Surgical treatment 
requires extensive procedures including adhesiolysis, fistula takedown, and 
reconstruction of the abdominal wall. 
Most publications report a multistage approach.3-5 In the first stage the enteric fistula is 
repaired and the abdomen closed temporarily. In the second stage the abdominal wall 
is repaired. The two stage repair has the disadvantage that new fistulas may develop 
between stages due to insufficient protection of the viscera, whereas retraction and 
atrophy of abdominal wall musculature may complicate delayed closure. Furthermore, 
patients are subjected to multiple operations with their coinciding risks and hospital 
stays.  
One-stage repair of enteric fistula in the presence of an abdominal wall defect involves 
a single operation increasing the patient’s convenience and provides direct 
physiological protection of the anastomoses. This approach includes more extensive 
surgery including abdominal wall reconstruction in a contaminated environment, with 
concerns of high mortality and morbidity and recurrences of fistula and hernia. Most 
surgeons are reluctant to implant synthetic mesh in this hostile environment during the 
abdominal wall reconstruction, due to fear of infectious complications requiring re-
operation for mesh removal. Biologic grafts are a popular alternative to synthetic mesh 
for this reason, although they are very expensive and concerns are being raised 
regarding their long-term durability.6  
At our institution we perform one-stage repair primarily utilizing the Component 
Separation Technique (CST) described by Ramirez et al. for abdominal wall 
reconstruction, combined with synthetic mesh when deemed necessary. We believe the 
use of light-weight polypropylene mesh, preferably in a sublay position, combined 
with careful perioperative measures is a feasible and safe option in these patients. This 
study reports on the safety of our treatment strategy and is the first to provide long-
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term out-patient clinical follow-up to determine durability of the abdominal wall 
repair, with a follow-up exceeding 5 years.  
 
Methods 
Chart review with clinical follow-up 
All patients who underwent one-stage repair of their enteric fistula(s) and abdominal 
wall defect over a 10 year period (2000-2009) at the Radboud University Medical 
Center were identified for retrospective chart review. No other (multi-staged) 
treatment strategies were utilized in the study period. 
 
Outcomes and data extraction 
The primary outcomes were safety and durability of the treatment strategy. Safety was 
defined by mortality, medical and wound morbidity with a special focus on recurrent 
fistulization, and mesh infection and removal. Rate of recurrent hernia was used to 
determine durability of the repair. All patients were clinically and prospectively 
assessed at least three years after surgery to determine recurrent hernia. 
The following data were extracted from the medical records: demographic variables 
(sex, age, BMI), history (type and amount of laparotomies), co-morbidities 
(pulmonary, cardial, renal, gastro-intestinal, metabolic, ASA score), risk factors 
(smoking, alcohol, steroids use), cause and size of abdominal wall defect, 
intraoperative variables (duration, blood loss, technique, iatrogenic damage), length of 
hospital/IC stay, postoperative (≤ 30 days after operation) major surgical (hematoma, 
seroma, skin necrosis, infection, wound dehiscence) and medical complications 
(pneumonia, postoperative ileus, urinary tract infection), and reoperations. 
Postoperative complications are presented according to the Clavien-Dindo grading 
system,63 a validated and reproducible surgical complication classification system 
based on therapeutic consequences (Figure 1). 
The size of the abdominal wall defect is defined as the surface area (cm2) calculated 
using the formula for an ellipse: π * ½ length (cm) * ½ width (cm). The axes of the 
defect were determined by CT imaging. 
  
Statistical analysis 
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Odds ratios were calculated using univariate regression to identify variables associated 
with the outcomes recurrent hernia, wound morbidity and medical morbidity. Risk 
factor variables used were age, body mass index (BMI), diabetes mellitus, chronic 
obstructive pulmonary disease (COPD), American association of anesthesiologists 
(ASA) score, smoking, n previous laparotomies, size of defect, n of anastomoses, 
mesh placement, incomplete fascial closure, procedure duration, blood loss and wound 
infection (used only as predictor of recurrent hernia). Additionally, Clavien-Dindo 
grade was regressed on length of stay. P values < 0.05 were considered statistically 
significant. A Kaplan-Meier survival curve was generated to display the probability of 
recurrence free survival in time. Analyses were performed with SPSS version 16.0 
(SPSS, Chicago, IL). 
 
Treatment strategy 
All patients with an enteric fistula in the presence of an abdominal wall defect 
followed a standard work-up in the study period.2 First, patients are stabilized by 
treating septic complications, correcting metabolic disturbances, and optimization of 
wound care. The gastro-intestinal tract and abdominal wall are then visualized by CT 
imaging and fluoroscopy and/or endoscopy. This allows for proper determination of 
fistula location and bowel involvement, alongside abdominal wall musculature quality 
and size of defect. One-stage repair is performed in all patients by a team of 
experienced gastro-intestinal and abdominal wall surgical specialists and is scheduled 
at least three months after the last laparotomy when patients are in an optimal 
metabolic state. 
Fistula takedown is performed either by segmental bowel resection or wedge excision. 
Gastro-intestinal continuity is always restored without creation of protective 
enterostomies. If direct primary closure of the abdominal wall is not possible, 
autologous repair is the first choice utilizing CST as described previously.8 Complete 
fascial approximation is always the aim during closure. Lightweight macroporous 
polypropylene mesh is additionally applied when necessary at the surgeon’s discretion, 
either due to poor myofascial tissue quality or inability of closure without undue 
tension. In selected cases of loss of domain and poor quality of the fascia a pedicled or 
free tensor fascia lata flap is utilized. 
 
Results 
Chart review with clinical follow-up. 
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Patient and hernia characteristics divided by whether or not a mesh was placed is 
presented in Table 1. Thirty-nine (27 male) consecutive patients with a mean age of 
61.2 (range 30 – 81) underwent one-stage repair of their abdominal wall defect and 
enteric fistula. The mean BMI was 24.4 kg/m2 (19.6 – 43.3). Patients had undergone a 
median of 5 previous laparotomies (range 2 – 16) and 32 (80%) were tertiary referrals.  
Fistulization developed postoperatively in 36 (92.3%) and spontaneously in 3 (7.7%) 
patients (2 due to Crohn disease, 1 due to an umbilical herniation with strangulated 
small bowel). The median number of fistulas per patient was 1 (range 1 – 12). Fistulas 
were high-output (> 500 mL/24 hours) in 29 (74.4%) patients and 13 (33.3%) patients 
had recurrent fistulas. The small and large bowel were involved in 33 (84.6%) and 6 
(15.4%) patients, respectively. The abdominal wall defects had a mean size of 247.9 
cm2 (range 33.4 – 613.2), determined using CT using the formula for an ellipse.  
Takedown of fistulas was achieved by segmental bowel resection in 35 (89.7%) 
patients, by wedge resection in 3 (7.7%) and by both techniques in 1 (2.6%) patient. 
Continuity of the intestinal tract was restored without protective enterostomies in all 
patients requiring a median number of 2 anastomoses (range 1 – 6).  
CST was used in 34 (87.2%) patients to reconstruct the abdominal wall. A lightweight 
polypropylene mesh was used in 12 of these (35.3% of CST repairs) patients as 
reinforcement of the repair, 4 in which complete fascial closure was unobtainable. 
Mesh was placed sublay (between rectus muscle and posterior rectus sheath) in 10 
patients and intraperitoneally in 2. In three (7.7%) patients a tensor fascia lata flap was 
used (without mesh), two of which were combined with CST. Primary suture repair 
was sufficient for closure in 3 (7.7%) patients. The Rives-Stoppa technique was 
employed (without CST) in one (2.6%) patient.  
Mean duration of surgery was 266 min. (range 119 – 384) and mean blood loss was 
1497 cc (range 200 – 6350). Eighteen patients were on the ICU for a median period of 
7 (range 1 – 96) days. The median postoperative length of stay was 20 (range 7 – 209) 
days and was strongly dependent upon Clavien-Dindo grade (P<0.001). 
 
Short-term complications 
Postoperative complications according to the Clavien-Dindo classification system are 
presented in Figure 1. There was one (2.6%) surgery related in-hospital death resulting 
from anastomotic leakage and sepsis, in a patient with resection of six small bowel 
fistulas and restoration of continuity with three anastomoses. Twenty-four wound 
complications developed in 18 (46.2%) patients. Skin necrosis and wound infection 
were the most common complications, occurring in 8 (20.5%) and 7 (17.9%) patients, 
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followed by seroma formation in 2 (5.1%) of which 1 necessitated incision and 
drainage, hematoma in 2 (5.1%) of which 1 necessitated incision and drainage, abscess 
in 2 (5.1%) necessitating drainage and recurrent enteric fistula in 2 (5.1%) patients. 
One patient developed partial necrosis of the tensor fascia lata flap requiring surgical 
debridement. Two surgical debridements for skin necrosis (5.1%) were extensive 
resulting in split-thickness skin graft placement over the wound. One infection 
involved the mesh and required partial mesh resection while all other infections could 
be treated with local wound measures. The two enteric fistulas (occurring in a patient 
with mesh placement and a patient without) both spontaneously closed during 
conservative treatment including negative pressure therapy and total parenteral 
nutrition. Wound complications divided by patients who did and did not receive 
synthetic mesh for abdominal wall repair are presented in Table 1.  Diabetes was the 
only variable associated with the development of wound complications (OR=12.73, 
P=0.025). 
Medical complications were seen 36 times in 23 (59%) patients, including sepsis in 8 
(20.5%), postoperative ileus in 6 (15.4%), urinary tract infection in 5 (12.8%), 
respiratory tract infection in 4 (10.3%), SIRS in 4 (10.3%), 1 (2.6%) deep venous 
thrombosis and 1 (2.6%) pulmonary embolism, and 7 miscellaneous complications. 
Risk factor variables statistically associated with medical complication development 
were age (OR per year=1.07, P=0.039), size of defect (OR per 100 cm2=1.11, 
P=0.026), number of anastomoses (OR per anastomosis=2.26, P=0.041), procedure 
duration (OR per 100 min.=2.86, P=0.018) and blood loss (OR per 500 cc=1.62, 
P=0.013). Overall, 28 (71.8%) patients experienced a wound and/or medical 
complication. 
 
Long-term out-patient follow-up 
In addition to the initial surgery related mortality, five patients died during long-term 
follow-up (≥ 3 years) due to unrelated causes resulting in a total of six (15.4%) 
patients lost to follow-up. These patients had no recurrence at last clinical follow-up 
(mean 13.2 months [range 1 – 31]). The other 33 patients were clinically assessed and 
interviewed at least 3 years after surgery. Twelve of these (36.4%) patients had 
developed a recurrent hernia after a mean follow-up of 62.7 months (range 36 – 130). 
The median time to recurrent hernia was 17.5 months (range 2 – 53). Figure 2 shows 
the Kaplan-Meier curve of recurrence-free “survival” in time for all patients. Six 
recurrences were reoperated using synthetic mesh resulting in two new recurrences, 
while six were treated conservatively because recurrences were small and 
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asymptomatic or benefits of repair were not considered to outweigh the risks of 
surgery. No risk factor variables were identified for recurrent hernia. 
 
Table 1 Patient and hernia characteristics and wound complications divided by patients 
with and without mesh placement 
 Mesh placed* 
(n=13) 
No mesh placed 
(n=26) 
Patient/hernia characteristics    
 Male (%) 10 (76.9) 16 (61.5) 
 BMI, kg/m2 25.6  23.9  
 Diabetes (%) 4 (15.4) 4 (30.8) 
 COPD 4 (15.4) 4 (38.5) 
 ASA score, median 3  2  
 Smoker 7 (26.9) 2 (15.4) 
 n previous lapartomies, median 5  5  
 Size of defect, mean cm2** 333.5  199.9  
 Fistulas, mean 1.9  1.7  
Wound complications    
 Infection (%) 3 (23.1) 4 (15.4) 
 Skin necrosis (%) 3 (23.1) 5 (19.2) 
 Abscess (%) 0 (0) 2 (7.7) 
 Hematoma (%) 1 (7.7) 1 (3.8) 
 Recurrent enteric fistulization (%) 1 (7.7) 1 (3.8) 
 Seroma (%) 1 (7.7) 1 (3.8) 
 Any wound complication (%) 7 (53.8) 11 (42.3) 
     
 Recurrent hernia (%) 2 (15.4%) 10 (38.5%) 
 
* Lightweight macroporous polypropylene mesh 
** Using the formula for an ellipse (π * ½ length * ½ width). Size of defects using the formula 
length * width are respectively (mesh and non-mesh) 424.6 and 253.2 cm2 
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Figure 1 Rates of postoperative complications according to the Clavien-Dindo classification system.7 
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Discussion 
The management of patients with enterocutaneous fistulization in the presence of 
abdominal wall defects is a major challenge. Except for a single postoperative death, 
‘one-stage’ repair resulted in successful treatment of all fistulas in the current study. 
However, the procedure results in significant surgical and medical morbidity. 
Abdominal wall reconstruction, mostly using CST enforced with mesh in one-third of 
cases, resulted in long-term durability in 6 to 7 out of 10 patients. 
About half of patients experienced wound complications. This is similar to the 
literature on one-stage repair,9-12 and is on par with ventral hernia repair in various 
complex and contaminated settings.6, 13 There is agreement in the literature that 
surgical treatment of intestinal fistulas involves resection of the afflicted bowel 
segment, as oversewing often results in recurrence.14 Only two (5.1%) postoperative 
recurrent fistulizations occurred, comparing favourably with other studies.2, 9, 11, 12, 15 
Both of these were transient refistulizations responding promptly to conservative 
treatment. 
Multi-staged approaches to enteric fistula takedown and abdominal wall repair are 
aimed at dividing the risk of surgery over multiple procedures and creating a more 
optimal situation for definitive abdominal wall repair. Dionigi et al. reported such an 
approach resulting in a 31.5% fistula recurrence rate after the first procedure to repair 
the gastrointestinal continuity. The postoperative mortality rate was 21% after the 
definitive repair. Other studies report multi-staged approaches to open abdomens 
without fistulas resulting in fistulization in about 10% of patients during the ‘waiting 
period’. It is reasonable to assume this rate will be significantly higher in patients in 
whom fistulas are repaired.3, 4 Furthermore, it is important to note that even planned 
repair of (very) large ventral hernias coincides with significant surgical morbidity, 
with rates up to 58%.16 With regard to patient convenience but also financial costs, 
length of hospital stay is another important outcome when comparing treatment 
strategies. The median length of postoperative stay was 20 days in the current study. 
Validation of the Clavien-Dindo classification system of complications proved 
successful as this was a strong predictor of length of stay. Unfortunately, no studies 
report total length of stays specifically for multi-staged repair of enterocutaneous 
fistula and abdominal wall defects. Data from our institution show that hospital stay 
after planned large ventral hernia repair is a median of 9 days. Taking into 
consideration the morbidity and lengths of stays associated with multiple surgeries 
including fistula takedown and protective ostomy fashioning., ostomy takedown and 
planned ventral hernia repair, the one-stage repair seems superior to a multi-staged 
approach. 
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Recurrent hernia occurred in 36.4% of patients in the current study with at least three 
years follow-up in every patient, and a mean follow-up of over five years. Half of 
patients with recurrences underwent additional surgery for repair. It is important to 
note that the current follow-up is much longer than any report describing long-term 
durability of one-stage repair in the literature.11, 12 It is already well-known,16 and again 
becomes clear from the Kaplan-Meier curve in Figure 2 that recurrences continue to 
occur years after surgery, with half of recurrences occurring after one and a half years 
in the current study. Taking this into consideration, the current treatment strategy 
seems valid when comparing long-term outcomes with other studies. Not surprisingly, 
there were more recurrences in the non-mesh group (n=10, 38.5%) compared to the 
mesh group (n=2, 15.4%), supporting the notion that mesh reduces recurrences even 
after contaminated hernia repair. The much lower recurrence rate found at 12 months 
Figure 2 Kaplan-Meier curve illustrating the probability of recurrence-free survival in time. 
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(12.1%), underscores the scientific importance of long and rigorous follow-up to 
approach true recurrence rates after abdominal wall repair.  
The CST is the most popular choice for abdominal wall repair after enteric fistula 
takedown, allowing for an autologous reconstruction. Many surgeons are reluctant to 
implant non-absorbable synthetic mesh during contaminated abdominal wall 
reconstruction due to fear of mesh-related complications that might necessitate 
reoperation explanting the mesh. The Ventral Hernia Working Group recently advised 
against synthetic mesh use in non-clean surgical settings.18 However, the evidence 
cited regarding synthetic mesh includes studies that are 24 to 32 years old, utilizing 
inferior techniques and materials.19-21 Lightweight macroporous polypropylene mesh 
was additionally applied in the current study when deemed necessary to achieve a 
sufficient abdominal wall repair. We believe placing the mesh in a well-vascularized 
envelope between the rectus muscle and posterior rectus sheath (avoiding contact with 
the viscera) alleviates many problems. Three patients in the mesh group (two sublay 
and one intraperitoneal repairs) underwent additional laparotomies during follow-up. 
In both the sublay cases the abdomen was approached by going straight thru the mesh 
and no bowel to mesh adhesions were encountered. In the patient with intraperitoneal 
mesh dense adhesions had formed between mesh and small bowel resulting in 
iatrogenic damage during adhesiolysis necessitating over-sewing the perforation. 
Interestingly, in the current study the placement of mesh resulted in rates of wound 
complications similar to patients without mesh placement (Table 1). No meshes were 
explanted except for a small partial mesh resection in one patient in which the anterior 
rectus sheath could not be completely closed over the mesh. Although these numbers 
are certainly too small to draw definitive conclusions, several other studies suggest 
synthetic mesh placement can be safe in clean-contaminated and various contaminated 
procedures,22-27 but these observations need further study. 
Biologic mesh is an attractive alternative to synthetic mesh for abdominal wall repair 
in contaminated wound environments with potential to decrease infectious 
complications. However, results after one-stage procedures are disappointing. Two 
studies including one-stage enterocutaneous fistula takedown and abdominal wall 
repairs using biologic mesh combined with CST reported recurrent fistulization in 
nearly half of patients.11, 28  Position of the material may be (partially) accountable for 
this. Krpata et al. reported 4 refistulizations in 15 patients after intraperitoneal biologic 
mesh placement, compared to 1 out of 19 patients with retro-rectus pre-peritoneal 
placed mesh. These findings did not reach significance (P=0.11), likely due to small 
sample size. Looking at long-term outcome, 32.4% of hernias recurred after only 20 
months follow-up.12 Initial abdominal wall defect size was comparable to that in our 
series but patients were more obese increasing early complication and recurrence rates. 
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In another study the same group reported hernia recurrences in over half of patients by 
three years follow-up after utilizing biologic mesh for repair of various infected and 
(clean-) contaminated abdominal wall defects.6 Additional studies with long follow-up 
are needed to answer the question if biologic grafts can truly stand the test of time or if 
they are in fact an expensive form of temporary closure in a multi-staged strategy. In 
any case, biologic grafts are not recommended as a bridging material as they seem to 
perform similar to absorbable synthetic mesh in these circumstances, resulting in very 
high recurrence rates.29, 30 
The current study is retrospective and spans a long period of time. However, given the 
rarity of this disorder and the variability of its manifestation, it is not possible to 
construct a randomized controlled trial in a reasonable time-frame in a homogeneous 
patient group. The current treatment strategy was the only one utilized in the study 
period for the current patient population, reducing selection bias. This study shows that 
one-stage abdominal wall reconstruction with enteric fistula takedown is feasible at the 
cost of considerable morbidity. Synthetic mesh utilization when needed seems safe, 
prompting further study of its use in contaminated abdominal wall repairs. This study 
by far presents the longest clinical out-patient follow-up in these patients showing that 
our treatment strategy utilizing CST with synthetic mesh on-demand results in a 
durable repair in 6 to 7 out of 10 patients. 
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Abstract 
Background: Biologic grafts hold promise of a durable repair for ventral hernias with 
potential for fewer complications than synthetic mesh. This systematic review was 
performed to evaluate the effectiveness and safety of biologic grafts for ventral hernia 
repair. 
Methods: Databases Medline, Embase and Cochrane CENTRAL were searched for 
studies on biologic grafts for repair of ventral hernias. Outcomes are presented as 
weighted pooled proportions. 
Results: Twenty-five retrospective studies were included.  Recurrence depended on 
wound class, with an overall rate of 13.8% (95% confidence interval [CI] 7.6－21.3). 
Recurrence rate in contaminated/dirty repairs was 23.1% (95% CI 11.3-37.6). 
Abdominal wall laxity occurred in 10.5% (95% CI 3.7-20.3) of patients. Surgical 
morbidity rate was 46.3% (95% CI 33.3-59.6). Infection occurred in 15.9% (95% CI 
9.8-23.2) of patients, but only led to graft removal in 4.9% of cases. 
Conclusions: No randomized trials are available to properly evaluate biologic grafts 
for ventral hernia repair. The current evidence suggests that biologic grafts perform 
similarly to other surgical options. Biologic grafts are associated with a high salvage 
rate when faced with infection. 
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Introduction 
Incisional hernia is a common complication after laparotomy, occurring in 10-20% of 
cases.1,2 Since the introduction of synthetic prostheses, repair of the defect with 
polypropylene mesh or expanded polytetrafluorethylene has become the mainstay of 
treatment showing good short- and long-term results.3,4 Drawback of prosthetics is 
adhesion formation to the viscera which may cause bowel obstruction or erosion into 
the viscera.5 Surgeons are also reluctant to implant synthetic prostheses in complex 
hernias because of increased risk of infection and mesh extrusion. Complicated hernias 
have not been properly defined, but usually include repairs combined with bowel 
surgery or in presence of enterocutaneous fistulas, multiple recurrent hernias, previous 
or current (mesh) infection, and hernias following trauma or tumour resection. 
Biologic grafts have been introduced as an alternative to synthetic mesh. They consist 
of an extracellular collagen matrix. The graft is incorporated into the surrounding 
tissue by ingrowth of fibrocollagenous tissue and blood vessels. During incorporation 
the graft is gradually degraded and replaced by native tissue, theoretically remodelled 
into a neofascia to withstand the mechanical forces of the abdominal wall.6 
Commercially available biologic grafts used for ventral hernia repair are derived from 
human and porcine dermis, porcine small intestinal submucosa (SIS), and bovine 
pericardium. After harvesting, all tissues undergo decellularisation aimed at prevention 
of a foreign-body response. Some biologic grafts are dehydrated during processing to 
extend shelf-life, reduce extensibility, make them easier to handle, and to limit the loss 
of growth factors during storage. A minority of biologic grafts undergo additional 
cross-linking. During this process, extra bonds are added between the polymers of the 
collagen matrix aimed at controlling the enzymatic degradation of the graft, which is 
claimed to be beneficial in a contaminated environment.  
Due to their biocompatible nature, biologic grafts hold promise of a durable repair and 
lower infection propensity compared to synthetic mesh. The aim of this systematic 
review was to summarise and evaluate the use of biologic prostheses for ventral hernia 
repair under clean and contaminated conditions, with focus on recurrence and 
complications.   
 
Methods 
Search methods for identification of studies 
Electronic databases were searched to identify relevant studies. No restrictions were 
set on language or publication status. By using PubMed and Ovid, the search covered 
databases MEDLINE (including In-Process & Other Non-Indexed Citations, 1950-
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Present), EMBASE (1980-Present) and the Cochrane Central Register of Controlled 
Trials (CENTRAL). Current registered trials were also identified in the metaRegister 
of Controlled Trials (mRCT). Considering the scarcity of studies on the biological 
materials, a high sensitivity with a consequently low precision was chosen for the 
search strategy. The following search terms were used: hernia, abdominal-wall defect, 
reconstruction and repair. These were combined with terms for the brand- (Alloderm®, 
Collamend®, FlexHD®, Peri-Guard®, Permacol®, Pelvicol®, Strattice®, Surgisis®, 
Tutomesh®, Veritas®, Xenmatrix®) and generic names (human acellular dermal 
matrix/allograft, acellular dermis, small intestinal submucosa, porcine dermal 
matrix/graft, porcine dermis, bovine pericardium) of the various collagen-based 
prostheses. All terms were searched for as free text and where possible, mapped to 
Medline Subjects Headings (MeSH). Preliminary screening of titles and abstracts was 
undertaken after which full-text articles of eligible studies were retrieved for 
evaluation. The reference lists of all included and excluded studies were manually 
scanned for additional studies missed in the electronic search. To prevent double-
counts of data, different studies by the same authors were scanned for uniqueness with 
regard to included patients. The most recent study with the longest follow-up was 
chosen in the case of overlap. The last search was performed on 16 November, 2010. 
The characteristics and costs of the biologic grafts used in ventral hernia repair were 
sought in the literature, on the manufacturer’s website, and via telephone contact with 
the manufacturer and/or distributor. Costs presented are based on standard sheet sizes 
and exclude any form of discount. 
 
Inclusion and exclusion criteria  
Studies including male and female adults over the age of 18 who underwent definitive 
repair of all types (incisional, epigastric, Spiegel (lateral ventral) and (para-) umbilical) 
of ventral hernia were selected. In addition, reconstruction of large defects created 
during surgery (e.g. TRAM-flap reconstruction, tumour resection) or trauma were 
included. The biological prosthesis had to be the sole graft material used to repair the 
defect. Studies on biologic grafts placed as reinforcement or as a bridging material 
were included. Studies with less than seven patients were excluded.  
The methodological quality and risk of bias of each individual remaining study was 
assessed by subjecting it to a modified version of the MINORS (Methodological Index 
for Non-Randomized Studies) tool 7 (Table 1). This instrument was constructed and 
validated for appraisal of non-randomized trials in surgery.7 In the modified version a 
score of two on each item results in a maximum score of 14. Studies that scored a zero 
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on items 2, 5 or 7, or had a total score of less than 8 were excluded from analysis of 
the primary outcome. All articles selected for inclusion during the search process were 
scored independently by two authors (NJS, RPB).  Disagreement was resolved by 
discussion and consensus. 
 
Primary and secondary outcome 
The primary outcome of this systematic review was recurrence as defined by the 
authors in the individual reports, including only studies with a follow-up of at least 12 
months. Secondary outcome measures were counted irrespectively of follow-up 
duration and included mortality, laxity of the repair, surgical site infection, deep 
(fascial) wound dehiscence, seroma and haematoma formation, enterocutaneous 
fistula, and total number of surgical complications. 
 
  Table 2 Modified Methodological Index of Non-Randomised Studies (MINORS) 
Item Criteria Option Score
1 A clearly stated aim ·     Not reported
·     Partially reported, no clear aim 
·     Clear aim 
0
1 
2 
2 Minimum of 5 patients included ·     No
·     Yes 
0
2 
3 Inclusion of consecutive patients ·     Not reported
·     Patients in a certain time period 
·     Consecutive patients + characteristics 
0
1 
2 
4 Diagnostic modality of follow-up ·     Not reported/unclear/telephone used 
·     Clinical examination 
·     Clinical examination + CT/Ultrasound 
0
1 
2 
5 Surgical methods (i.e. anatomical 
placement of prosthesis, surgical 
technique, bridge/reinforcement used) 
·    Not reported
·     Incomplete 
·     Reported clearly, appropriate to aim 
0
1 
2 
6 End-points clearly stated in Methods 
section 
·    Not reported/unclear
·     Stated, but inadequate 
·     Clearly stated 
0
1 
2 
7 End-points appropriate to aim ·    Not reported 
·     Recurrences only 
·     Recurrences and postoperative complications 
0
1 
2 
  
  Maximum score: 14
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Data extraction and subgroup formation 
All data were extracted using a pre-designed data form. The demographic variables 
age, BMI, size of defect, co-morbidities, and ASA-score, the indication for surgery 
and wound class, and the surgical technique (open or laparoscopic, reinforcement or 
bridging, anatomical position) were noted.  Reinforcement repair is defined as the 
placement of a graft to augment approximated native fascia, whereas in bridging there 
is no (complete) approximation of native fascia. The anatomical position of the 
prosthesis was defined as subcutaneous on top of the anterior rectus fascia (‘onlay’), 
between the rectus muscle and the posterior rectus fascia (‘pre-peritoneal underlay’ or 
Rives-Stoppa technique), behind the posterior rectus sheath (‘intraperitoneal underlay’ 
or modified Rives-Stoppa technique) or within the defect and sutured directly to the 
fascial edges (‘interpositional’ or ‘inlay’).  
Certain assumptions were necessarily made while extracting information, due to lack 
of consistency of reporting and terminology in the reports. Only complications 
explicitly noted in the methods or results section were counted. Laxity, diastasis and 
‘bulging’ were all grouped as laxity of the repair. Superficial wound dehiscence was 
counted as a wound infection. Total number of surgical complications per study was 
calculated by adding up all reported surgical complications. In case additional data 
were needed, authors were contacted. 
Subgroups were formed for wound class (clean/clean-contaminated, 
contaminated/dirty, complicated), biologic graft (Alloderm, Permacol, Surgisis), and 
surgical technique (reinforcement, bridging). Where necessary, patients from a single 
study were divided between different subgroups. Wound classification was done 
according to the US National Research Council group.8 Patients classified by the 
authors were grouped accordingly. If this was not done by the authors the indications 
for surgery were reviewed to determine the wound classes. The classes ‘clean’ and 
‘clean-contaminated’ were grouped together, as well as ‘contaminated’ and ‘dirty’. 
The third group (complicated) consisted of patients who could not be stratified into the 
first two groups (clean/clean-contaminated and contaminated/dirty), and/or had 
complex, complicated or potentially contaminated hernias as noted by the authors. 
In the wound class subgroups, data allowed for extraction of the outcomes recurrence, 
infection, and total surgical morbidity. Biologic grafts were analysed with regard to the 
outcomes recurrence, laxity, seroma, and total surgical morbidity. Surgical techniques 
were analysed with regard to the outcomes recurrence and laxity.  
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Statistical analysis 
Weighted pooled proportions with 95% confidence intervals (CI) using the random-
effects (DerSimonian-Laird) model were calculated for all primary and secondary 
outcomes and are presented for subgroups and the whole group. Differences in 
weighted pooled proportions were analysed using the chi-square test and only 
performed on outcomes that could be stratified by wound class. A P-value < 0.05 was 
considered statistically significant. The odds ratio (OR) with 95% CI were calculated 
to quantify statistically significant different outcomes. The heterogeneity of the wound 
class subgroups was quantified using I2. Analysis of outcome differences between 
grafts was not undertaken because insufficient data left subgroups that were too small 
or empty after stratification by both wound class and graft type. Univariate regression 
analysis was performed to regress the outcome recurrence on to the predictors 
infection and overall surgical complications to explore their relationship. Median 
scores were calculated for the modified MINORS indices and for the reported means 
of months follow-up, age, BMI, and size of hernia defect. Univariate analyses were 
performed using SPSS 169. All other analyses were done using StatsDirect statistical 
software.10 
 
Results 
Systematic review 
The search strategy yielded a total of 1152 titles and abstracts (Figure 1). A total of 27 
studies11-37 were included in systematic review. Seventeen studies provided sufficient 
follow-up and were included for primary outcome analysis and 25 studies were 
included for secondary outcome analysis.  
Although various studies reported on using prospectively collected data, none of them 
elaborated on how data was collected according to a protocol rendering them 
qualitatively indistinguishable from the retrospective studies.  The median modified 
MINORS score of the included studies was 11 (range 8-14) (Table 2).  
Most studies reported age (82%) and BMI (52%), while less than half reported ASA 
score (44%) and size of defect (40%). The median of reported means were 54.5 years, 
32.0 kg/m2 and 150.0 cm2 for age, BMI and size of defect, respectively. All reported 
median ASA-scores were 3. No differences between subgroups were found for age 
(P=0.108) or BMI (P=0.123).  
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Table 2 Study characteristics and recurrence rates for ventral hernia repair with biologic grafts 
Reference Year 
MINORS 
index 
Graft used 
No. of 
patients 
Mean size 
of defect, 
cm2 
No.  of C/D 
procedures (%) 
No. of recurrences (%) 
Follow-up 
(range) 
Clean/Clean-Contaminated     
 Buinewicz et al.14 2004 10 Alloderm 36 86.4 0 (0) 1 (2.8) 20 (8－32) 
 Glasberg et al.17 2006 12 Alloderm 54 166 0 (0) 0 (0.0) 18.5 (9－30) 
 Gupta et al.18 2006 10 Alloderm 33 NS 0 (0) 8 (24.2) 29 (NS)
 Boehmler et al.13                    2009 11 Alloderm 31 NS 0 (0) 0 (0) 20.4 (NS)
 Helton et al.36 2005 13 Surgisis 21 202 0 (0) 0 (0) 14 (2－29) 
 Gupta et al.18 2006 10 Surgisis 38 NS 0 (0) 0 (0) 19 (NS)
Overall C/CC (95% CI)*   Various 213  2.9% (0.2－8.3)  
Contaminated/Dirty     
 Buinewicz et al.14 2004 10 Alloderm 8 86.4 8 (100) 1 (4.5) 20 (8－32) 
 Alaedeen et al.11                    2007 11 Alloderm 11 NS 11 (100) 2 (18.2) 14 (2－68) 
 Taner et al.28 2009 13 Alloderm 11 NA 13 (100) 0 (0) 12 (± 4)
 Ueno et al.37 2004 13 Surgisis 20 NS 20 (100) 6 (30.0) 15.7 (NS)
 Helton et al.36 2005 13 Surgisis 19 202 19 (100) 8 (42.1) 14 (2－29) 
 Gupta et al.18 2006 10 Surgisis 3 NS 3 (100) 0 (0) 29 (NS)
 Connolly et al.31 2008 10 Permacol 12 NA 12 (100) 5 (41.7) 29 (16－84) 
Overall C/D (95% CI) *   Various 84   23.1% (11.3－37.6)  
Complicated*     
 Kolker et al.21 2005 8 Alloderm 16 NS 9 (56.3) 0 (0) 16 (9－23) 
 Jin et al.19 2007 10 Alloderm 37 122 16 (43.2) 12 (32.4) 22.2 (15－37) 
 Candage et al.15 2008 12 Alloderm 46 NS 17 (37.0) 14 (30.4) 12.1 (NS)
 Lee et al.22 2009 11 Alloderm 68 NS 54 (79.4) 21 (30.9) 15.4 (NS)
 Parker et al.34                         2006 10 Permacol 9 NS 5 (55.6) 1 (11.1) 18.2 (NS)
 Shaikh et al.35  2007 12 Permacol 20 180 5 (25.0) 3(15) 18 (6－36) 
 Hsu et al.32 2009 13 Permacol 28 150 NS 3 (10.7) 16 (10－23) 
 Loganathan et al.33 2010 10 Permacol 10 NS NS 1 (10.0) 12 (3－62) 
Overall ‘Complicated’ (95% CI)†   Various 234   19.4% (11.4－29.0)  
     
Overall combined (95% CI)*    13.8% (7.6-21.3) 
 
* This subgroup contains groups of patients for which the outcomes could not be stratified per wound class, and/or that contained 
cases with unclear surgical indications that were classified by the corresponding authors as either ‘complex’, ‘complicated’, ‘potentially 
contaminated’ or ‘high-risk’; 
† Weighted pooled proporƟon using random eﬀects (DerSimonian-Laird) model; 
NS: Not specified; NA: Not available; C/CC: Clean/Clean-contaminated; C/D: Contaminated/Dirty 
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Alloderm, Permacol and Surgisis 
Three biologic grafts are found almost exclusively in the ventral hernia literature and 
were included for primary outcome analysis, namely Alloderm, Permacol and Surgisis. 
Alloderm is an allograft derived from human cadaveric dermis and is available in sizes 
up to 16 x 20 cm and costs $35,31 per cm2. Varying thicknesses are available: 0.79-
2.03 mm (‘Thick’) and 2.06-3.30 mm (‘X-Thick’). To prevent physical and chemical 
alterations due to sterilisation, after decellularisation Alloderm is not sterilized but 
instead treated with antibiotic agents and packaged aseptically. Alloderm needs to be 
stored refrigerated, undergo a 2-step rehydration (10-40 minutes depending on 
thickness), and be pre-stretched for hernia repair to prevent otherwise expected laxity.  
Permacol is derived from porcine dermis and has the largest grafts available with sizes 
up to 28 x 40 cm, costing $18,97 per cm2. Grafts are available with thickness varying 
0.5 mm to 1.5 mm. After decellularization Permacol is sterilised by gamma radiation 
and is packaged in a hydrated state that make it usable straight away without any 
preparation. Permacol undergoes additional cross-linking during processing by 
hexamethylene diisocyanate aimed at decreasing its bio-degradability which might be 
accelerated in contaminated wounds.  
Surgisis is made from porcine small intestinal submucosa and is available in sizes up 
to 20 x 30 cm. The cost per cm2 graft is $20,00. Material harvested from small 
intestinal submucosa is thin, but Surgisis undergoes lamination to make it thick 
enough (up to 2.0 mm) for hernia repair. This graft undergoes ethylene oxide 
sterilisation and is packed dehydrated, making rehydration necessary before 
implantation. Surgisis has been found to retain certain proteoglycans, 
glycosaminoglycans and angiogenic growth factors which potentially stimulate cell 
attachment and vascularisation. 
 
Mortality 
Mortality was reported in 19 series11,12,14-16,18-20,22,23,27,28,30,31,33-37 including 879 patients. 
Thirty-six (4.1%) patients died of whom 20 (2.3%) within 30 days of surgery. One 
study described two deaths following multiple attempts to repair enterocutaneous 
fistulas.16 All other deaths were noted as unrelated to the ventral hernia repair (e.g. 
multiple organ failure, congestive heart failure, disseminated intravascular 
coagulation).  
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Figure 1 Search flow-chart in accordance with PRISMA. Search performed in databases Cochrane 
Central Register of Controlled Trials (CENTRAL), EMBASE, MEDLINE(R) and MEDLINE(R) In-Process 
& Other Non-Indexed Citations using PubMed and Ovid. 
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Surgical morbidity 
Table 3 presents the surgical morbidity divided by wound class. Overall surgical 
morbidity could be extracted for 1152 patients out of 25 studies11-18,20-26,28-37 in which 
584 (46.3%; 95% CI 33.3－59.6) surgical complications were documented. Infectious 
complications were reported most often. Wound infections were reported in 246 of 
1109 (15.9%; 95% CI 9.8－23.2) patients.12,14-18,20,22-30,32,34-37 In twelve patients (4.9%) 
the prostheses had to be removed.26,29,34,36 Other infectious complications were intra-
abdominal abscesses in 2.4% and miscellaneous in 2.7%.  
Seroma formation was reported in 115 of 827 (14.2%, 95% CI 9.5－19.5) patients 
(Table 4).14-18,21,23,24,26,28,32,35,37 Five cases of explantation after significant seroma 
formation were documented in one report of repair with Surgisis.17 All other seromas 
resolved either spontaneously or after percutaneous aspirations. Haematomas were 
reported 9 times in 354 (3.0%; 95% CI 1.4－5.3) patients.12,14,15,17,20,22,24,33,35 
Deep wound dehiscence necessitating operative intervention was documented in 16 of 
191 (8.6%; 95% CI 6.2－11.2) patients.12,22,24,36 The postoperative course was 
complicated by an enterocutaneous fistula in 59 out of 756 patients (6.5%; 95% CI 
3.5－10.3).13-16,21-23,25,27,30,32,34 Fifty-six percent was related to fistula takedown 
performed concomitantly with the hernia repair, 10.4 % after bowel surgery and in 
12.6 % in patients with open wounds or after simple ventral hernia repair.  
Other post-operative wound-related complications were skin necrosis/breakdown (14 
out of 83 patients, 16.9%), and graft rejection/degradation (4/157, 2.5%). Medical 
complications were inconsistently reported. 
The data allowed for comparison of morbidity between wound classes regarding 
infection and total surgical morbidity using the chi-square test. Infection (P=0.0077) 
and total surgical morbidity (P<0.0001) were both dependent upon wound class. 
Infection was significantly higher in the contaminated/dirty group than in the 
clean/clean-contaminated group (P=0.0016; OR=1.9, 95% CI 1.24-2.91). Infection 
was also significantly higher in the complicated group than in the clean/clean-
contaminated group (P=0.004; OR=1.7, 95% CI 1.16-2.39).  
The contaminated/dirty subgroup showed a significantly higher total surgical 
morbidity rate compared to the clean/clean-contaminated subgroup (P=0.0064; 
OR=1.8, 95% CI 1.15-2.75). The complicated subgroup also had significantly higher 
overall surgical morbidity compared to the clean/clean-contaminated subgroup 
(P<0.0001; OR=3.3, 95% CI 2.39-4.58).  
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Recurrence 
Seventeen studies11,13-15,17-19,21,22,28,31-37 with a total enrolment of 531 patients met the 
inclusion criteria for the primary outcome. Overall, there were 86 recurrences (13.8%; 
95% CI 7.6－21.3) (Table 3). Weighted pooled recurrence rates for each wound class 
are presented in Table 6 and Figure 2. There were significantly less recurrences in the 
clean/clean-contaminated group, as compared to the contaminated/dirty group 
(P<0.0001; OR=55.9, 95% CI 8.5－2321.3) and the complicated group (P<0.0001; 
OR=39.0, 95% CI 6.5－1581.0) (Table 3). No significant difference was found 
between the contaminated/dirty and the complicated subgroup (P=0.2233).  
To identify factors associated with recurrent hernia, univariate regression was 
performed. Postoperative infection (r2=0.325, P=0.011) (Figure 3) and total surgical 
morbidity (r2=0.189, P=0.038) (Figure 4) were revealed as significant explanatory 
variables for recurrent hernia. 
 
Laxity  
Laxity of the repair was documented in 8 studies12-14,17,18,21-23 including 451 patients 
and occurred in 51 patients (10.5%; 95% CI 3.7-20.3). All cases of laxity were 
reported with the use of Alloderm.  
 
Surgical technique. 
Recurrence and/or laxity by type of closure were adequately documented in 14 studies 
including 380 patients.11-15,17,19,27,28,30,31,32,35,37 In patients who underwent 
reinforcement, recurrence occurred in 14 out of 161 (8.1%; 95% CI 2.2-17.2). Laxity 
was observed in 9 out of 72 (9.7%; 95% CI 0.1-32.1) patients. Only three studies (75 
patients) provided the mean size of defect specifically for reinforced repairs and 
ranged 86-180 cm2.14,19,35 
In patients in whom the defect was bridged recurrence occurred in 39/219 (21.8%; 
95% CI 7.5-40.9). Laxity was reported in 28/138 (21.0%; 95% CI 14.8-28.0) patients. 
Mean size of defect could be extracted for bridging repairs in seven studies (168 
patients), with a median of 158.0 (range 147-210) cm2.12,14,17,19,27,30,32 
Of all repairs, underlay placement of the graft was the most employed technique 
(57.3%), followed by inlay (25.9%), onlay (14.7%) and ‘sandwich’ placement 
including both onlay and underlay placement of prostheses (2.1%). About a third of 
the authors (31.0%) reported the additional use of components separation technique in 
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some or all of their patients to achieve primary fascial closure. Inadequate reporting 
made it impossible to relate component separation technique or the type of anatomic 
graft position to any study outcome. 
 
Discussion 
The current systematic review evaluated postoperative morbidity and recurrence rate 
after ventral hernia repair with biologic grafts. Half of the patients suffered wound-
related morbidity. Infectious complications developed in a fifth of patients, but only 
 
Table 3 Pooled proportions of recurrence, infection and total surgical morbidity divided by wound 
class 
Complication Wound 
class 
No. of 
studies 
No. of 
patients 
Incidence % (95% CI)† Significance
Recurrence C/CC 5 213 9 2.9 (0.2－8.3)  
 C/D 7 84 22 23.1 (11.3－37.6) P < 0,0001§
 Comp.† 8 234 55 19.4 (11.4－29.0)  
 Overall 17‡ 531 86 13.8 (7.6－21.3)  
    
Infection C/CC 5 365 60 4.7 (0.1－20.6)  
 C/D 7 224 61 19.3 (6.8－36.2) P = 0.0077§
 Comp. † 10 480 118 22.3 (15.3－13.3)  
 Overall 20‡ 1109 246 15.9 (9.8－23.2)  
    
Total surgical 
morbidity 
C/CC 5 235 74 32.5 (9.2－61.9)  
 C/D 8 160 72 52.4 (23.8－80.2) P < 0.0001§
 Comp. † 12 725 437 50.3 (33.4－67.2)  
 Overall 25 1152 584 46.3 (33.3－59.6)  
 
* Weighted pooled proportion using random effects (DerSimonian-Laird) model;  
† This subgroup contains groups of patients for which the outcomes could not be stratified per 
wound class, and/or that contained cases with unclear surgical indications that were classified by the 
corresponding authors as either ‘complex’, ‘complicated’, ‘potentially contaminated’ or ‘high-risk’; 
‡ Does not add up because one or more studies were split into multiple groups 
§ Statistically significant difference using chi-square test. 
C/CC: Clean/Clean-Contaminated; C/D: Contaminated/Dirty; Comp.: Complicated 
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rarely necessitated graft removal. Overall recurrence rate was 13.8%, after a mean 
follow-up of 18 months. Recurence rate was low (2.9%) in clean and clean 
contaminated cases and increased with the extent of contamination. Nearly a quarter of 
the patients undergoing contaminated, dirty, or otherwise complicated repair 
experienced a recurrence. Overall, laxity of the repair occurred in one out of ten 
patients.  
 
Quality of studies 
The quality of evidence rates a four (recommendation grade C) according to the 
Oxford Centre for Evidence-based Medicine (CEBM) ‘Levels of Evidence’.55 The 
current findings are troubled by heterogeneity of patient and hernia characteristics 
within and between studies. Interpretation of data was troubled by uniformity in 
definitions, terminology and reporting. Classification of hernias following the  
 
 
Table 4 Pooled proportions of infection, seroma, and total surgical morbidity divided by biologic graft 
Complication Material No. of 
studies 
No. of 
patients 
Incidence % (95% CI) * 
Infection Alloderm 14 926 224 17.1 (9.3－26.7) 
 Permacol 4 64 3 6.1 (1.7－13.0) 
 Surgisis 3 101 15 14.9 (0.4－44.8) 
    
Seroma 
formation 
Alloderm 10 718 93 13.2 (8.8－18.4) 
 Permacol 2 48 3 7.6 (1.9－16.4) 
 Surgisis 2 61 19 26.0 (0.3－59.2) 
    
Total surgical 
morbidity 
Alloderm 16 947 502 46.5 (29.7－63.7) 
 Permacol 6 86 26 28.7 (17.2－41.8) 
 Surgisis 3 101 46 45.7 (36.2－55.3) 
 
* Weighted pooled proportion using random effects (DerSimonian-Laird) model 
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European Hernia Society (EHS) guidelines was not possible.56 Limited follow-up is a 
well recognized flaw in many studies. In this review a study follow-up of at least 12 
months was considered sufficient to provide a reliable outcome, realising that 
recurrence rates are underestimated and increase up to and beyond 13 years after 
repair.4,57 Despite these limitations, results of the current study are meaningful because 
a large number of patients who underwent ventral hernia repair using biologic grafts 
was included, encompassing 531 patients to determine recurrence rate and 1152 
patients for secondary outcome parameters. Also, outcome stratification by wound 
class made more homogenous groups. 
 
Postoperative morbidity 
Postoperative morbidity increased with wound class, overall occurring in nearly half of 
patients. Because of the inability to stratify surgical complications by both wound 
Figure 2 Meta-analysis (random-effects model) of proportions of recurrences of a. 
clean/clean-contaminated (I2=68.4%), b. contaminated/dirty (I2=52.9%) and c. 
‘complicated’ (I2=64.2%) ventral hernia repair with biologic grafts. The square size 
represents the weight of the study, and the horizontal line through the square represents 
the confidence interval of the effect estimate. 
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class and biologic graft, safety comparisons between different grafts are hard to 
undertake. Still, certain outcomes were surprising and deserve further attention. 
Seroma formation was the second most common postoperative complication, 
occurring in 14.2% of patients. Noteworthy is the high rate of seroma formation found 
with use of Surgisis, which is also observed after laparoscopic hernia repair.44,47 This 
may be due to delamination of the graft or an enhanced inflammatory response. Gupta 
et al. performed histological analysis on grafts explanted after significant seroma 
formation and found that they were only partially incorporated and remodelled into 
fibrocollagenous tissue, allowing seroma formation between the different 
(unincorporated) layers of the graft.18 
An exaggerated inflammatory response to small intestinal submucosa grafts was 
reported in three publications. Helton et al. observed a pronounced inflammatory 
response in 6 out of 53 patients (11%) in whom a Surgisis graft was implanted.36 Fluid 
aspiration around the graft presented a negative culture and the inflammatory response 
rapidly decreased in all patients with anti-inflammatory medication. Zheng et al 
observed transient non-infectious oedema and pain in patients treated for rotator cuff 
injury with Surgisis grafts (MH Zheng, unpublished data). Similar inflammatory 
responses were observed after implantation of small intestinal submucosa derived 
products in pubourethral sling procedures.58 Cell remnants and other immunogenic 
material, non-collagenous proteins, growth factors, and glycosaminoglycans found in 
porcine SIS may be responsible.59-61  
Infection was the most common post-operative complication and increased with the 
extent of wound contamination, with an overall rate of 15.9% (Table 3). The high 
infection rates seem to refute the claims that biologic grafts are infection-resistant due 
to their bio-compatibility and direct access of immune cells. However, the majority of 
infections were superficial and the biologic graft could nearly always be salvaged. 
Grafts were removed in only 4.9% of infected cases.  
In recent meta-analysis of incisional hernia repair with synthetic mesh, open repairs 
resulted in seroma formation in 15.5% and haemorrhagic complications in 5.9%. 
Infection not requiring mesh removal occurred in 10.1%, and infections requiring 
removal occurred in 3.5%, meaning a quarter of all infections required mesh 
removal.62 Meta-analysis of the components separation technique for ventral hernia 
repair revealed an 18.9% infection rate, contributing to an overall complication rate of 
23.8%.63 Given the current evidence, biologic grafts do not seem to result in fewer 
surgical complications than other techniques. However, biologic grafts are associated 
with a high salvage rate in cases of infection. After synthetic mesh repair, mesh 
removal is often mandatory when infection develops.  
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Figure 3 Univariate regression with recurrence rate as outcome and infection rate as
predictor (r2=0.325, P=0.011). Circles represent observed rates in the studies, and
the line represents  the linear regression. 
Figure 4 Univariate regression with recurrence rate as outcome and overall surgical
morbidity rate as predictor (r2=0.189, P=0.038). Circles represent observed rates in
the studies, and the line represents the linear regression. 
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Recurrence and laxity  
Recurrence rates were also related to the extent of wound contamination. 
Reconstruction in a contaminated field is a major indication for the use of biologic 
grafts. Surprisingly, about a quarter of repairs in the included studies were performed 
under clean or clean-contaminated conditions. In this group recurrence rate was low 
(2.9%) and similar to recurrence rates after synthetic mesh repair found in meta-
analysis.62 
The recurrence rates for the contaminated/dirty and complicated subgroups were 
23.1% and 19.4%, respectively. Despite the reluctance to use synthetic mesh in a 
contaminated environment, similar results were reported after synthetic mesh repair in 
selected contaminated and complex ventral hernia repairs including concomitant 
enterostomy closure, necrotic bowel resection, enterocutaneous fistula takedown and 
other elective bowel procedures.64-70 Recurrence rates varied between 0% and 21% and 
morbidity between 15.8% and 26%. Given these results, there are still possible 
indications for synthetic mesh use in the certain compromised wound environments. 
However, the option of a one-staged repair in grossly infected wounds still make 
biologic grafts a potential attractive alternative to two-staged repair with synthetic 
mesh. Techniques of autologous repair have been summarised and also yield similar 
results.63 Of these, the components separation technique met with wide acceptance, 
yielding an 18.2% rate of recurrence found in a meta-analysis63 and more recent 
studies showing even lower rates.71,72 In view of the current evidence, biologic grafts 
have similar results to synthetic mesh or autologous repair in either clean, 
contaminated, or complicated ventral hernia repair. 
Laxity is a common complication with use of biologic grafts, showing an overall rate 
of 10.5%. Unlike hernias which can be debilitating and coincide with risk of 
strangulation, laxity does not necessarily affect a patients functionality and it is unclear 
what effect it has on quality of life. However, its occurrence is considered a negative 
outcome.  
All reported cases of laxity in this review were related to repairs with Alloderm. The 
high elastin/collagen ratio, insufficient pre-stretching, no additional cross-linking, and 
thin and vulnerable border regions due to the dermatome harvest from human cadavers 
may all be responsible for bulging. Laxity is rarely investigated with the use of 
synthetic mesh and the prominent focus it receives in studies on biologic grafts may be 
an attention bias. However, in their study comparing human acellular dermal allograft 
(Alloderm) to polypropylene mesh repair of abdominal wall defects after TRAM flap 
harvesting, Boehmler et al. reported rates of bulging and other complications of 29% 
and 39% in the Alloderm group and 7% and 17% in the polypropylene mesh group, 
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respectively.13  
When taking laxity into account alongside reherniation, a quarter of all patients 
experienced full or partial failure of integrity of their abdominal wall reconstruction. 
 
Surgical technique 
A relevant aspect of hernia repair, whether reinforcing of bridging the defect, is the 
anatomic position of the prosthesis. Unfortunately, the data did not allow for pooled 
analysis. In individual reports it was found that interpositional (inlay) placement of the 
prostheses while bridging the defect resulted in higher recurrence rates as compared to 
methods in which an adequate overlap between the prosthesis and the adjacent fascia 
was created.16,19,24,26  
 
Costs 
A major issue surrounding biologic grafts is their high price. Depending on the choice 
of product, a 150 cm2 prosthesis costs between $2845 and $5311. In the clinic, proper 
evidence and clear indication for their use is thus paramount for the provision of not 
only effective but also efficient health-care. Claims are made by the industry that long-
term financially beneficial outcomes are to be expected with biologic grafts when 
taking into account less short- and long-term complications as compared to other 
techniques.73 These analyses are based on scant literature, and should be strengthened 
by more evidence from properly designed trials comparing the various techniques 
available. 
The current review did not compare biologic with synthetic prostheses. No RCT‘s are 
available yet that compare the results of both techniques. However, postoperative 
morbidity and recurrence rates seem to be similar between biological and synthetic 
prostheses in non-dirty fields. Considering the high costs of biologic grafts, they are 
not recommended in these situations. The use of biologic grafts results in high 
complication and recurrence rates in contaminated and dirty fields, but is associated 
with a high salvage rate of the prosthesis in cases of infection, and potentially offers a 
one-stage repair in these compromised surgical fields. Biologic grafts are not popular 
in Europe due to their high costs, and more convincing evidence of their performance 
and proper indication is awaited. FDA- reported adverse events with use of biologic 
grafts warrant caution and judicious decision-making, and they have not been 
approved for utilization in abdominal wall reconstruction in contaminated fields.74 
Studies with longer follow-up are essential to properly determine the durability of 
biologic grafts given their bio-degradable nature. 
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Summary 
Chapter 1 provides an introduction and outline of the current thesis. Chapter 2 goes 
into detail about the current background knowledge regarding the two most important 
forms of abdominal wall hernias: wound dehiscence and incisional hernia. Risk factors 
and proposed pathophysiological mechanisms are outlined. Various patient and hernia 
characteristics are important predictors in determining the chance of perioperative 
complications and hernia recurrence. The options for opening and closing the abdomen 
and for repair of hernias are discussed. The treatment algorithm used at our institution 
for the various kinds of ventral hernias is presented. 
In Chapter 3 the outcome of an international effort is presented in which consensus is 
reached regarding criteria to be used when describing the “complex (abdominal wall) 
hernia patient”. Three consensus meetings were convened by hernia experts. 
Discussion was aided by a systematic review of the literature to explore current 
classification systems and to evaluate the evidence regarding risk factors and surgical 
options. Level of Evidence (LoE) according to the Oxford Centre for Evidence Based 
Medicine (CEBM) was applied to the variables.  
Consensus was reached on 22 patient and hernia variables for "complex" hernia 
criteria inclusion which were grouped under four categories: "Size and location", 
"Contamination/soft tissue condition", "Patient history/risk factors", and "Clinical 
scenario". This framework allows for uniform description of complex hernia patients. 
The variables were further divided in three patient severity classes ('Minor', 
'Moderate', and 'Major') to provide guidance for peri-operative planning and measures, 
the risk of a complicated post-operative course, and the extent of financial costs 
associated with treatment of these hernia patients. It was concluded that the evidence 
regarding risk factors and complex hernia repair is low. However, it is important to 
first agree on hernia and patient elements that are most relevant (i.e., having 
implications for treatment and prognosis) when describing the ‘‘complex’’ hernia 
patient, rather than using non-validated classification systems, based on low-evidence 
literature, that do not take important differences into account. 
In Chapter 4 the various surgical techniques for parastomal hernia repair are reviewed 
using systematic review and meta-analysis. Study inclusion and quality evaluation was 
performed using the MINORS score. Study design, number of patients included and 
evaluated, surgical technique (open or laparoscopic, anatomical mesh position, 
keyhole, or Sugarbaker mesh technique), reinterventions, and duration of follow-up 
were extracted. Outcomes of the different techniques were compared using logistic 
regression analysis. A total of 30 studies were included in analysis, including 106 
suture repairs, 157 onlay mesh repairs, 42 sublay mesh repairs, 65 open intraperitoneal 
200 
 
mesh repairs, and 363 laparoscopic mesh repairs. Suture repair resulted in a 
significantly more recurrences compared to mesh repair, with an odds ratio (OR) of 
8.9. Recurrence rates for mesh repair ranged from 6.9% to 17% and did not differ 
statistically. In the laparoscopic repair group, the Sugarbaker technique yielded fewer 
recurrences than the keyhole technique (OR 2.3). Postoperative morbidity did not 
differ between techniques. The overall rate of mesh infections was low at 3% and 
comparable for each type of mesh repair. It was concluded that suture repair of 
parastomal hernia should be abandoned because of high recurrence rates. The use of 
mesh in parastomal hernia repair significantly reduces recurrence rates and is safe with 
a low overall rate of mesh infection. In laparoscopic repair, the Sugarbaker technique 
is superior over the keyhole technique regarding recurrences. 
Chapter 5 reviews biologic mesh use for parastomal hernia repair. All reports on repair 
of parastomal hernias using a collagen-based biologic scaffold to reinforce or bridge 
the defect were included. Outcomes were recurrence rate, mortality and morbidity. 
Four studies were included in review, with an overall recurrence rate of 15.7% and 
wound-related morbidity in 26.2% of patients. No mortality of graft infections were 
reported. It was concluded that the use of reinforcing or bridging biologic mesh for 
parastomal hernia repair results in acceptable rates of recurrence and complications. 
However, given the similar rates of recurrence and complications achieved using 
synthetic in this scenario, as is clear from Chapter 4, the evidence does not support use 
of biologic grafts. 
Chapters 6 through 8 are devoted to the Component Separation Technique (CST). 
This autologous method of large ventral hernia repair was popularized by Ramirez et 
al. in 1990.25 The key elements of the procedure are bilateral release of the external 
oblique muscle after which medial advancement of the rectus muscles is possible, and 
a release of the posterior rectus sheath to accomplish complete approximation in the 
midline. Dynamic restore of the anatomy of the abdominal wall is an advantage of 
CST over prosthetic bridging. 
Chapter 6 presents a study aimed at determining the long-term durability of the CST 
without mesh addition to repair large and complex abdominal wall hernias. Seventy-
five consecutive patients were prospectively evaluated in the out-patient clinic at least 
one year after index operation. Also, the literature pertaining to CST without mesh was 
systematically reviewed with a focus long-term outcome and modality of follow-up. 
After a mean of 40.9 months thirty-nine (38.7%) had developed a recurrent hernia, 
which was significantly higher than that found in the literature (14.4%). Sixty-four 
percent of studies in the literature were unclear about the method of determining 
recurrent hernia or included telephone follow-up and questionnaires. Studies with the 
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best follow-up regarding duration and modality form the outliers with the highest 
recurrence rates. It was concluded that CST without mesh addition results in a high 
recurrence rate when adequate follow-up methods are applied, and this technique 
should be reserved for patients in whom there is a contra-indication for synthetic mesh 
use. 
Mesh infection resulting in mesh removal is a greatly feared complication and the 
reason its use is deferred from in non-clean wound settings. However, evidence 
supporting this is either anecdotal or decades old and regards obsolete mesh materials 
and surgical technique. In Chapter 7 the safety of CST with synthetic mesh in large 
and contaminated ventral hernia repair is evaluated. In this retrospective study, 137 
records of consecutive patients were reviewed with a special focus on postoperative 
surgical site infections (SSI’s) and need for mesh explantation. Patients received a 
lightweight macroporous polypropylene based mesh. Subgroups were formed based on 
the wound contamination grade. There were 29 (21.2%) SSI’s in total. Rate of SSI 
increased with the extent of contamination with the following distribution: 4 out of 56 
(7.1%) clean repairs, 6 out of 34 (17.6%) clean-contaminated repairs, 3 out of 19 
(15.8%) contaminated repairs, and 8 out of 28 (28.6%) dirty/infected repairs. Overall, 
mesh needed to be removed in only 7 patients (5.1%), and did not seem to be related to 
the extent of contamination. It was concluded that contaminated wounds are not a 
contra-indication for synthetic mesh use, provided modern mesh materials and surgical 
technique are used, and appropriate perioperative measures are taken. The benefits of 
mesh use, reducing future recurrences and additional repairs, seem to outweigh the 
small risk of mesh infection and removal. 
In Chapter 8 the safety and durability of one-stage repair of abdominal wall defects 
with enteric fistulas is evaluated. Chart review was performed of 39 consecutive 
patients that underwent one-stage repair. Short-term outcomes included morbidity 
(wound and medical) and mortality. A prospective out-patient follow-up took place at 
least 3 years after surgery to determine long-term durability of repair. Component 
Separation Technique (CST) was used in 34 (87.2%) and synthetic mesh in 13 (33.3%) 
patients. There was one post-operative death. Twenty-five wound complications 
developed in 18 (46.2%) patients, including surgical-site infection in 8 (20.5%) 
patients. Two (5.1%) recurrent enteric fistulas developed and were treated 
conservatively resulting in closure. Medical complications were seen 36 times in 23 
(59%) patients. Twelve out of 33 (36.4%) living patients had developed a recurrent 
hernia after a mean follow-up of 62.7 months. It was concluded that one-stage 
abdominal wall reconstruction with enteric fistula takedown is feasible at the cost of 
considerable wound and medical morbidity. This study presents the longest clinical 
out-patient follow-up in these patients and shows that our surgical strategy including 
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CST with on-demand synthetic mesh results in a durable reconstruction in 6 to 7 out of 
10 patients. 
In Chapter 9 the repair of clean and contaminated ventral hernias using biologic mesh 
was evaluated. Biologic mesh consists of a collagen matrix derived from human or 
animal tissue. It has been developed as an alternative to synthetic mesh for use in non-
clean wound environments, with the potential to decrease rates of infectious 
complications and mesh removal. Systematic review and meta-analysis was performed 
to summarize study data. The methodologically quality of studies was evaluated using 
the MINORS score and data was extracted regarding patient and hernia characteristics, 
surgical technique, morbidity and reherniation. Alloderm (human cadaveric dermal 
matrix), Permacol (additionally cross-linked porcine dermis) and Surgisis (laminated 
small intestinal submucosa) grafts were used almost exclusively in the literature. 
Twenty-five retrospective studies were included. Recurrence depended on wound 
class, with an overall rate of 13.8%. The recurrence rate in contaminated/dirty repairs 
was 23.1%.  Abdominal wall laxity occurred in 10.5% of patients. The surgical 
morbidity rate was 46.3%, of which infection in 15.9% of patients. Infection led to 
graft removal in only 4.9% of cases. It was concluded that the literature is of low 
quality, but the available evidence suggests that biologic grafts seem to perform 
similarly to other surgical options, including Component Separation Technique and 
synthetic mesh repair. However, when faced with infection the graft salvage rate is 
high. 
 
General discussion 
Complex abdominal wall hernias represent a special challenge to abdominal wall 
surgeons. The term ‘complex’ is often used to describe an abdominal wall hernia for 
various reasons, including increased expected perioperative morbidity and 
necessitating a more complex abdominal wall reconstruction. However, there is no 
consensus on which variables to use when describing complex hernias. Secondary to 
this is a non-uniform reporting of hernia and hernia patient characteristics in the 
literature, making it very hard to compare outcomes between studies. A framework for 
defining complex hernia patients as is presented in Chapter 2 is a first step in 
overcoming these problems. It is essential to reach agreement on which factors make a 
hernia complex, based on its influence on the expected perioperative planning and 
work-up, technical challenge, prognosis and financial costs. A next step would be to 
create and validate treatment algorithms for the various kinds of complex hernias, 
including reliable advice on which biomaterials should be utilized. 
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Parastomal hernias constitute a special kind of incisional hernia. Its incidence will 
increase seen as more cancer patients are surviving, whereas obesity is becoming an 
endemic problem. After review and meta-analysis of the literature it was clear that 
there is need for proper randomized controlled trials comparing laparoscopic versus 
open repair, and the ‘keyhole’ versus Sugarbaker technique. The study by Hansson et 
al. confirms the Sugarbaker is a superior method of repair (Level of Evidence 2b).4 
Ostomy fashioning in the setting of complex abdominal wall defects remains a 
problem. The first results of the PREVENT trial show that there are advantages to 
prophylactic mesh placement during ostomy fashioning to prevent parastomal hernia.89 
This has also been shown recently in studies by Hauters et al. and by Serra-Aracil et 
al.90, 91 Given the small amount of problems associated with the mesh in patients with 
concomitant complex abdominal wall defects, prophylactic mesh also seems useful in 
these situations.  
The CST remains the most popular autologous method of repair for large ventral 
hernias. The technique is burdened by high wound morbidity rates, most commonly 
infection, seroma formation and skin necrosis.21 Recurrence rates after CST without 
mesh for large ventral hernias have been low in the literature, with the majority below 
10% (Chapter 6). However, most studies are unclear about their method of follow-up, 
or include telephone and postcard questionnaires. Also, many studies include patients 
with short follow-up periods, often as short as 1 month, despite having a mean follow-
up of over a year. This undoubtedly results in an underestimation, and true rates are 
probably much higher. In fact, the only randomized controlled trial evaluating CST, 
performed at the Radboud university medical center, found a 50% recurrence rate.44 It 
is well known that direct suture repair results in unacceptably high recurrence rates, 
and it is unlikely that release of the external oblique or transverse muscle aponeurosis 
solves this problem completely. Modifications of CST have been developed to reduce 
complications, mainly by minimizing subcutaneous undermining and sparing the peri-
umbilical perforators.28, 92 A posterior component separation was recently described by 
Rosen’s group, in which the transversus abdominis muscle is divided from the internal 
oblique muscle, after which a Rives-Stoppa mesh repair is performed.93 Although 
these modifications initially show promising results, comparative studies are needed to 
properly delineate their advantages. 
The placement of a mesh prosthesis probably improves long-term outcomes of large 
ventral hernia repair, as has been shown for smaller incisional hernias.94 Synthetic 
mesh placement is usually deferred from in contaminated wound environments due to 
fear of mesh infection resulting in its removal. Claims are usually based on anecdotal 
evidence. The Ventral Hernia Working Group recently published guidelines regarding 
type of mesh depending upon patient co-morbidities and contamination class.46 
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Unfortunately, the evidence they present regarding synthetic mesh use is decades old, 
or is in relation to expanded polytetrafluorethylene mesh, which is considered obsolete 
for use in a contaminated environment.95 A study evaluating the safety of synthetic 
mesh in contaminated wounds found a very low rate of mesh infection and mesh 
removal (Chapter 8). Mesh was removed in less than 5% of contaminated repairs, 
which included enterocutanous fistula takedown and infected mesh removal. 
Moreover, mesh infection and subsequent removal was distributed fairly evenly over 
the contamination classes with no obvious predilection for the higher classes. It seems 
there is need for change in the current paradigm that there is no place for synthetic 
mesh in contaminated hernia repair. The presence of enteric fistulas in the abdominal 
wall defect creates a severely contaminated situation. Possibly the most vital factor in 
attaining good results for these patients is a rigorous and protocolled patient work-up, 
an aspect of the treatment strategy that is mostly neglected in our reports and in the 
literature. Patients with open abdomens and/or enteric fistulas often have metabolical 
disturbances of fluids and electrolytes, are often malnourished with low albumin 
levels, lose a significant proportion of lean mass, may have impaired lung function, 
and often have other co-morbidities such as diabetes mellitus and impaired renal 
function further complicating the situation. Moreover, the presence of bowel contents 
outside the lumen may lead to localized abscess, soft tissue infection or even 
generalized peritonitis. The complete treatment plan necessarily involves several 
stages often spanning very long periods of time in which the patient is admitted. First, 
septic complications are treated, metabolic disturbances are corrected and the wound 
management is optimalized. Surgery is planned 3 - 12 months after the last 
laparotomy, when the patient is in the best possible state. Restoration of the 
gastrointestinal tract, and reconstruction of the abdominal wall is performed in one or 
more stages. Provided the necessary pre- and perioperative measures are taken, our 
one-stage approach including CST with synthetic mesh on-demand, at the surgeon’s 
discretion, coincides with good results comparing favorably with the literature 
(Chapter 7). None of the meshes needed removal, and only 5.1% of enteric fistulas 
recurred, responding promptly to conservative treatment resulting in closure.  
Type of material and surgical technique are also important factors in achieving good 
results in complex hernia repair. Macroporous, light-weight polypropylene mesh 
allows for easy tissue ingrowth and shows significant clearance of bacteria compared 
to heavier or multi-layered synthetic mesh.96 Placement of the mesh in a sublay 
position results in significantly fewer recurrences compared to any other position, 
whereas onlay placement increases chance of recurrence (Chapter 8). Meta-analysis of 
studies shows that the sublay technique also results in fewer surgical site infections as 
compared to the onlay technique.97 Placing the mesh in a well-vascularized envelope 
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between rectus muscle and posterior rectus sheath most likely contributes to these 
favorable results. 
 
Biologic mesh has grown to be a popular alternative to synthetic mesh over the past 
decade in the United States of America, with the potential to decrease infectious 
complications and allow for a durable one-stage repair of contaminated hernias. In 
Europe biologic grafts have not claimed a place in the treatment of contaminated 
hernias. The treatment algorithm used at our institution (Chapter 1) includes the use of 
CST and even synthetic mesh during contaminated procedures, such as colostomy 
takedown and excision and closure of enterocutaneous fistula, whereas in selected 
cases of extensive contamination in which CST does not suffice for closure a two-
staged strategy can be employed. Importantly, the cost-effectiveness of biologic mesh 
has not at all been proven, or are developed by industry and are based on selected low 
quality literature.98 Studies reporting on its use have shown acceptable results (Chapter 
3), comparable to CST without mesh. Although infection and overall wound morbidity 
rates are significant, occurring respectively in 19% and 52% of patients undergoing 
contaminated hernia repair, grafts only rarely had to be removed owing to infection. 
The recurrence rate is 23% after contaminated hernia repair which seems acceptable in 
these situations. However, the follow-up period is relatively short in these studies, 
LoE Description 
1a(-) Systematic review with homogeneity (with heterogeneity: 1a-) of prospective cohort studies.  
1b Prospective cohort study with good follow-up (>80%, adequate follow-up duration) 
1c ‘All or none’ case-series
2a(-) Systematic review with homogeneity (with heterogeneity: 2a-) of 2b and better studies 
2b Retrospective cohort study, or prospective cohort study with poor follow-up 
2c Ecological studies 
3a(-) Systematic review with homogeneity (with heterogeneity: 3a-) of 3b and better studies 
3b Non-consecutive cohort study, or very limited population 
4 Case-series or superseded reference standards
5 Expert opinion without explicit critical appraisal, or based on physiology, bench research or "first principles" 
LoE: Level of Evidence 
Table 1 Level of Evidence according to the Oxford Centre for Evidence Based Medicine
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raising the question whether these grafts can stand the test of time. This concern 
becomes all the more apparent considering their biodegradable nature. A recent study 
presenting the longest follow-up to date of contaminated ventral hernia repair using 
biologic mesh reports recurrences in over half of patients by three years.24 Although 
more studies with lengthy follow-up periods are necessary to confirm this finding, it 
would seem that biologic grafts might in fact be an expensive form of temporary 
closure in a two-staged strategy, or must eventually rely on the concomitant 
autologous repair (CST) to prevent recurrence. 
The present thesis focused on the reconstruction of various forms of complex 
abdominal wall hernias, namely parastomal hernia, large and contaminated ventral 
hernia. Figure 1 provides an updated overview of the best available treatment options, 
along with the associated best level of evidence (Table 1), provided by the studies 
performed at the Radboud university medical center and the hernia literature. 
 
 
 
 
  
 
  
Level of Evidence 1
Level of Evidence 2/3
Level of Evidence 4/5 
or
CST: Component Separation Technique;  
LoE: Level of Evidence (according to Oxfords Centre for Evidence Based Medicine) 
Figure 1 Flow-chart presenting 
the best available reconstruction 
options and associated evidence 
regarding the various complex 
hernia repair discussed in the 
current thesis. 
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Samenvatting 
Hoofdstuk 1 geeft een inleiding en schetst de hoofdlijnen van het huidige proefschrift. 
Hoofdstuk 2 beschrijft in meer detail de huidige stand van zaken omtrent de twee 
belangrijkste vormen van buikwanddefecten: wond dehiscentie en littekenbreuk. 
Risicofactoren en veronderstelde pathofysiologische mechanismen worden toegelicht. 
Verschillende eigenschappen van patiënt en hernia zijn belangrijke voorspellers voor 
het ontwikkelen perioperatieve complicaties en recidief hernia. De technieken van 
toegang tot en sluiten van het abdomen alsmede die voor herstel van 
buikwanddefecten worden beschreven. Het behandelalgoritme dat toegepast wordt 
voor de verschillende vormen van buikwanddefecten in onze instelling wordt 
gepresenteerd. 
In Hoofdstuk 3 worden de resultaten van een internationaal consensusgroep 
gepresenteerd waarin criteria zijn uitgewerkt waarmee men de “complexe hernia 
patiënt” kan beschrijven. Drie consensusbijeenkomsten vonden plaats. Discussie werd 
ondersteund door systematische review van de literatuur waarmee huidige classificatie 
systemen en wetenschappelijk bewijs over risicofactoren en chirurgische opties 
werden samengevat. Level of Evidence (LoE) gradering volgens de Oxford Centre for 
Evidence Based Medicine (CEBM) werd toegepast op de variabelen. 
Consensus werd bereikt voor 22 patiënt en hernia criteria en gegroepeerd in vier 
categorieën: “Grootte en locatie”, “Contaminatie/weke delen toestand”, “Patiënt 
voorgeschiedenis/risicofactoren” en “Klinisch scenario”. Deze indeling staat een meer 
uniforme beschrijving van de hernia populatie toe. Variabelen werden verder 
onderverdeeld in drie ‘severity classes’ (“Minor”, “Moderate” en “Major”) om een 
indicatie te geven voor de mate van perioperatieve planning, risico voor een 
gecompliceerd beloop en financiële kosten geassocieerd met de behandeling van de 
verschillende patiëntengroepen. Er werd geconcludeerd dat het bewijs betreffende 
risicofactoren en complexe hernia reconstructies summier is. Het is belangrijk om eerst 
overeenstemming te bereiken over de beschrijving van de herniapopulatie in plaats van 
gebruik te maken van niet-gevalideerde classificatiesystemen gebaseerd op literatuur 
van inferieure kwaliteit die belangrijke verschillen niet in acht nemen.  
In Hoofdstuk 4 worden de chirurgische opties voor herstel van parastomale hernias 
geëvalueerd door systematic review en meta-analyse. Studie inclusie gebeurde op 
basis van de MINORS score. Studie ontwerp, aantal patiënten en chirurgische techniek 
(open, laparoscopisch, anatomische positie mesh, keyhole of Sugarbaker techniek), 
reïnterventies en follow-up werden geëxtraheerd. Uitkomsten werden vergeleken 
middels logistische regressie analyse. Dertig studies werden geïncludeerd waarin 
reconstructies werden uitgevoerd door middel van primair sluiten in 106, onlay mesh 
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herstel in 157, sublay mesh herstel in 42, open intraperitoneaal mesh herstel in 65 en 
laparoscopische mesh herstel in 363 patiënten. Primair sluiten resulteerde in 
significant meer recidieven vergeleken met mesh herstel, met een odds ratio (OR) van 
8.9. Recidief percentages voor mesh herstel varieerde van 6.9% tot 17% zonder 
significante verschillen. In de laparscopische groep resulteerde Sugarbaker techniek in 
minder recidieven dan keyhole techniek (OR 2.3). Postoperatieve morbiditeit 
verschilde niet tussen technieken. Infectie van mesh was laag (3%) en verschilde niet 
per mesh techniek. Er werd geconcludeerd dat mesh voor herstel van parastomale 
hernias het aantal recidieven significant reduceert en een veilige optie is met lage kans 
op infectie.   
Hoofdstuk 5 evalueert het gebruik van biologische meshes voor herstel van 
parastomale hernias. Alle studies over herstel van parastomale hernias met een uit 
collageen bestaande biologische mesh voor versteviging of overbruggen van defecten 
werden geïncludeerd. Uitkomsten waren recidief, mortaliteit en morbiditeit. Uit vier 
studies kwam een recidiefpercentage van 15.7% en postoperatieve wondproblemen 
deden zich voor in 26.2%. Er was geen mortaliteit of mesh infectie. Er werd 
geconcludeerd dat biologische mesh voor herstel van parastomale hernias resulteert in 
acceptabele hernia recidief en complicatie percentages, maar gezien de gelijksoortige 
resultaten van synthetische mesh (Hoofdstuk 4) wordt het gebruik ervan hierdoor niet 
ondersteund. 
Hoofdstuk 6 tot en met 8 zijn gewijd aan de Componenten Separatie Methode (CSM). 
Deze autologe methode om grote mediane buikwanddefecten te herstellen werd 
beschreven door Ramirez et al. in 1990. Sleutelelementen zijn de bilaterale mobilisatie 
van de musculus obliquus externus en incisie en mobilisatie van de achterste 
rectusschede, waarna de rectus spier naar mediaal gebracht kan worden. Dynamisch 
herstel van de anatomie van de buikwand is een voordeel van CSM ten opzichte van 
het overbruggen van het defect met een synthetische prothese. 
Hoofdstuk 6 presenteert een studie gericht op het aantonen van de duurzaamheid van 
de CSM zonder mesh gebruik. Op de polikliniek werden 75 achtereenvolgende 
patiënten prospectief beoordeeld minimaal een jaar na operatie. De literatuur over 
CSM werd ook systematisch in kaart gebracht met aandacht voor lange termijn beloop 
en modaliteit van follow-up. Na gemiddeld 40.9 maanden ontwikkelde 39 (38.7%) 
patiënten een recidief hernia en dit was significant hoger dan in de literatuur (14.4%). 
Vierenzestig procent van studies in de literatuur waren onduidelijk over modaliteit van 
follow-up of maakte gebruik van telefonische en papieren enquêtes. Studies met de 
betrouwbaarste en langste follow-up hadden de hoogste recidiefpercentages. Er werd 
geconcludeerd dat CSM zonder gebruik van synthetische mesh resulteert in een hoge 
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recidiefpercentage als adequate follow-up wordt gehandhaafd. Deze techniek moet 
behouden worden voor patiënten bij wie een contra-indicatie bestaat voor gebruik van 
synthetische mesh.  
Geïnfecteerde mesh resulterend in verwijderen van het materiaal is een sterk gevreesde 
complicatie en de reden dat gebruik ervan wordt vermeden in niet-schone wond 
gebieden. Bewijs hiervoor is anekdotisch of is decennia oud en gebaseerd op obsolete 
materialen en chirurgische technieken. In Hoofdstuk 7 wordt de veiligheid van CSM 
met synthetische mesh voor herstel van grote gecontamineerde mediane 
buikwanddefecten geëvalueerd. In deze retrospectieve studie werden 137 patiënten 
geëvalueerd met een focus op postoperatieve wondinfecties en mesh explantatie. Er 
werd gebruik gemaakt van lichtgewicht macroporeuze polypropyleen mesh. 
Subgroepen gebaseerd op wondclassificatie werden gemaakt. Er waren in totaal 29 
(21.2%) infecties. Infectie percentage steeg bij hogere wondklasses: 4 uit 56 (7.1%) in 
schoon wondgebied, 6 uit 34 (17.6%) in schoon-gecontamineerd wondgebied, 3 uit 19 
(15.8%) in gecontamineerd wondgebied en 8 uit 28 (28.6%) in vies/geïnfecteerd 
wondgebied. De mesh prothese werd verwijderd in maar 7 patiënten (5.1%) en leek 
niet geassocieerd met wondclassificatie. Er werd geconcludeerd dat gecontamineerde 
wonden geen contra-indicatie zijn voor synthetische mesh gebruik als moderne 
materialen en chirurgische technieken worden gebruikt en adequate perioperatieve 
maatregelen worden genomen.  
In Hoofdstuk 8 wordt de veiligheid en duurzaamheid van het in één tempo (‘one-
stage’) herstellen van grote buikwanddefecten met enterocutane fisteling geëvalueerd. 
Statusonderzoek van 39 achtereenvolgende patiënten werd uitgevoerd. Korte termijn 
resultaten waren morbiditeit (wond en systemisch) en mortaliteit. Een prospectieve 
poliklinische follow-up werd uitgevoerd minimaal drie jaar na operatie om 
duurzaamheid van de reconstructie te beoordelen. CSM werd gebruikt in 34 (87.2%) 
en synthetische mesh in 13 (33.3%) patiënten. Er was een enkele postoperatieve 
mortaliteit. Vijfentwintig wondcomplicaties deden zich voor in 18 (46.2%) patiënten 
waaronder infectie in 8 (20.5%) patiënten. Twee (5.1%) recidief enterocutane fistels 
ontwikkelde en werden succesvol conservatief behandeld. Systemische complicaties 
werden 36 keer gezien in 23 (59%) patiënten. Twaalf van de 33 (36.4%) levende 
patiënten ontwikkelde een recidief buikwanddefect na een gemiddelde follow-up 
termijn van 62.7 maanden. Er werd geconcludeerd dat het in één tempo herstellen van 
grote buikwanddefecten met enterocutane fisteling haalbaar is maar gepaard gaat met 
veel morbiditeit. Deze studie presenteert de langste klinische follow-up in deze 
patiëntengroep en laat zien dat onze strategie waarbij CSM, waar nodig gecombineerd 
met synthetische mesh, resulteert in een duurzame reconstructie in 6 tot 7 uit 10 
patiënten.  
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In Hoofdstuk 9 wordt het gebruik van biologische mesh in schoon en gecontamineerd 
wondgebied geëvalueerd. Biologische mesh bestaat uit een collageen matrix afkomstig 
van menselijk of dierlijk weefsel. Het werd ontwikkeld als alternatief voor 
synthetische mesh voor gebruik in niet-schone wondomgeving om potentieel het risico 
op infectieuze complicaties en mesh explantatie te verminderen. Systematische review 
en meta-analyse werd uitgevoerd om studie data samen te vatten. De methodologische 
kwaliteit van de studies werd beoordeeld met de MINORS score. Demografische 
gegevens werden verzameld, alsmede hernia karakteristieken, chirurgische techniek, 
morbiditeit en reherniatie, Alloderm (menselijk cadaver dermale matrix), Permacol 
(ge-crosslinked porcine dermis) en Surgisis (gelamineerde dunne darm submucosa) 
protheses werden bijna uitsluiten gebruikt in de literatuur. Vijfentwintig retrospectieve 
studies werden geïncludeerd. Reherniatie was afhankelijk van wondklasse met een 
gemiddelde van 13.8%. Recidiefpercentage in gecontamineerde/geïnfecteerde 
reconstructies was 23.1%. Buikwand laxiteit deed zich voor in 10.5% van patiënten. 
Wondcomplicatie percentage was 46.3% waaronder 15.9% infecties. Infectie leidde tot 
het verwijderen van de mesh in maar 4.9% van gevallen. Er werd geconcludeerd dat de 
literatuur van lage kwaliteit is, maar het huidige bewijs suggereert dat biologische 
mesh gelijke prestaties levert ten opzichte van andere chirurgische opties, waaronder 
Componenten Separatie Methode en synthetische mesh herstel. Indien infectie optreedt 
dan kan biologische mesh vaak wél gespaard worden. 
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Beste Professor Bleichrodt, 
Ik ben nog nooit zo dankbaar geweest hoe toeval mij op de juiste plek op het juiste 
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groter wordende passie voor onderzoek aan u te danken. Uw rust, integriteit en 
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Oude en nieuwe collega’s, chirurgen, verpleegkundigen, (poli)medewerkers en 
secretaresses, 
Heel veel dank voor de fijne tijd en op belangrijke momenten hulp en steun. Jannie en 
Hans, dank voor alle hulp en geduld. 
 
Vrienden en paranimfen, 
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223 
 
Slater NJ, Knaapen L, Bokkerink WJW, Biemans MJA, Bleichrodt RP, van Goor H. 
Large contaminated ventral hernia repair using Component Separation Technique with 
synthetic mesh is safe. Submitted. 
Hupkens P, van Abeelen MHA, Schijns W, Kooloos JGM, Slater NJ, Ulrich DJO. 
Medial lower leg perforator flaps:  An anatomical study to localize and classify 
perforators of the medial lower leg. Submitted. 
Hupkens P, Hameeteman M, Westland PB, Slater NJ, Vasilic D, Ulrich DJO. Breast 
Reconstruction using the Profunda Artery Perforator Flap from the Posteromedial 
Thigh Region: Combining the Benefits of its Predecessors. Submitted. 
Hupkens P, Schijns W, Van Abeelen M, Kooloos JG, Slater NJ, Ulrich DJ. Lateral 
lower leg perforator flaps: An anatomical study to localize and classify lateral lower 
leg perforators. Microsurgery 2014. Epub ahead of print. 
Slater NJ, van Goor H, Bleichrodt RP. Large and complex ventral hernia repair using 
‘Components Separation Technique’ without mesh results in a high recurrence rate. 
Am J Surg 2014. Epub ahead of print. 
Slater NJ, Bokkerink WJW, Konijn V, Bleichrodt RP, van Goor H. Safety and 
durability of one-stage repair of abdominal wall defects with enteric fistulas. Ann Surg 
2014. Epub ahead of print. 
Slater NJ, Montgomery A, Berrevoet F, Carbonell AM, Chang A, Franklin M, 
Kercher KW, Lammers BJ, Parra-Davilla E, Roll S, Towfigh S, van Geffen E, Conze 
J, van Goor H. Criteria for definition of a complex abdominal wall hernia. Hernia 
2014; 18:7-17. 
Slater NJ, van der Kolk M, Hendriks T, van Goor H, Bleichrodt RP. Biologic grafts 
for ventral hernia repair: a systematic review. Am J Surg 2013; 205:220-230. 
Hansson BM*, Slater NJ*, van der Velden AS, Groenewoud HM, Buyne OR, de 
Hingh IH, Bleichrodt RP. Surgical techniques for parastomal hernia repair: a 
systematic review of the literature. Ann Surg 2012; 255: 685-695. 
* both authors contributed equally 
Slater NJ, Bleichrodt RP, van Goor H. Wound dehiscence and incisional hernia. 
Surgery (Oxford) 2012; 30: 282-289. 
Slater NJ, Hansson BM, Buyne OR, Hendriks T, Bleichrodt RP. Repair of parastomal 
hernias with biologic grafts: a systematic review. J Gastrointest Surg 2011;15: 1252-
1258.


   
227 
 
Nicholas Jonathan Slater werd geboren op 5 februari 1984 in Thurso, Schotland. In 
1991 verhuisde hij naar Nederland. Na het behalen van zijn HAVO diploma heeft hij 
gereisd en meerdere studies geëxploreerd: Informatica (1 jaar), Rechten (1 jaar) en 
Psychologie (Bachelor). In 2007 begon hij aan zijn studie geneeskunde aan de 
Radboud Universiteit Nijmegen welke hij in 2013 afrondde. Tijdens het tweede 
studiejaar kwam hij in contact met Prof. dr. Rob P. Bleichrodt en werd de wereld van 
complexe buikwanddefecten voor hem geopend. Het onderzoek dat toen startte 
resulteerde uiteindelijk in dit proefschrift welke hij grotendeels tijdens zijn studie en 
coschappen heeft voltooid, mede onder begeleiding van Prof. H. van Goor. Tijdens 
zijn studie heeft hij tevens gewerkt als webdeveloper en als heftruck chauffeur. Voor 
zijn wetenschappelijke prestaties won hij meerdere prijzen waaronder de faculteitsprijs 
voor beste masterscriptie en ontving hij van de Rector Magnificus de oorkonde ‘De 
Universitaire Studieprijs’ in 2012. Hij presenteerde zijn resultaten onder andere in 
New York, Orlando, Gdańsk, Barcelona, Kopenhagen en Edinburgh. Na zijn 
afstuderen heeft hij als arts-assistent een half jaar gewerkt bij de Heelkunde waarna hij 
de stap heeft gemaakt naar de Plastische en Reconstructieve chirurgie in het 
Radboudumc waar hij nu werkzaam is. 
 
